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Programmed cell death (PCD) refers to any form of cell death that is coordinated 
by the genome. PCD consists of complex molecular pathways which directly cause the 
death of a cell. The most well-known form of PCD is an animal-specific process known 
as apoptosis, of which the underlying molecular pathways are well-characterized. 
However, despite the observation that PCD occurs ubiquitously throughout the tree of 
life, little is known regarding the molecular mechanisms of PCD in non-animal systems. 
In response to a number of different environmental stressors, Chlamydomonas reinhardtii 
undergoes a form of PCD which exhibits characteristics of apoptosis, including DNA 
laddering, accumulation of reactive oxygen species, and externalization of 
phosphatidylserine. The presence of these shared features between C. reinhardtii PCD 
and apoptosis suggests that similar molecular pathways may underlie the two processes. 
Despite this, many of the genes required for apoptosis in animals appear to be absent in 
C. reinhardtii. In the present study, we first employed a large-scale, homology-based, 
bioinformatics approach to predict the gene products that contribute to C. reinhardtii 
PCD. From the list of sequences that were obtained by these methods, we selected several 
entries to study in further detail using a reverse genetic approach. We obtained C. 
reinhardtii mutant strains, each with an insertional mutation in one of the selected genes, 
from the Chlamydomonas Library Project (CLiP) and validated that the insert had been 
mapped accurately in each of the mutant strains. To determine the effects of losing any of 




inducing heat stress. First, we sought to determine if the loss of a single selected gene 
would affect the ability of cells to undergo PCD in response to stress. Second, we wanted 
to determine if the loss of one of the selected genes would alter either the timing or 
intensity of phenotypes characteristic of C. reinhardtii PCD. Our results suggest a role 
for several of the selected genes in PCD, and future studies will be aimed at further 
characterizing these roles in more detail. 
KEY WORDS:  Programmed cell death, Chlamydomonas reinhardtii, Apoptosis, 






I believe that who we are is, in large part, a product of the people that we interact 
with. Nothing is ever accomplished alone, and none of this would have been possible 
without the help from many people. Both my mom and my better half, Hannah, have 
been enormously supportive of me throughout this time, and I can't thank them enough 
for that. 
I would like to thank my advisor, Dr. Gaillard. I could not have asked for a better 
mentor, and I would not be where I am today without the unfathomable amounts of time 
and energy that she invested in me as a researcher. Starting work in her lab has been one 
of chief defining moments in my life, and I count myself fortunate to have stumbled into 
the amazing opportunity of working for her. I will very much miss her lab. 
I am very grateful also to the other faculty members in the Department of 
Biological Sciences at SHSU. In particular, my committee members, Dr. Harper and Dr. 
Choudhary, were always open and willing to answer the many questions that I have had 
throughout the years. Dr. Choudhary helped immensely with the genetic components of 
this work, and Dr. Harper was incredibly patient as he walked me through the statistical 
aspects. Additionally, I would also like to thank Dr. Harper and Dr. Bobby LaRue for 
allowing us to use their instruments for DNA quantification. 
Finally, I would like to thank our funding sources. The Department of Biological 
Sciences and the Joey Harrison award funded this research. The College of Science and 








TABLE OF CONTENTS....................................................................................................vi 
LIST OF TABLES..............................................................................................................ix 
LIST OF FIGURES.............................................................................................................x 
CHAPTER I:   INTRODUCTION TO PROGRAMMED CELL DEATH ...................... 1 
A Brief History and Overview of Programmed Cell Death ........................................ 1 
Functional Aspects of PCD Under Normal Conditions ............................................... 2 
PCD as a Response to Stress ....................................................................................... 7 
Molecular Mechanisms of PCD ................................................................................... 9 
Uncertainty in the Conservation of PCD ................................................................... 22 
On a Potential Conservation of PCD ......................................................................... 25 
A Case for the Characterization of PCD in Unicellular Organisms .......................... 30 
Chlamydomonas reinhardtii and Programmed Cell Death ....................................... 31 
Objectives .................................................................................................................. 35 
Significance ............................................................................................................... 36 
CHAPTER II:   PREDICTION OF PCD GENES IN CHLAMYDOMONAS 
REINHARDTII ....................................................................................... 39 
Introduction ................................................................................................................ 39 
Materials and Methods .............................................................................................. 44 




CHAPTER III:   SELECTION AND VERIFICATION OF C. REINHARDTII 
MUTANT STRAINS ............................................................................. 94 
Introduction ................................................................................................................ 94 
Materials and Methods .............................................................................................. 96 
Results and Discussion ............................................................................................ 105 
Summary .................................................................................................................. 127 
CHAPTER IV:   ASSESSMENT OF PCD PHENOTYPES IN MUTANT STRAINS 
OF C. REINHARDTII .......................................................................... 129 
Introduction .............................................................................................................. 129 
Materials and Methods ............................................................................................ 134 
Results and Discussion ............................................................................................ 144 
Summary .................................................................................................................. 167 
CHAPTER V:   PROJECT SUMMARY, STUDY LIMITATIONS, AND FUTURE 
STUDIES ............................................................................................. 173 
Project Summary ..................................................................................................... 173 
Limitations and Future Studies ................................................................................ 175 
Concluding Remarks ............................................................................................... 197 
 References .…………………………………………………………………………… 199 
Appendix A …………………………………………………………………………… 235 
Appendix B .…………………………………………………………………………... 240 
Appendix C …………………………………………………………………………… 244 
Appendix D …………………………………………………………………………… 249 
 
viii 
Appendix E …………………………………………………………………………… 257 
Appendix F …………………………………………………………………………… 277 
 
ix 
LIST OF TABLES 
Table                                                                                                                              Page 
1 Molecular contributors to PCD in Budding Yeast ................................................ 18 
2 Stress-induced PCD in C. reinhardtii and the resulting features .......................... 33 
3 Putative molecular contributors to PCD in Chlamydomonas reinhardtii ............. 34 
4 Gene Ontology annotations assigned to the C. reinhardtii predicted PCD 
proteins .................................................................................................................. 52 
5 Predicted contributors to C. reinhardtii PCD ....................................................... 59 
6 C. reinhardtii proteins selected for further study .................................................. 93 
7 Insertional characteristics of C. reinhardtii strains with a mutation in the 
selected genes........................................................................................................ 97 
8 Cassette and genomic primers used for verification of the mutant strains. .......... 99 
9 PCR conditions for amplification of insertional loci and cassette-genome 
junctions .............................................................................................................. 101 
10 Summary of results obtained during verification of mutant strains. ................... 128 
11 Comparison of PCD features in each mutant strain to the parent WT strain. ..... 168 
 
x 
LIST OF FIGURES 
 Figure     Page 
1 Cellular integration of stress and other signals determines cell fate ........................... 8 
2 Example of the hierarchal classification system in Gene Ontology .......................... 42 
3 Overview of the methods used to predict and characterize C. reinhardtii proteins 
which participate in PCD ........................................................................................... 45 
4 Composition of the Custom PCD Database ............................................................... 49 
5 Percent identities of the filtered BLASTp alignments between the C. reinhardtii 
proteome and the PCD database ................................................................................ 51 
6 Frequencies of GO terms assigned to the C. reinhardtii dataset ............................... 53 
7 Overlap of annotations from the three GO categories assigned to the C. 
reinhardtii dataset ...................................................................................................... 54 
8 Distribution of annotation levels from each of the three GO categories assigned 
to the C. reinhardtii dataset ....................................................................................... 55 
9 Distribution of the most abundant GO terms from each category assigned to the 
C. reinhardtii dataset ................................................................................................. 57 
10 Alignment and annotation of the BI-1 proteins from C. reinhardtii, plants, 
humans, and yeast ...................................................................................................... 69 
11 Alignment and annotation of the IRE-1 proteins from C. reinhardtii, plants, 
humans, and yeast ...................................................................................................... 73 
12 Alignment and annotation of the E2F proteins from C. reinhardtii and humans ...... 78 
13 Alignment and annotation of the E2F proteins from C. reinhardtii and plants ......... 79 
 
xi 
14 Alignment and annotation of the TAT-D proteins from C. reinhardtii, plants, 
yeast, and humans ...................................................................................................... 83 
15 Alignment and annotation of the LSD-1 homologs from C. reinhardtii and plants .. 88 
16 Alignment and annotation of the PIG3 proteins from C. reinhardtii, humans, and 
plants .......................................................................................................................... 91 
17 CIB1 Cassette with C1 and C2 Primer binding sites shown. .................................. 107 
18 The effect of cassette orientation on the cassette primer positioning and 
elongation direction ................................................................................................. 108 
19 The effect of cassette orientation on the binding sites and elongation direction of 
the suggested genomic primers ................................................................................ 109 
20 Visualization of the components of the two cassette-genome amplicons ............... 110 
21 Verification of the bi-1 mutant strain. ..................................................................... 113 
22 Verification of the ire-1 mutant strain. .................................................................... 115 
23 Verification of the e2f mutant strain. ....................................................................... 118 
24 Verification of the tat-d mutant strain. .................................................................... 121 
25 Verification of the lsd-1 mutant strain. .................................................................... 124 
26 Verification of the pig3 mutant strain. ..................................................................... 126 
27 Morphologies of the C. reinhardtii strains utilized in this study ............................. 147 
28 Growth curves of the bi-1, ire-1, and pig3 mutant strains and parent WT strain .... 149 
29 Stress-induced loss of metabolic activity in the bi-1, ire-1, and pig3 mutant 
strains compared to the parent WT strain ................................................................ 151 
30 Loss of plasma membrane integrity in the bi-1, ire-1, and pig3 mutant strains 
and parent WT strain during PCD ........................................................................... 154 
 
xii 
31 Phosphatidylserine externalization in the bi-1, ire-1, and pig3 mutant strains 
compared to the parent WT strain during PCD ....................................................... 158 
32 ROS accumulation in the bi-1, ire-1, and pig3 mutant strains compared to the 
WT strain during PCD ............................................................................................. 162 
33 Relative growth area of the bi-1, ire-1, and pig3 mutant strains during PCD ......... 164 







Introduction to Programmed Cell Death 
A Brief History and Overview of Programmed Cell Death 
Programmed cell death (PCD) can be defined as any form of cell death that is 
initiated and mediated by the cell’s own genome. During PCD, a series of tightly 
controlled and energy-dependent molecular events directly results in the death of the 
cell.1 PCD is distinct from accidental cell death (ACD), which is not a biological process, 
and hence is not coded for by the genome.2 Rather, ACD nearly always comes about as a 
result of an intense and rapid-onset physical or environmental stressor. The primary 
distinction between these two broad categories of cell death is, while ACD occurs 
passively, PCD is an active process which requires the input and expenditure of energy to 
carry out.2 
The term programmed cell death was introduced in 1964 and was first used to 
describe a phenomenon observed during the development of the silkmoth musculature.3 
The process was described as a “programmed” death, due to the ability of the researchers 
to predict which cells would die, and when, during the developmental process. Prior to 
the coinage of this term, researchers had observed that individual cells of multicellular 
organisms often die during normal physiological processes.4 However, it wasn’t until 
1972 that a clear case was made for the existence of PCD as a form of death distinct from 
necrosis, which was, at the time, defined as the unintended death of the cell that is 
brought about as the result of injury.5,6 Subsequent genetic-based studies in the nematode 




genes, coded for by the cell’s own genome, were responsible for the death of certain cells 
at specific times during development.7–9  
In recent years, the scope of organisms which have been utilized for PCD studies 
has increased dramatically. Studies in PCD have been, and are currently being, conducted 
in a wide variety of organisms, including mammals, fruit flies, plants, yeast, and even 
bacteria. The understanding of the molecular and cellular basis for PCD processes has 
had an extraordinary impact on mankind’s understanding of development, homeostasis, 
cellular communication, and human disease.  
Functional Aspects of PCD Under Normal Conditions 
Though the concept of a genetically-coded “suicide” program superficially seems 
paradoxical, PCD is an essential and regularly-occurring component of life.  
Multicellular Organisms Currently, PCD is best understood in the context of 
multicellular organisms. In such systems, PCD is an essential and regularly-occurring 
process which plays critical roles in the normal development and homeostasis of the 
organism. Dysregulation of the ability to undergo PCD is a major contributor to a number 
of human diseases, including cancer10, Alzheimer’s disease11, and Parkinson’s disease12. 
During development, PCD occurs both in gametes and the developing embryo13. 
In germline cells, PCD is induced when deleterious mutations accumulate or when DNA 
damage is induced. In this way, PCD functions to protect the integrity of the genome by 
preventing a genetically-compromised gamete from passing on unfavorable traits to the 
organism's offspring.13,14 During animal embryonic development, certain cells are “pre-
determined” to die at specific times. In this context, PCD facilitates the formation and 




unnecessary physical features, such as vestigial interdigital webbing and sex-specific 
structures.15,16 Similarly to animals, PCD also plays a vital role in the proper development 
of plant-specific structures, such as the root cap and xylem tracheary elements.17 
For maturing and post-developmental multicellular organisms, PCD is one of the 
primary means by which tissue homeostasis is maintained.18 In rapidly-renewing tissues, 
such as the skin, hematopoietic system, and lining of the intestine, the deletion and 
replacement of specific differentiated cell types is a continually-ongoing process. This 
controlled cell turnover serves several purposes, including the maintenance of tissue size 
and shape, the elimination of aged or damaged cells, and the removal of cell types which 
frequently come into contact with the outside environment, as such cells have an 
inherently higher basal mutation rate relative to other cell types.18 
Unicellular Organisms Though best understood in the context of multicellular 
organisms, PCD is also known to be a regularly-occurring process in unicellular 
organisms. For many years, the role of PCD in unicellular organisms has been unclear. In 
the context of multicellular organisms, the purpose of PCD is somewhat intuitive: the 
death of specific cells, under certain conditions, benefits the organism as a whole. In 
other words, cellular PCD programs were likely selected for their ability to increase the 
fitness potential of the organism. The observation that unicellular organisms can undergo 
PCD is inconsistent with this notion. In the case of unicellular organisms, the cell 
comprises the organism. Consequently, the death of the cell is also the death of the 
organism and thus could not increase the organism's reproductive fitness. Why then, 
would such a seemingly detrimental program be maintained in unicellular organisms? 




for PCD in unicellular organisms is that, in such systems, PCD acts at the population, 
rather than the organismal, level.19  
To understand the phenomenon of unicellular PCD and how it relates to the 
community as a whole, it is first necessary to briefly review intercellular communication 
in unicellular organisms. The processes by which unicellular organisms sense and 
respond to changes in cell density are referred to as quorum sensing (QS). Although QS 
mechanisms have been characterized primarily in bacteria, similar density-sensing 
mechanisms have been observed in unicellular eukaryotes as well.20  Unicellular 
organisms utilize these signaling systems to synchronize gene expression and, at least to 
some degree, act as a multicellular entity.21 The existence of these social behaviors in 
unicellular organisms, in conjunction with the observation that the death of some cells 
benefits surrounding kin, has led to the notion that unicellular PCD acts at a level above 
the organismal level.22 
Indeed, a compelling justification has been presented to support the hypothesis 
that PCD in unicellular organisms functions at the population level. In sporulating 
bacteria, such as Bacillus and Clostridium, a subgroup of the population forms 
endospores in response to nutrient depletion.23,24 During sporulation, cell division 
produces both a prespore, which will eventually develop into the mature endospore, and a 
mother cell, within which the prespore resides during the maturation process. Following 
the maturation of the prespore into the endospore, the mother cell undergoes autolysis, 
and the mature spore is released from the corpse of the mother cell.19 
In response to low nutrient abundance, the gram-negative soil bacterium 




body25. Within the fruiting body, M. xanthus cells differentiate into one of three cell 
types: 10% of the population form spores, 30% of the population differentiate into rods, 
and the remaining cells, localize to space between the spore-forming cells and the 
peripheral rod cells. Each cell type has a defined role within the fruiting body. The cells 
which sporulate will, at the completion of sporogenesis, become spores that are highly 
resistant to a number of extracellular conditions. The spores are located at the top of the 
fruiting body and are dispersed from the into the surrounding area, in search of a 
favorable growth environment. Cells which have differentiated into rods localize to the 
periphery of the assembly and act as physical supports for the growing structure. The 
undifferentiated cells exist between the peripheral rod cells and the innermost sporulating 
cells, and undergo autolytic PCD, supplying the adjacent cells with a source of 
nutrients.26,27 
The life cycle of the eukaryote Dictyostelium discoideum bears many similarities 
to that of M. xanthus, in that individual D. discoideum cells amass to form a multicellular 
fruiting body in response to nutrient starvation.28 Moreover, the formation of D. 
discoideum fruiting bodies is dependent on a subpopulation of cells undergoing PCD.29 
During the initial stages of fruiting body formation, individual D. discoideum cells 
aggregate to form a multi-cellular mound, referred to as a slug.29 Cells within the slug 
differentiate into two broad cell types: prestalk cells and prespore cells.28 Once integrated 
into the slug, differentiated cells localize to specific locations of the structure in 
preparation of fruiting body formation. Pre-stalk cells migrate to the front of the 
structure, while pre-spore cells assemble the rear.28 During the transitionary stages 




the formation of intracellular vacuoles. This enlargement serves to elevate the prespore 
cells at the top of the fruiting body, allowing for an increased area of spore dispersal. In 
addition, cells comprising the stalk contribute to the overall stability of the structure by 
secreting a cellulose coat which is integrated into both the extracellular matrices of 
individual cells and to the periphery of the stalk.30 Approximately 20% of the cells of the 
fruiting body die as during this process. 
Controlled cell death and lysis also play crucial roles in maintaining the integrity 
and homeostasis of biofilms.19 Biofilms are complex biological communities which form 
on a solid surface, and are comprised of microorganisms and a matrix of biomolecules, 
called extracellular polymeric substances (EPS).31  The EPS is produced by the cells 
comprising this structure, and consists of proteins, polysaccharides, and extracellular 
DNA (eDNA). The incorporation of eDNA into the biofilm is facilitated by QS signals, 
through which the death and lysis of some cells is achieved.32,33  eDNA contributes to the 
overall stability of the biofilm by stably binding to other EPS polymers in the matrix.34 
Furthermore, eDNA aids in the adhesion of cells to one another, as well as to the solid 
surface.32,33,35 Following the primary attachment of cells to a solid surface, the affixed 
microorganisms initialize the production of EPS components, allowing the integration of 
other cells into the growing biofilm. In addition to contributing the release of eDNA to 
growing biofilms, PCD may also play roles in established biofilms by providing a source 
of nutrients under starvation.31 Moreover, the death of some members of the mature 
biofilm allows for the detachment of other members into the area. This mechanism of 
severance facilitates the dispersal of cells into the surrounding environment, providing 




Cumulatively, these examples provide evidence supporting the hypothesis that 
PCD in unicellular organisms acts at the population, rather than the organismal, level. 
That the death of individual cells can, in some instances, provide a benefit to surrounding 
cells remains uncontested. However, whether the death of some cells in a unicellular 
community is truly an altruistic death is a matter of debate.27 For example, in the case of 
fruiting body formation in M. xanthus, it has been proposed that the cells which undergo 
autolysis are induced to do so by neighboring cells.27 Indeed, a precedence for such 
behaviors has been established, as other examples of inter-cellular “self-killing” have 
been documented in bacteria. For example, during the early stages of sporulation in B. 
subtilis, the sporulating cells produce extracellular substances which induce PCD in 
neighboring non-sporulating cells.36 Cannibalization of these dead cells provides a source 
of nutrients to the mother cell, which may be sufficient to reverse the process of 
sporulation.36 Another example of self-killing is a phenomenon observed in 
Streptococcus pneumoniae known as fratricide, in which competent cells induce the death 
of nearby non-competent sister cells in order to take up the released DNA and integrate it 
into their own genome via recombination.37 Thus, at least in some in instances of 
unicellular PCD, the death of the cell is induced by neighboring cells. As such, in the 
population sense, it is not entirely clear whether unicellular PCD came to be as the result 
of intraspecies competition or as an endogenous system of altruism.  
PCD as a Response to Stress 
In addition to occurring under normal conditions, PCD is also a cellular response 
to “emergency” situations, such as stress. Under such conditions, the cell detects the 




(Figure 1). Common external sources of PCD-inducing stress include osmotic stress, high 
or low temperatures, UV light, anoxia, pathogens, and various chemicals/compounds.38–42 
Internal sources of PCD-inducing stresses include oxidative stress, DNA damage, and the 
unfolded protein response (UPR).43–45  
 
Figure 1. Cellular integration of stress and other signals determines cell fate. Figure was, 
in part, from Reape and McCabe46 and Galluzzi et. al47. 
 
As mentioned previously, the primary characteristic that distinguished PCD from 
ACD is that PCD is a genetically-encoded process. At the onset of a mild to moderate 
stress event, both pro-death and pro-survival genes are upregulated and/or activated. This 
activation of confounding pathways primes the cell to quickly initiate pathways which 
lead to either survival or cell death.48 Thus, stress-induced PCD is brought about as the 
result of pro-death signaling pathways prevailing over pro-survival pathways.48 Here, it 
should be reiterated that the activation of these pathways is demonstrative of PCD as an 
active and energy-dependent process. It should also be noted that while extreme stresses 
do induce cell death, the death is passive and occurs as a direct result of the stressor itself 
rather than as a consequence of genetically-encoded molecular pathways.48 It is by this 
distinguishing feature that the death of a cell can be determined as PCD or ACD in 


































Molecular Mechanisms of PCD 
In the following paragraphs, a brief overview of the PCD field as it stands today 
will be presented. In particular, the primary molecular mechanisms by which stress-
induced PCD is initiated and executed within the cell will be summarized, and an 
emphasis will be placed on highlighting both the shared and unique features of PCD 
programs in phylogenetically-diverse organisms. 
Animals By far, PCD has been most well-characterized in mammals, primarily 
due to the immediate applicability of mammalian PCD to medicine. The most well-
studied form of PCD in any system is a process termed apoptosis.15 Apoptosis can 
proceed along either an extrinsic or intrinsic pathway.49 The extrinsic apoptotic pathway 
is activated by the binding of extracellular ligands to the ectodomains of cell surface 
death receptors, which then pass the signal to the cell’s interior, activating the 
intracellular apoptotic pathways. The intrinsic pathway of apoptosis is activated by 
intracellular signaling which occurs in response to an internal stress signal, such as 
hypoxia, ER stress, DNA damage, or the accumulation of reactive oxygen species (ROS).  
Members of the B cell lymphoma 2 (BCL-2) family play a core role in the 
regulation of apoptosis. BCL-2 family proteins are divided into three classes, depending 
on the combination of BCL-2 homology (BH) domains that each possesses.50 The first 
group of BCL-2 proteins is the pro-apoptotic effectors BAX, BAK, and BOK, which 
contain BH1, BH2, and BH3 domains. The second group, the pro-apoptotic BH3-only 
proteins, is comprised of BID, BIM, BAD, BCL-2-interacting killer (BIK), BCL-2 
modifying factor (BMF), BCL-2– adenovirus E1B 19 kDa-interacting protein 3 (BNIP3), 




apoptotic proteins, which contain BH1, BH2, BH3, and BH4 domains. These include 
BCL-2, BCL-XL, BCL-W, and MCL1.50 
While the molecular events involving the BCL-2 family members have yet to be 
fully elucidated, the activities of these proteins appear to centralize around the 
oligermization of the pro-apoptotic BCL-2 effector proteins within the outer 
mitochondrial membrane.50 The BH3-only proteins appear to be the primary regulators of 
this process and act by either blocking the inhibitory actions of the anti-apoptotic BCL-2 
proteins, or by enhancing the functions of the BCL-2 effector proteins.50 
Regardless of whether the apoptotic process is initiated along the extrinsic or 
intrinsic pathway, the end result is the same in both cases: the recruitment of BH3-only 
proteins results in the activation of BCL-2 effector proteins, which translocate to the 
mitochondrion and form a pore in the outer membrane called the mitochondrial 
permeability transition pore (MPTP). The formation of the MPTP results in the loss of 
mitochondrial outer membrane potential (MOMP) and the release of contents from the 
mitochondrial intermembrane space (IMS).51 
The formation of the MPTP represents a crucial step in the apoptotic process 
which is colloquially referred to as the “point of no return”. Prior to the loss of MMP, the 
death process is considered to be reversible, either by endogenous signaling pathways or 
pharmacological intervention.48 Following the formation of the MPTP, however, the cell 
is irrevocably committed to carrying out the PCD program. The MPTP brings about the 
death of the cell by two primary mechanisms.51 First, the MPTP directly disrupts energy-
producing processes carried out by the mitochondrion, resulting in the cessation of ATP 




results in the activation of pathways which lead to the disassembly and degradation of 
intracellular components.48  
 The most established apoptotic factor released from the mitochondrion is 
cytochrome c, which binds and activates cytosolic APAF-1.51 Activated APAF-1 
monomers homopolymerize to form a complex called the apoptosome. Formation of the 
apoptosome leads to the activation of caspase 9, which then cleaves and activates 
procaspases 3 and 7, which then proceed to activate other executioners of the apoptotic 
program.49  
The formation of the mitochondrial pore also results in the release of other 
proteins that are crucial to the execution phase of the apoptotic process: apoptosis-
inducing factor (AIF), endonuclease G (endoG), high-temperature requirement 2 
(HtrA2/Omi), and second mitochondria-derived activator of caspase/direct IAP binding 
protein with a low pI (Smac/DIABLO). Following its release from the mitochondrial 
intermembrane space into the cytosol, AIF translocates to the nucleus, where it is 
believed to mediate chromatin condensation and genomic fragmentation.52,53 Upon the 
loss of mitochondrial membrane potential, endoG translocates to the nucleus, where it 
carries out its endonuclease activity and creates nucleosomal fragments by cleaving 
chromatin DNA.54 Finally, HtrA2/Omi and Smac/DIABLO obstruct the anti-apoptotic 
process by binding and inhibiting the inhibitor of apoptosis (IAP) family members, which 
would normally function to impede the apoptotic functions of caspase-3 and caspase-9.51 
The transcription factor p53, perhaps the most renowned participant in the 
apoptotic process, is highly active during the initiation and execution stages of both the 




expressed at constant levels. The inactive form is present in the cytosol, bound to its 
negative regulator, MDM2. At the onset of stress, MDM2 is ubiquinated, tagging it for 
destruction by the proteasome. With its inhibitor destroyed, p53 rapidly accumulates 
within the cytoplasm. Following activation by post-translational modifications, p53 is 
translocated to the nucleus, where it stimulates the transcription of a number of different 
genes. First, p53 activates stress-related genes in an attempt to cope with the stress.56 If 
the cell succumbs to the stress, p53 activates pro-apoptotic genes to execute apoptosis.51  
Cells which have undergone apoptosis exhibit a number of characteristics which 
distinguish them from non-apoptotic cells. As such, these phenotypes are useful in the 
detection of cells that have undergone apoptosis. These phenotypic changes include, but 
are not limited to, cell shrinkage57, nuclear condensation58, DNA fragmentation59, a 
change in the mitochondrial membrane potential (MMP)60, the rapid accumulation of 
reactive oxygen species (ROS)61, and the externalization of the phospholipid 
phosphatidylserine (PS) to the outer leaflet of the cytoplasmic membrane62.  
Though the current understanding of PCD has come primarily from studying the 
apoptotic process, multiple forms of PCD have been documented in animals.22 In recent 
years, numerous examples of these so-called “alternative” PCD types have been 
identified. These include necroptosis63,64, pyroptosis65, ferroptosis66, and autophagic 
death67, to name a few. Each variant of PCD appears to rely on a different set of 
molecular pathways, resulting in features that can sometimes be used to distinguish 
between PCD phenotypes.  
Plants During PCD, plant cells exhibit many of the of the characteristics of 




condensation, phosphatidylserine externalization, DNA laddering, TUNEL-positive 
nuclei, mitochondrial permeabilization and depolarization, and delocalization of 
cytochrome c from the mitochondrion.68 Importantly, however, while apoptotic cells 
display all of these phenotypes and others, whether a plant cell displays any or all of 
these features during PCD is dependent on the cell type, as well as the nature, intensity, 
and duration of the stressor.68 Furthermore, as is the case with animal cells, plant cells 
similarly appear to have the capacity to undergo multiple and distinct forms of PCD, each 
of which results in a different combination of detectable phenotypes. Several schemes 
have been proposed for classifying the various subroutines of plant cell death, but a 
single standardized method of categorizing plant PCD has yet to be adopted by the plant 
PCD community.69–72  
The molecular basis for PCD in plant cells is still somewhat of an enigma. 
Though efforts made by researchers in recent years have revealed much of the molecular 
mechanisms of plant PCD, an incomplete picture of the process remains.68 Many of the 
proteins known to be essential for animal PCD appear to be absent in plants, at least by 
available computational models that predict protein function based on primary 
sequence.68 This presents the possibility that the pathways underlying plant PCD may 
have diverged substantially from apoptosis. Despite this, many continue to argue for the 
existence of apoptosis in plants.68 
The current evidence indicates that plants do not possess caspases, which are key 
players in the mammalian apoptotic mechanism. Plants do possess metacaspases, which, 
though evolutionarily related to caspases, do not cleave at the same peptide sequence. 




debate amongst experts.73,74 While there is evidence to suggest that metacaspases do 
participate in plant PCD, the exact role that these proteins play in vivo has not been well 
characterized.75 Of note, one protein, tudor staphylococcal nuclease (TSN), has been 
identified as a conserved substrate between caspase-3 and metacaspase II during animal 
and plant PCD, respectively.76  
Though plants presumably lack “true” caspases, plant genomes do appear to 
contain genes which code for products with caspase-like activity, meaning that the 
sequence cleaved by a caspase in animal cells is targeted by some other enzyme in plant 
cells. Furthermore, many of these putative caspase-like proteins have been implicated to 
play roles in plant PCD, though the majority of their proteolytic targets in vivo are largely 
unknown.77  
In addition to the apparent absence of caspases, plants also do not possess BCL-2 
family members, another family of proteins that are instrumental in regulating the 
apoptotic process. Interestingly, however, is that BCL-2-associated anthogene (BAG) 
proteins have been identified in plants.78,79 As in animal cells, BAG proteins act as co-
chaperones for Hsp70 and act to suppress cell death in plant cells.80 It has been argued 
that the occurrence of the conservation of proteins which interact with BCL-2 family 
members in a non-animal lineage is suggestive of a conserved PCD program between 
plants and animals.  
As plant PCD is accompanied by changes in mitochondrial morphology, loss of 
MMP, and the subsequent release of cytochrome c, the mitochondrion is also thought to 
play a role in plant PCD.81 Further evidence for this role was demonstrated in a study 




This resulted in nuclear alterations that are typical of PCD, including DNA laddering, 
high molecular weight fragmentation of DNA, and chromatin condensation, whereas the 
addition of purified cytochrome c had no noticeable effect on these features. The authors 
originally postulated that a Mg+-dependent nuclease residing in the intermembrane space 
of the mitochondrion was the causative agent of the observed high molecular weight 
cleavage and chromatin condensation, though it has more recently been proposed that the 
dependency of this effect on the co-addition of cytosolic extract with the damaged 
mitochondria suggests that additional players are likely required.81 
While comparisons between plant and animal cell death, in an attempt to parallel 
the two processes, are commonplace, it is indisputable that two organelles, which are 
absent in animals, participate in plant PCD. The first such organelle is the vacuole. The 
vacuole is believed to have evolved as a way for plants to combat infection by pathogens 
in the absence of a dedicated immune system.83 Vacuole-mediated PCD can proceed by 
either a destructive or nondestructive route.72 During the non-destructive variant, the 
vacuole fuses with the plasma membrane, and is dependent on the caspase-1-like activity 
of the proteasomal subunit PBA1. This fusion causes the discharge of vacuolar contents 
into the extracellular space, resulting in the indirect death of the cell, though the exact 
mechanisms of how the death of the cell is brought about have not yet been described.72 
This extracellular release of enzymes is believed to have evolved as a means of attacking 
bacterial cells which, in plants, do not enter the cells themselves, but instead proliferate in 
the extracellular space.84 The destructive subtype of vacuole-mediated PCD is 
characterized by the intracellular collapse of the vacuolar membrane, which results in the 




the cytoplasm.85 This mechanism is believed to have evolved as a way of combatting 
viral infection, as viruses must enter the plant cell in order to reproduce. The intracellular 
release of hydrolytic enzymes serves to eliminate viral material in an attempt to prevent 
the virus from spreading to nearby cells. One consequence of the vacuolar membrane 
collapse is the degradation of intracellular components, leading to the death of the cell. 
The other, and perhaps more obvious, plant-specific organelle involved in PCD is 
the chloroplast. In animals, the primary source of reactive oxygen species during normal 
metabolism is the mitochondrion. While plants do have functional mitochondria, the 
chloroplast serves as the primary producer of ROS in plants.86 The chloroplast generates 
large quantities of ROS by two metabolic pathways: the photosynthetic pathway and the 
chlorophyll synthesis pathway.86 The photosynthetic pathways take place in the thylakoid 
membranes of the chloroplast via the reaction centers Photosystem I (PSI) and 
Photosystem II (PSII). PSI is necessary for the light-dependent generation of superoxide 
radicals (O2-), which are then utilized to generate H2O2. PSII is involved in the generation 
of singlet oxygen (1O2).86 Consistent with the hypothesis that chloroplast-produced ROS 
contributes to plant PCD, the absence of light prevents the accumulation of H2O2 in the 
chloroplast and dramatically slows the rate of PCD in Nicotiana tabacum leaves.87 The 
opposite effect is seen during exposure to intense light, which can induce PCD in plants 
by the surplus of ROS produced by overactive photosynthetic machinery.88 Another 
significant source of ROS that originates from the chloroplasts are the intermediates of 





In addition to being a significant producer of ROS, the chloroplast is thought to 
play roles in plant PCD which may exist independently of its function in ROS generation. 
In a mechanism which highly resembles the release of cytochrome c from the 
mitochondrion, cytochrome f has been documented to be released from the thylakoid 
membranes of the chloroplast into the cytosol during plant PCD.90–92 The similarity 
between these two processes has led to the hypothesis that the cytochrome f may play a 
role similar to cytochrome c during plant PCD. Further support for this hypothesis was 
established when purified cytochrome f was demonstrated to induce DNA laddering and 
caspase-3-like activity.90 
Unicellular Organisms  
Eukaryotes In unicellular eukaryotes, PCD has been most-thoroughly studied in 
the budding yeast Saccharomyces cerevisiae. Yeast cells have been observed to undergo 
PCD in response to a number of different environmental stressors, including H2O2, acetic 
acid, ethanol, osmotic pressure, UV irradiation, heat, exposure to heavy metals, and 
various chemical treatments.93,94  
Yeast cells undergoing PCD exhibit a number of phenotypes which are associated 
with PCD in animals. These features include chromatin condensation, accumulation of 
ROS, externalization of phosphatidylserine, loss of plasma membrane integrity, loss of 
mitochondrial membrane potential, and the formation of the mitochondrial outer 
membrane pore.95 DNA degradation can be visualized during PCD in S. cerevisiae cells 
by TUNEL staining. Interestingly, DNA laddering is not observed when genomic DNA 
from PCD cells is run on a agarose gel; rather, a distinct “smear” is commonly noted.96–98 




detail, it has been proposed that the absence of DNA laddering can be attributed to the 
chromatin structure of S. cerevisiae, as little to no linker regions exist between 
nucleosomes in this organism.99  
The molecular basis for PCD in S. cerevisiae has been characterized in some 
detail, though much is still to be learned.95 Several orthologs of PCD participants from 
other phyla have been identified in yeast ( 
Table 1). Notably, several of the key players in apoptosis, such as p53, MDM2, 
BCL-2 family members, and caspases, do not appear to be present in yeast. Of note, 
however, is that several S. cerevisiae proteins with putative caspase-like activity have 
been described. Also worth noting is the presence of a single metacaspase in S. 
cerevisiae. 
Table 1 
Molecular contributors to PCD in Budding Yeast 
Yeast Protein Orthologs Functions in S. cerevisiae PCD 
Nma111 HtrA2/Omi Pro-apoptotic. Serine protease which aggregates in the 
nucleus during PCD.100 Cleaves Bir1 through unknown 
mechanisms.101 
Bir1 IAP Anti-apoptotic. Localized to nucleus and cytoplasm. 
Cleaved by Nma111 during PCD.102  
Ndi1 Aif/AMID Pro-apoptotic. Mitochondrial nuclease which 
trasnlocates to nucleus upon loss of MMP. Contributes 
to degradation of nuclear DNA.103,104 
Nuc1 EndoG Pro-apoptotic. Mitochondrial nuclease which 
trasnlocates to nucleus upon loss of MMP. Contributes 





Yeast Protein Orthologs Functions in S. cerevisiae PCD 
Esp1 Separin Pro-apoptotic. Putative caspase-like seperase. During 
PCD, cleaves Mcd1, a cohesin that is responsible for 
maintenance, and repair, of DNA. A small C-terminal 
peptide fragment of Mcd1 translocates to the 
mitochondria during PCD, leading to the loss of 
mitochondrial membrane potential.106  
Kex1 Caspase-like Likely pro-apoptotic. Serine carboxypeptidase. Loss of 
this gene results in decreased caspase-like activities in 
response to PCD-inducing stress.107  
Cyclin C Cyclin C Pro-apoptotic. Localizes to the mitochondria after stress, 
causing hyperfission and nuclear fragmentation.108 
Ybh3 Bax Pro-apoptotic. Putatively Bax-like. Following stress, 
translocates to the mitochondrion, where it induces 
MMP.109 
Yca1 Metacaspases Pro-apoptotic. Believed to be a central mediator of yeast 
PCD, but the mechanisms by which it performs this 
function remains largely unknown.94 
TatD TatD Pro-apoptotic. Endo-/exo-nuclease which contributes to 
DNA degradation.110 
Dnm1 Drp1 Pro-apoptotic. Interacts with Fis1 during PCD to induce 
mitochondrial fission.111 
Fis1 Fis1 Pro-apoptotic. Interactions with Dnm1 during PCD to 
induce mitochondrial fission.111 
Note: This table has been adapted, in part, from Strich112. 
Similarly to what is observed in animal cells, cytochrome c is released from the 
mitochondria during yeast PCD. In spite of this shared PCD feature between animals and 
yeast, an APAF-1 ortholog has yet to be identified in yeast. As APAF-1 provides the link 
between cytochrome c and apoptosis in animals, the lack of a detectable APAF-1 
ortholog in yeast casts doubt as to whether the liberation of cytochrome c from the 




In addition to yeast, PCD processes have also been documented in other 
unicellular eukaryotes. As the signaling mechanisms for these observed PCD programs 
have yet to be characterized in detail, they will not be discussed here, though their 
occurrences are reviewed elsewhere.113,114 Of note, however, is a study in which a 
putative p53-like protein was discovered to be present in the slime mold Entamoeba 
histolytica.115  
Bacteria Intriguingly, a number of apoptotic characteristics have been observed 
during bacterial PCD. These include plasma membrane depolarization, externalization of 
phosphatidylserine, DNA degradation, accumulation of ROS, cell shrinkage, and DNA 
condensation.116 
The molecular basis of PCD in bacteria is poorly characterized.116 Following is a 
discussion of the most-studied bacterial PCD pathway, which involves the mazEF 
pathway. mazEF is widely distributed throughout bacteria, so it functions as an excellent 
starting point for discussions centering around bacterial PCD.  
mazEF is an example of a toxin-antitoxin (TA) system. TA systems are quite 
prevalent in bacterial cells, and serve to initiate cell death when certain conditions are 
met.117 A TA system is composed of two or more genes which exist as an part of an 
operon. The two fundamental components of a generalized TA system include a toxin, 
which is lethal to the cell, and the corresponding antitoxin, which blocks the lethal effects 
of the toxin.118 Because the two genes are nested within a single operon, they are 
expressed simultaneously. As a result of being co-expressed with its antitoxin, the toxin 
has little to no effect on the cell. The mazEF system is an example of a Type II TA 




proteins, and the antitoxin inhibits the functions of the toxin directly via protein-protein 
interactions.119  
The involvement of the mazEF system in bacterial PCD is well established, 
though the exact role that this system plays during PCD has not been fully elucidated.116 
Under normal conditions, the antitoxin, mazE, is bound to the toxin, mazF. In response to 
a PCD-inducing stress, mazE is degraded, freeing mazF from its inhibitor. Once 
activated, mazF, an endoribonuclease, is believed to selectively inhibit the bulk synthesis 
of proteins by cleaving mRNA transcripts at ACA sequences.120 Under this model, the 
translation of cell death inhibitors is inhibited, while the translation of cell death effectors 
remains unaffected.119 Interestingly, mazF-induced cell death can be annulled by 
exogenous expression of the mazE antitoxin, but only up to a certain point.121 This 
indicates that the PCD process is reversible up to the so-called “point of no return”.116  
The execution steps of bacterial PCD following initiation by mazF are not well 
characterized.116 The loss of plasma membrane polarization and subsequent degradation 
of the cell wall is under the control of the holin-like CidA and antiholin-like LrgA 
endogenous bacterial proteins.116 Holins were first characterized as bacteriophage-
encoded proteins which coordinate the membrane permeabilization and lysis of infected 
bacterial cells at specified times.122 Holins achieve this by oligomerizing in the bacterial 
membrane to form a pore. Notably, however, is the observation that endogenous holin- 
and antiholin-like genes are widespread throughout bacteria.116 
While the exact mechanism underlying the interaction between CidA and LrgA 
remains unknown, both proteins localize to the bacterial plasma membrane. Under non-




Furthermore, during bacterial PCD, the association of LrgA and CidA is disrupted, 
through unidentified mechanisms. Following this, CidA monomers oligomerize to form a 
pore in the plasma membrane, resulting in the depolarization of the cell.123  
Utilizing this information, a tentative model for stress-induced bacterial PCD has 
been proposed.116 In this scenario, the bacterial TA and SOS responses are activated in 
response to stress, causing the cell to enter a quiescent state. During this period, the 
bacterial cell attempts to cope with the stress. An inability of the cell to adequately cope 
results in the inactivation of LrgA. This inactivation allows for CidA to oligomerize, 
resulting in the loss of plasma membrane integrity and depolarization of the cell. The end 
result of this process is nuclease activation, which causes DNA fragmentation, as well as 
the recruitment and activation of extracellular peptidoglycan (PG) hydrolases, which 
results in cell wall degradation and subsequent autolysis.116 
Uncertainty in the Conservation of PCD 
Arguments for the Conservation of PCD The phrase “similar but different” has 
been used to comparatively describe the animal and plant PCD processes.68 Similar 
idioms have been employed to relate unicellular PCD to that of animals.124,125 The 
abundance of shared features during PCD in distantly-related phyla, such as 
phosphatidylserine externalization, genomic fragmentation, and the accumulation of 
reactive oxygen species, has led to the hypothesis that similar mechanisms underlie PCD 
in distantly-related organisms. 
Some evidence from transgenic studies is consistent with the notion of a 
conserved PCD program between phylogenetic lineages. Here, an emphasis will be 




animal anti-apoptotic BCL-2 and Bcl-XL proteins in plant cells was sufficient to attenuate 
the plant PCD response.126 Furthermore, overexpression of pro-apoptotic Bax promotes 
rapid cell death in transgenic plant cells.127 Intriguingly, the Bax protein localizes to both 
the mitochondrion and chloroplast when expressed in plants, leading to the hypothesis 
that a yet-undiscovered Bax-like protein may exist in plants.127  
As in plants, the heterologous expression of Bax from animals in yeast cells 
results in cell death with features of apoptosis.128 Similarly, the expression of anti-
apoptotic BCL-XL or BCL-2 in yeast cells attenuated PCD in response to stress.129,130 
Moreover, co-expression of Bax with BCL-XL or BCL-2 in yeast cells attenuated the 
lethal effect of Bax.130–132 Of interest, heterologous BCL-XL or human BCL-2 can 
functionally replace the anti-PCD effects of endogenous yeast Fis1, suggesting that Fis1 
may act in a similar manner to that of the antiapoptotic BCL-2 family members.111 
Perhaps the most intriguing results involving the heterologous expression of Bax 
come from a recent study in bacteria.133 When expressed in E. coli, the pro-apoptotic 
BCL-2 effectors Bax and Bak oligomerize to the bacterial plasma membrane to induce 
cell death and lysis.133 Additionally, a mutated form of Bax, which causes defective 
apoptosis in animal cells, was also unable to induce PCD in bacterial cells.133 Moreover, 
the co-expression of Bax with constitutively-active Bid repressed bacterial cell death. 
Finally, replacement of the endogenous holin in lambda bacteriophage resulted in 
functional bacteriophage particles.133 The results of this study demonstrate a previously-
undiscovered mechanistic link between bacterial cell death and the loss of MOMP during 
apoptosis. A number of parallels have been drawn between the mechanisms of the BCL-2 




bacteria.116 Namely, both systems function in mediating membrane disruption by 
controlling the formation of a pore, are regulated by homologous proteins, and control a 
terminal point of no return during cell death, as proteins downstream of pore formation 
(caspases in animals, peptidoglycan hydrolases in bacteria) carry out the execution of cell 
death.116 
Arguments Against a Conserved PCD Although the current number of PCD 
studies that have been conducted in non-animal organisms are small in comparison to the 
number of studies carried out in animal systems, a review of the current literature 
suggests that substantial variation is likely to underlie the molecular mechanisms by 
which phylogenetically-distant organisms initiate and execute PCD. This concept is 
supported by the sparsity of discernable animal PCD homologs in non-animal lineages. 
The presence of shared PCD features in distinct lineages does not, in and of itself, 
sufficiently support the claim that the processes are similar at a mechanistic level. A 
phenotype is brought about primarily as the result of genes which encode molecular 
pathways that produce the phenotype. Importantly, the phenotypes that result from 
genomic variation, not the genes themselves, are acted on by natural selection.134 As 
such, natural selection may drive the evolution of distinct genes to produce the same 
phenotype. This concept of convergent evolution establishes that shared phenotypes 
between phylogenetically-distant species cannot necessarily be attributed to a 
conservation of the underlying molecular pathways.134 Indeed, the observation that 
plants, in the presumed absence of true caspases, have evolved to maintain the observed 
"caspase-like" activities may be an example of this. Moreover, the emerging 




that at least some of the mechanisms of plant PCD are distinct from PCD in organisms 
that lack chloroplasts. While these observations do support the notion that PCD processes 
are distinct, at least in some ways, between phyla, the degree to which these differences 
exist between such organisms has yet to be fully determined, and the majority of 
arguments for and against the conservation of PCD pathways throughout the tree of life 
are founded in the context of an incomplete understanding of PCD in these organisms.  
Furthermore, another important observation to be made is that, even amongst 
animals, in which PCD is considered to be well conserved, the molecular mechanisms of 
various PCD processes are very distinct from one another; PCD in mammals is, at a 
molecular level, very different from PCD in non-mammal animals.135 This observation 
raises questions as to how related mammalian PCD might be from even more diverged 
organisms, such as plants. 
On a Potential Conservation of PCD   
The discovery that the individual cells of a multicellular organism can, in a 
genetically-dependent fashion, initiate and execute their own death represented a shifting 
paradigm in the field of biology. The additional observation that the self-induced death of 
damaged or aged cells provides a benefit to the organism as a whole, in a seemingly 
altruistic manner, was a paradigm shift in its own right. Hence, it is unsurprising that 
many of our own ideas and notions of PCD have been influenced by the emphasis that 
has historically been placed on the apoptotic process.134 The discovery that organisms 
which are phylogenetically distant from animals also utilize PCD led to the proposition 
that perhaps the mechanisms of cell death are not a recent evolutionary development, but 




unicellular eukaryotes, and even in prokaryotes, is in agreement with this postulation. 
When subsequent studies revealed that unicellular organisms utilize PCD at a population 
level, parallels were immediately drawn between the apparent social aspects of PCD in 
unicellular organisms and the cooperative nature of PCD in multicellular organisms. 
Namely, that both processes provide a benefit to surrounding cells. This led to the 
successive prediction that the social aspects of PCD between animals and unicellular 
organisms are evolutionarily linked, and thus, may be evolutionarily conserved at the 
molecular level.134 This idea of a "core" molecular mechanism by which cells bring about 
their own destruction has pervaded the scientific community for many years, and has had 
an extraordinary impact on the way that PCD is perceived.134 There are several points 
that require attention with regard to the notion of a conserved PCD program. 
On the Emergence of PCD in Evolutionary History Though it is unclear as to 
how and when PCD evolved, the observation that contemporary bacterial species undergo 
PCD has led to the speculation that PCD may have emerged prior to the rise of 
eukaryotes. Thus, much of our understanding of the early PCD processes comes from 
studies in bacteria. As described above, our current conception of PCD indicates that 
PCD serves a collective purpose in many, if not all, unicellular populations.  
The initial findings of a role for cell death in multicellular organisms, as well as 
the additional discovery of its genetic basis, led to a so-called "fascination for function", 
in which PCD became widely viewed within an implicit conceptual framework of both 
purpose and design.134 The observations that unicellular organisms also undergo forms of 
death that are genetically-controlled, and that the group, rather than the organism as a 




reasoning used to explain PCD in multicellular organisms to explain PCD in unicellular 
organisms.134 Stated another way, the discoveries of the beneficial effects to neighboring 
cells in both unicellular and multicellular organisms was used as a way to relate the two 
processes. As a consequence of this ambiguous logic, PCD became subliminally 
perceived to have emerged when it became required to perform the evident functional 
roles within a unicellular community, and that this collective role of PCD may have given 
rise to the cooperative nature of PCD observed in more complex multicellular 
organisms.134 While such a notion does make sense on some intuitive level, and, as a 
result, is easily digested by the majority of those in the field of biological sciences, this 
line of reasoning raises an important problem when viewed from the perspective of 
evolutionary theory: such a view implies that a complex set of genes and molecular 
pathways facilitating the induction of cell death emerged precisely when and where it 
was required in ancestral organisms.134 
The assumption that the functions of PCD observed in contemporary organisms 
were the driving forces behind the initial emergence of PCD fails to take into account a 
core principle of evolutionary theory: descent with modification.134 For instance, there 
are examples in which a complete dissociation exists between the functional advantage 
that a given set of genes currently confers to an organism and the initial reason for which 
these genes emerged and were maintained. Thus, rather than the perspective that "PCD 
was selected for because of the benefits that it provides", a more evolutionary sound 
viewpoint may be that "PCD was adapted to provide the benefit that it is observed to 
provide today". When the evolution of PCD is framed in such a manner, the point 




PCD in early evolution are required to comprehend the molecular contrivances of ancient 
PCD programs.134 Moreover, an understanding of both the acquisition of the ability to 
undergo PCD, as well as the selective pressures which maintained and modified the 
functional aspects of PCD, are necessary in order to relate the functional and molecular 
aspects of PCD between unicellular and multicellular organisms. 
On the Conservation of PCD Programs  
The notion that PCD programs are not directly selected for, but are instead a 
"tolerated" as byproducts of other selective pressures, is a prominent hypothesis for the 
emergence of PCD in early life and maintenance of PCD throughout evolutionary 
history.134 Under this model, PCD is postulated to have evolved through a series of 
stages, wherein gene products that are under selection for advantageous traits they 
provide develop additional functions to participate in PCD. Thus, any and all gene 
products that confer a trait that is beneficial to the organism could potentially be adapted 
to participate in PCD. Because natural selection acts at multiple levels of organization, 
one implication of the multi-step model of PCD evolution is that the selective pressures 
facilitating the major transitions from unicellularity to complex multicellularity likely 
played a role in shaping PCD processes in these emerging organisms. 
Co-Selection at the Molecular Level One way in which this idea might manifest 
is at the molecular level. The majority of known genes are pleiotropic, meaning that the 
expression of the gene has an effect on multiple phenotypes. Thus, a phenotype that is not 
directly acted on by natural selection, assuming that the trait is not maladaptive, and may 
be co-selected with another phenotype that is directly selected for. In the context of PCD, 




participate in essential cellular processes. In agreement with this, many of the genes 
encoding processes such as cell cycle progression and metabolism are involved in PCD. 
An important implication of this, however, is that natural selection exerts distinct 
selective pressures on different organisms/groups/populations, depending on which 
adaptations most increase fitness. This is generally observed by environmental pressures. 
Hence, the features selected for in one group will not be exactly identical to those 
selected for in a different group. As a consequence, the genetic mutations that produce 
the phenotypes under selective pressure will be different between any two groups. 
Moreover, the random nature of genetic mutations dictates that, even between two 
closely-related groups, some variation of the phenotype selected for will be exist, 
implying that the function of the co-selected phenotype may also be altered between 
these two groups. Thus, selective pressures exerted on essential cellular functions will 
successively shape the genomic sequences which carry out these functions. This will, in 
turn, have a substantial effect on the PCD functions of that pleiotropic gene.  
Co-Selection at the Cellular Level A second way by which the effect of co-
selection may have resulted in the divergence of PCD processes is in the context of 
intracellular structure. The mitochondria and chloroplasts are both eukaryotic organelles 
which arose as the result of endosymbiotic interactions between bacterial cells and their 
primitive eukaryotic hosts. The traits selected for in these cases were the abilities to 
generate large quantities of energy. The indispensable role of the mitochondrion has been 
well established in animal PCD. Characteristics similar to that of its animal counterpart 
have been observed during plant PCD, though it has yet to be shown that the plant 




above, the presence of chloroplasts in plants and their absence in animals, in conjunction 
with the purported involvement of the chloroplast during plant PCD, implies that distinct 
mechanisms exist in the ways by which plants and animals carry out PCD.  
In addition, the prokaryotic origin of these organelles likely had considerable 
ramifications for the evolution of eukaryotic PCD. One such implication of the early 
host-endosymbiont relationship is that many of the aspects of eukaryotic PCD may be 
artifacts of bacterial PCD pathways. It is intriguing to note that, in both plants and 
animals, proteins involved in PCD may have been inherited from the prokaryotic 
endosymbiont. In animals, this is exemplified by the mitochondrial serine protease 
HtrA2, a homolog of the bacterial stress tolerance protein HtrA.137 Additionally, the plant 
homolog of a different bacterial protein, LrgB, was recently identified in A. thaliana. 
Though a role for bacterial LrgB has yet to be described, it exists as a constituent of the 
same operon as the antiholin-like LrgA. In Arabidopsis, LrgB localizes to the chloroplast 
and has been implicated to play a role in plant PCD.138   
A Case for the Characterization of PCD in Unicellular Organisms  
Ultimately, a detailed comparison of the molecular pathways underlying PCD 
requires a detailed understanding of the participants of each. With regard to PCD 
pathways, the sole process that has been thoroughly-described at the molecular level is 
apoptosis. Even still, much remains to be understood regarding the molecular 
mechanisms of apoptosis.  
That the ability to undergo PCD is widespread throughout the evolutionary tree 
suggests the early development of PCD programs in evolutionary history.134 Because of 




potential to shed light on the molecular basis of PCD in an evolutionary context. Thus, it 
is here argued that an understanding of the molecular mechanisms which underlie PCD in 
unicellular organisms is foundational to understanding how PCD processes evolved in 
other life forms. 
The results of a recent genomic study utilizing bioinformatics suggests that there 
may exist a “core” PCD program that has been conserved in unicellular eukaryotes.139 
The presence of such a mechanism amongst representative ancestral organisms may have 
great potential in shedding light on the enigmatic nature of the evolution and 
diversification of PCD. Moreover, such a mechanism has the invaluable potential to 
identify aspects of PCD that are conserved among higher organisms, such as plants and 
animals, which may subsequently lead to identification of divergent mechanisms which 
underlie these processes. 
Chlamydomonas reinhardtii and Programmed Cell Death 
Green algae occupy a unique position on the phylogenetic tree. Believed to be 
among the closest representative ancestors of higher plants, green algae serve as a 
primary model for studying processes in such organisms.140,141 This is, in part, because 
green algae possess functional chloroplasts. However, in addition, many plant-specific 
genes are found in green algae, making them an even more attractive organism in which 
to study plant processes.142 
Of note, several photosynthetic green algal species, including Micrasterias 
denticulata, Chlorella saccharophila, Dunaliella tertiolecta, Chlamydomonas reinhardtii, 
and Volvox carteri have been documented to undergo PCD in response to various 




including DNA laddering, externalization of phosphatidylserine, vacuolation, degradation 
of intracellular components, DNA fragmentation, and accumulation of reactive oxygen 
species.148 Intriguingly, as is observed in land plants, PCD in C. saccharophila is 
accompanied by the release of cytochrome f from the chloroplast, suggesting that this 
characteristic of plant PCD may have developed early in the divergence of PCD between 
plants and animals.91  
If green algae represent prime candidates for studies in PCD, Chlamydomonas 
arguably serves as a prime green algal candidate for such studies. C. reinhardtii is an 
extremely well-studied model organism with a genome that has been sequenced and 
annotated.149 Additionally, C. reinhardtii has been used to study a diverse array of 
biological processes, including motility150, ciliary structure and function151, lipid 
synthesis152, genetics of the chloroplast153,154, photosynthesis155, heterotrophic 
metabolism156,157, stress response and acclimation158, and biofuel production.159,160 
Furthermore, a particularly novel aspect of C. reinhardtii is the ability to form 
rudimentary multicellular structures.161 This, in conjunction with the fact that C. 
reinhardtii shares remarkable genomic similarities with its multicellular cousin, V. 
carteri, has led to the use of Chlamydomonas in laboratory studies seeking to understand 
the evolution of multicellularity.162 
Chlamydomonas serves as a superb model organism for eukaryotic cell biology 
due to its functional conservation with plants, animals, and other unicellular 
eukaryotes.149 These relationships have led to the light-hearted and colloquial coinage of 
light-hearted nicknames such as "planimal" or "green yeast" to describe Chlamydomonas. 




manipulation have established this organism as the preferred model for many forward 
genetic screens and other high-throughput studies.163–165  
Adding to the utility of C. reinhardtii as a model is the fact that more advanced 
genetic and molecular tools are continually being developed for use in this organism.166–
169 Targeted DNA editing in Chlamydomonas is now plausible, and techniques such as 
clustered regularly interspaced palindromic repeats (CRISPR) and zing-finger nucleases 
(ZfNs) have recently been described for use in C. reinhardtii.170,171 Moreover, the 
development of other molecular methods such as RNA interference (RNAi) and 
transactivator-like effectors (TALEs), as well as the creation of a C. reinhardtii knockout 
mutant library, have allowed for even further possibilities in the field of reverse 
genetics.172–174 
One process which has not been well characterized in Chlamydomonas is PCD. C. 
reinhardtii has been observed to undergo PCD in response to a number of environmental 
stressors. Interestingly, it appears that many of the typical phenotypes observed during 
mammalian apoptosis are also observed during C. reinhardtii PCD (Table 2). 
Table 2 
Stress-induced PCD in C. reinhardtii and the resulting features 
Stressor PCD Phenotypes 
UV radiation175,176 Cell shrinkage, vacuolation, chromatin fragmentation, DNA 
fragmentation, and phosphatidylserine externalization. 
Acetic Acid177 Accumulation of ROS, decrease in photosynthesis, DNA 
TUNEL-positive nuclei, DNA laddering. 
Mastoparan178 Cell shrinkage, vacuolation, cytoplasm shrinkage and 
separation from the wall, nuclear condensation, dramatic 





Heat147,179–181 ROS accumulation, DNA laddering, and phosphatidylserine 
externalization. 
Menadione182 Decrease in photosynthesis, ROS accumulation, upregulation 
of antioxidant enzymes, loss of MMP, DNA fragmentation, 
caspase-3-like activity. 
Hydrogen peroxide183,184 DNA fragmentation, ROS accumulation, caspase-3-like 
activity, and upregulation of antioxidant enzymes. 
Potassium chloride185 Cell shrinkage, distorted chloroplast, vacuolation, 
accumulation of ROS, upregulation of antioxidant enzymes, 
loss of MMP, DNA fragmentation, nuclear disruption 
 
The phenotypic similarities between C. reinhardtii PCD and mammalian 
apoptosis suggest that common molecular mechanisms underlie the two processes. As is 
true of PCD in non-animal organisms, however, is that much of the molecular machinery 
that is known to be essential for apoptosis, such as caspases or p53, appears to be absent 
from the predicted C. reinhardtii proteome. Furthermore, though several putative 
contributors to C. reinhardtii PCD have been identified (Table 3), detailed signaling 
pathways underlying this process have yet to be elucidated. As a result, the extent to 
which Chlamydomonas PCD and mammalian apoptosis are similar is currently unknown. 
Table 3 
Putative molecular contributors to PCD in Chlamydomonas reinhardtii  
Contributor Method of Detection Results 
DAD1176 RT-PCR Gene expression was downregulated 
during PCD. 
APAF-1176 Western blot Increase in protein abundance during PCD 
Caspase-1-like178 Enzymatic inhibitor 
and fluorescent 
substrate 
Early application of inhibitors reduced the 
percent death of the population. Increase in 





Caspase-3-like178 Enzymatic inhibitor Early application of inhibitors reduced the 
percent death of the population.  
Caspase-3-like183 Western blot, 
enzymatic inhibitor, 
fluorescent substrate, 
and measurement of 
substrate (PARP-1) 
cleavage. 
During PCD, higher levels of caspase-3-
like protein, higher levels of caspase-3-like 
activity, which were decreased in the 
presence of the inhibitor, and increased 
cleavage of PARP-1. 
Metacaspase-2184 RT-PCR Upregulated during PCD.  
AIF185 Western blot During PCD, cytoplasmic AIF levels 
increased, which were correlated with a 
change in mitochondrial membrane 
potential 
PIG8147 Northern blot Upregulated during PCD. 
 
Objectives 
As very little is known regarding the molecular underpinnings of PCD in C. 
reinhardtii, the overarching purpose of this work is to shed light on the genetic and 
molecular basis of PCD in C. reinhardtii. In order to achieve this goal, the following 
objectives are proposed.  
Objective 1: C. reinhardtii proteins which participate in PCD will be predicted by 
comparing the sequences of all C. reinhardtii proteins to the protein sequences which 
contribute to PCD in other organisms. Using this information, several C. reinhardtii 
proteins which show high sequential similarity to a known PCD protein will be selected 
for further analysis. 
Objective 2: To determine if each of the selected proteins is important in C. 




selected putative PCD protein will be subjected to PCD-inducing conditions and assayed 
for changes in typical PCD phenotypes.  
Significance 
There are both direct and indirect benefits to an understanding of the molecular 
mechanisms underlying C. reinhardtii PCD. 
Direct benefits C. reinhardtii has extensive potential for industry use. As a result 
of producing abnormally large amounts of dihydrogen during photosynthesis, ethanol 
through carbohydrate fermentation, and methane through anaerobic digestion, C. 
reinhardtii is currently being investigated as a potential source of clean biofuels as an 
alternative to fossil fuels.186–188 Additionally, other aspects of the microalgal metabolism, 
such as the production of carotenoids, long-chain polyunsaturated fatty acids, and 
vitamins, have instigated their use in the production of food and animal feed additives.189 
One area of developmental research in the biofuel industry aims to increase the quantity 
of algal-derived biofuels by altering the culture conditions in which the organism is 
grown. In particular, stressful conditions have been shown to dramatically influence the 
quantities of industry-usable compounds produced by microalgae.190 A thorough 
understanding of the molecular basis of PCD in C. reinhardtii has the potential to 
facilitate the development of PCD-resistant algal strains. This could allow for the 
culturing of C. reinhardtii under stressful conditions not otherwise possible, and thus may 
contribute to the commercial utilization of C. reinhardtii or other algal strains.  
Chlamydomonas is also used as a biomarker for various environmental studies 
which seek to determine the toxicity of various compounds.191–195 Many of the molecular 




understanding of PCD in C. reinhardtii could potentially help to elucidate specific and 
relevant information regarding the molecular basis underlying the toxicity of a given 
compound.  
Indirect Benefits Over 700 million years of evolution separate the chlorophytes 
(unicellular green algae) and streptophytes (non-chlorophyte green algae and land 
plants).196 As such, unicellular green algae represent a highly unique phylogenetic group. 
Because of the unique position that Chlamydomonas occupies on the phylogenetic tree, 
findings in this organism are often easily translated to other phylogenetic clades. 
Understanding PCD in C. reinhardtii is likely to have several benefits in this regard.  
As green algae pre-date multicellular plants, C. reinhardtii is often used as a 
model for physiological processes in higher plants.149 This seems particularly relevant in 
light of the fact that over 33% of the proteins predicted from the A. thaliana genome have 
not been characterized in terms of their biological roles.197 Understanding the PCD 
process in plants is a chief goal of many researchers, as the development of stress-
resistant crops is essential for expanding the space on which it is possible to grow crops, 
increasing crop yield, and sustaining a food source in an environment which is 
continually growing warmer.  
In addition, the phylogenetic position of C. reinhardtii is advantageous to 
evolutionary studies seeking to understand how PCD evolved and diversified in early life 
forms. As a unicellular eukaryote with photosynthetic machinery, Chlamydomonas is set 
apart from many of the traditionally-used models for PCD in unicellular eukaryotes, such 
as S. cerevisiae. Furthermore, given that the chlorophyte-streptophyte divergence 




excellent transitionary model with the potential to yield novel insights into other 
unicellular eukaryotes, higher plants, and animals.198 As such, not only could C. 
reinhardtii could aid in understanding how PCD evolved in early life, but it could also 





Prediction of PCD Genes in Chlamydomonas reinhardtii 
Introduction 
The rapid advancement of biotechnological advancements in recent years has 
triggered a precipitous outpouring of molecular data. This surge in the quantity and 
production rate of available data has resulted in the emergence of a new field of study: 
bioinformatics. In short, bioinformatics can be described as the interface between 
computing and molecular biology.198 In bioinformatics research, computational systems 
are used to analyze large amounts of biological data, most of which would be impossibly 
arduous to analyze manually. As computers are capable of handling and analyzing large 
quantities of information with astounding speed and efficiency, they are the ideal 
instruments on which to carry out the analysis of such data. The increasing abundance of 
molecular data, as well as the rapid advances made in computer science, have allowed for 
the development of new questions, hypotheses, and analyses in the field of biology.  
As a consequence of the large amounts of data produced by modern molecular 
studies, databases dedicated to the curation of biological data serve to gather, organize, 
and store information produced by researchers.199 A biological database usually 
specializes in one or several types of data, and a variety of databases exist for different 
types of biological data. Some databases collect sequence data, others gather data 
regarding the three-dimensional structure of biomolecules, and still others assemble 





A prominent area of research in the field of bioinformatics is sequence analysis.200 
The computational analysis of biological sequences has wide-reaching implications for 
the field  of biology. For example, given a fully sequenced genome, the individual genes 
which comprise the genome can be predicted. From any of these putative gene sequences, 
a corresponding transcript sequence can be predicted. The transcript sequence can be 
used to predict the amino acid sequence of the resulting protein. The amino sequence can 
be used to predict a number of functional characteristics of the protein, including three-
dimensional structure, functional domains, and active sites.  
Functional predictions of an uncharacterized protein are derived from similarities 
to proteins of known biological function. The evolutionary conservation of peptide 
function is often accompanied by the conservation of amino acids key to that function.201 
Thus, the functions of an indeterminate protein can be predicted by comparing its 
constituent amino acid sequence with the amino acid sequences of functionally-
characterized proteins. The most common method to search for sequential similarities 
between different proteins is to align the amino sequences with one another.202 Each 
alignment tool works slightly differently, as each method utilizes different algorithms to 
align the amino and calculate the strength of the alignment. The most widely utilized tool 
for sequence alignment is the Basic Local Alignment Search Tool (BLAST).200,202 
BLAST works by searching for regions of similarity between two sequences and moves 
outward in a bidirectional manner from the initial alignment until the terminus of one of 
the sequences is reached or until the regions of similarity end.203  
The Gene Ontology (GO) project is a database of gene product annotations, which 




the GO database, gene products are assigned one or more functional annotations, called 
GO terms. GO terms fall into one of three broad, and exclusive, categories: the biological 
processes (BP) in which the protein participates, the cellular components (CC), or where 
in the cell the protein localizes to, or the molecular functions (MF) that are carried out by 
the protein.204 
The three GO categories are structured as distinct hierarchical trees. In these 
acyclic graphs, each term can be related to one or more “parent” terms, which are broader 
in scope, or “child” terms, which are narrower in scope.205 Each of the three categories is 
the top parent node of its own graph, and is the broadest annotation of its constituent 
child nodes, which, in turn, are the parent nodes of their own constituent child nodes, and 
so forth (Figure 2). In addition, a single node can be considered the child of several 
parent nodes within its own graph, exemplifying the fact that a GO term can be relevant 
in a variety of different biological contexts.205 One benefit to being able to view GO 
terms in such a hierarchal manner is that it enables the visualization of the GO terms 





Figure 2. Example of the hierarchal classification system in Gene Ontology. The 
organization of GO terms can be visualized as vertically-connected nodes, depicting an 
ordered relationship. The parent nodes, located at a higher position on this diagram, are 
composed of one or more child nodes. In turn, each child node is the subset of at least one 
parent node. This example was created using BLAST2GO. 
 
GO terms for an uncharacterized protein sequence can be predicted using a 
variety of available tools.205 One such tool is BLAST2GO, a software that utilizes the 
results of a BLASTp alignment, in conjunction with other computational tools, in order to 
predict the GO term(s) for a query sequence.206 The advancements in the speed and 
processing power of computers allows for the batch processing of many sequences 
simultaneously, and tools like BLAST2GO are often used to predict GO terms for large 
datasets that consist of many sequences.  
The standardized BLAST2GO workflow for functional prediction of a protein 
sequence consists of several steps. First, a BLASTp search is carried out, using the 
protein(s) to be characterized as the query. Second, GO mapping is performed, wherein 
the GO terms associated with each of the subject sequences to which the protein of 




applying a mathematical formula called the annotation rule (AR). Briefly, the AR assigns 
GO terms to the protein of interest while accounting for 1) the strength of the alignment 
between the uncharacterized protein and the subject sequence, and 2) the strength of the 
GO annotation assigned to the subject. It then assigns the GO term of the lowest node 
which falls above a user-defined threshold. 
One potentially useful feature of BLAST2GO is that it assigns a level to each 
term in the GO database.207 In this system, each of the three GO categories are the first 
level of their own graph, child nodes of these categories are assigned to the second level, 
and so forth. Using Figure 2 as an example, “molecular function” would be assigned level 
1, both “binding” and “catalytic activity” would be assigned level 2, and “small molecule 
binding”, “carbohydrate binding”, “organic cyclic compound binding”, “heterocyclic 
compound binding”, and “ion binding” would be assigned level 3. In this way, the level 
system is intended to estimate the relative specificity of a GO term by informing the user 
of what level the term belongs to.207 
Since the C. reinhardtii genome was first published in 2007, it has been 
sequenced and reanalyzed a number of times. Each new release contains notable 
improvements in annotation and specificity.208 This continued improvement in quality 
makes C. reinhardtii an excellent organism for studies in bioinformatics. A total of 
19,526 amino acid sequences are predicted to be coded for by the current version of the 
C. reinhardtii genome (v5.5).  
As noted in the previous chapter, exceedingly little is known regarding the genetic 
basis for PCD in C. reinhardtii. A survey of the literature suggests that no large-scale 




purpose of this study was to predict, on a large scale, the proteins which participate in C. 
reinhardtii PCD using sequential similarities to annotated PCD proteins from other 
organisms. Furthermore, we sought to characterize these potential PCD proteins by 
assigning GO terms to the dataset.  
Materials and Methods 
Figure 3 provides a visual overview of the methods that were utilized in this 
section of the project. Detailed computational methods can be found in the appendices. 
Unless otherwise noted, all management, analysis, and visualization of the data used in 





Figure 3. Overview of the methods used to predict and characterize C. reinhardtii proteins which participate in PCD. Nodes with 
bolded text represent output of the pipeline. Green nodes represent steps used to retrieve subject sequences, red nodes represent steps 
used to align the C. reinhardtii proteome against the custom PCD database, and blue nodes represent the steps used to characterize the 
predicted PCD proteins in C. reinhardtii. 
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Retrieval of Annotated PCD Sequences Using the National Center for 
Biotechnology Information (NCBI) web page (https://www.ncbi.nlm.nih.gov), the 
RefSeq Protein database was queried for amino acid sequences that were annotated with 
the keywords “apoptosis”, “necrosis”, and/or “programmed cell death”. The sequences 
coded for by eukaryotic genomes were saved locally as three separate multi-FASTA files, 
where each file contained the results of a single keyword search. The accession numbers 
were extracted from each of the multi-FASTA files using the “Find” and “Replace” 
functions in the text editing software TextWrangler. These three lists of accession 
numbers were saved as separate text files. To determine the overlapping results between 
the three keyword searches, the R function “reduce” was used to identify the accession 
numbers which were present in more than one of the lists of accession numbers. 
In order to create a single list of results from all three keyword searches, the three 
files of accession numbers were combined into a single file. All duplicate accession 
numbers (resulting from items that were returned in multiple keyword searches) were 
removed from this combined file using the command line. To confirm that this operation 
removed the correct number of entries, the number of accessions that were removed from 
the file of combined search results was cross-referenced with the number of overlapping 
items identified using the “reduce” command above.  
To convert the combined list of accession numbers into a multi-FASTA file of 
amino acid sequences, a custom E-Utilities script was written to retrieve the amino acid 
sequence that corresponded with each accession number from the NCBI Entrez database. 




sequences in the multi-FASTA file was cross-referenced with the number of lines in the 
list of combined, non-redundant accession numbers.  
Alignment of the C. reinhardtii Proteome to the Annotated PCD Sequences A 
complete list of the predicted amino acid sequences coded for by the C. reinhardtii 
genome (v5.5) was downloaded as a multi-FASTA file from the Phytozome web page 
(https://phytozome.jgi.doe.gov/pz/portal.html). To access more computing power, an 
EC2 instance was created using Amazon Web Services (AWS) web page 
(https://aws.amazon.com). The multi-FASTA file of the C. reinhardtii proteome was 
uploaded to the AWS instance. Additionally, the multi-FASTA file of sequences from the 
combined keyword search results, obtained above, was also uploaded to the instance and 
formatted into a BLASTp database using the pre-installed BLAST+ software (version 
2.5.0).  
To identity C. reinhardtii sequences with similarities to one or more entries from 
the combined search results, a BLASTp protocol was carried out, in which the C. 
reinhardtii proteome was used to query the custom database of annotated PCD proteins. 
To facilitate any future use of BLASTp alignments in different formats, the raw output of 
BLASTp was specified to be in archive format (.asn). Using the blastformatter tool in the 
BLAST+ software, the archive-format file was used to create a new file of the BLAST 
results in tab-delimited format. Both formats of the BLASTp output were downloaded 
locally. To filter out the weaker matches, any alignments which had a bitscore <100 or a 
percent identity <25% were removed from the tab-delimited BLASTp results. From this 
list of robust alignments, the identifiers of the C. reinhardtii query sequences were parsed 




To retrieve the amino acid sequences of the C. reinhardtii queries that aligned 
robustly with a sequence from the database of PCD proteins, the list of C. reinhardtii 
identifiers was uploaded into Phytozome as a new list. This list was then used to retrieve 
and download the corresponding amino acid sequences as a multi-FASTA file. These 
sequences were termed the C. reinhardtii predicted PCD proteins (CrPPPs).  
Assignment of GO Terms to the Predicted C. reinhardtii PCD Proteins In 
order to predict functional characteristics of the CrPPPs, BLAST2GO was used to assign 
GO terms to the CrPPP dataset. The BLAST2GO software (version 4.1.9) was installed 
locally, and the multi-FASTA file of CrPPPs was imported into the program. The multi-
FASTA file of CrPPPs was uploaded to the previously-launched AWS instance. A 
BLASTp search was conducted within the instance, using the CrPPPs to query the 
RefSeq protein database. The BLASTP output file (.xml2) was downloaded locally and 
imported into the BLAST2GO software. In order to annotate the CrPPPs with GO terms, 
the mapping and annotation functions of BLAST2GO were applied to the dataset. These 
functions utilize the imported BLASTp results and the InterProScan servers to assign GO 
terms to the CrPPPs. 
Results and Discussion 
In this study, the amino acid sequences from the C. reinhardtii predicted 
proteome were aligned, using BLASTp, with protein sequences from the RefSeq database 
that were annotated to be involved in several types of PCD. Based on sequence similarity, 
C. reinhardtii proteins that aligned strongly with one of the annotated PCD proteins were 
predicted to participate in C. reinhardtii PCD. Finally, in order to predict characteristics 




Retrieval of Annotated PCD Sequences The keyword search results of the 
RefSeq Protein database are summarized in Figure 4a. The keywords “apoptosis”, 
“necrosis”, and “programmed cell death” searches returned 46,200, 33,249, and 12,238 
results, respectively. Of these, 79,647 entries were the results of only a single search, 
5,112 entries were results of both the “apoptosis” and “programmed cell death” searches, 
866 entries were results of both the “apoptosis” and “necrosis” searches, 9 entries were 
results of both the “programmed cell death” and “necrosis” searches, and 22 entries were 





Figure 4. Composition of the Custom PCD Database. A) Unique and overlapping results 
of the three ENTREZ searches. Each circle represents the results of a single keyword 
search and is composed of non-overlapping and overlapping regions with other circles. 
Areas of a circle which do not overlap with another circle represent results which are 
unique to a single keyword search. Areas which are overlaps between two or more circles 
represent results that appeared in those searches. The number within an area designates 
how many sequences fall into that category. B) Phylogenetic distribution of the combined 
NCBI search results. In this pie chart, the area of each slice represents the relative 
number of non-redundant results contributed by a single phylogenetic group. 
After compiling the search results into a single file and removing the duplicate 




majority (90%) of sequences came from animals, while 3% originated from protists, 3% 
came from fungi, and 4% were contributed by plants (Figure 4b). Though heavily skewed 
towards animals, this phylogenetic distribution is consistent with the observation that 
sequences annotated only with the keyword apoptosis, an animal-specific process, and/or 
necrosis, a process best characterized in animals, accounted for approximately 85% of the 
combined search results (Figure 4a). 
Taken together, these results support the notion that a knowledge gap currently 
exists between PCD in animals and PCD in other, phylogenetically distinct organisms. 
This difference in understanding has the potential to severely limit the ability to 
formulate hypotheses regarding the molecular basis for PCD in non-animals. Since 
homology-based functional predictions of protein sequences are currently dependent on a 
degree of sequential conservation between the sequences being compared, and because 
the sequential similarity of proteins tends to decrease with evolutionary distance, it 
follows that such strategies are likely to be much less effective when comparisons are 
drawn between phylogenetically distant organisms.  
Alignment of the C. reinhardtii Proteome with the Annotated PCD Sequences 
The output of the BLASTp alignments between the C. reinhardtii proteome and the PCD 
database consisted of 908,445 alignments in total. Filtration of the results to include only 
the alignments with a percent identity >25% and a bit score of >100 resulted in the 
removal of 806,009 alignments (88.72%). The remaining 102,436 alignments were saved 
as a new file (henceforth referred to as the “filtered results”). A count of the unique query 
identifiers in the filtered results file revealed that 2,389 unique CrPPPs matched strongly 




results, the majority of the CrPPPs possessed a percent identity of 25-50% with the 
aligned subject protein (Figure 5). One potential explanation for the abundance of 
alignments with a low percent identity is the profusion of subject sequences which are 
phylogenetically distant from C. reinhardtii (Figure 4b). 
 
Figure 5. Percent identities of the filtered BLASTp alignments between the C. reinhardtii 
proteome and the PCD database. The height of each bar represents the number of 
alignments which possess a percent identity within the indicated range specified on the x-
axis. 
Assignment of GO Terms to the C. reinhardtii Predicted PCD Proteins A 
single GO term consists of a GO name and the corresponding GO identifier. The output 
of BLAST2GO gives any and all predicted GO terms assigned to each of the input amino 
acid sequences. Furthermore, the software classifies each assigned GO term as a 
biological process, cellular component, or molecular function. All GO terms assigned to 
the CrPPPs were exported as a tab-delimited text file. Reformatting of the BLAST2GO 
output file provided the number of CrPPPS that were assigned a GO term from each 




reinhardtii dataset, and the number of different (unique) GO terms that were assigned to 
the dataset (Table 4). 
Table 4 
Gene Ontology annotations assigned to the C. reinhardtii predicted PCD proteins 
 Number of CrPPPs 
Assigned GO Terms 
Total Number of GO Terms 
Assigned to CrPPPs 
Unique Number of GO 
Terms Assigned to CrPPPs 
Biological Process (BP) 1663 2628 639 
Cellular Component (CC) 726 1203 212 
Molecular Function (MF) 2173 3945 455 
Note: “Unique” GO terms are those which were only counted once, regardless of how 
many times they were assigned to the CrPPPs. 
 
Of the 2,389 CrPPPs, BPs, CCs, and MFs were assigned to 69.6%, 30.4%, and 
90% of the CrPPPs, respectively (Table 4). For each of the three GO categories, the total 
number of GO terms assigned to the CrPPPs exceeded the number of CrPPPs that were 
assigned a GO term. This indicated that, for each GO category, a subset of the CrPPPs 
were assigned multiple GO terms. To determine the frequency of GO terms assignments, 
the number of GO terms assigned to each CrPPP was determined for the entire dataset 
(Figure 6). The majority of CrPPPs (85.6%) were assigned between one and four GO 





Figure 6. Frequencies of GO terms assigned to the C. reinhardtii dataset. The height of 
each bar represents the number of CrPPPs that were assigned the specified number of GO 
terms, found on the x-axis. One sequence, which was assigned 67 GO terms, was omitted 
from this figure. 
 
To determine the extent of the overlap between GO categories assigned to the 
CrPPPs, the number of sequences assigned GO terms from each category was determined 
(Figure 7). It was found that approximately 20% of the CrPPPs were assigned at least one 
GO term from each of the three GO categories. Additionally, almost half of the CrPPPs 
that were assigned an annotation were assigned at least one GO term from both BPs and 
MFs. This data is in agreement with the observation that terms from these two categories 
were assigned more abundantly to the CrPPPs than terms from cellular components 





Figure 7. Overlap of annotations from the three GO categories assigned to the C. 
reinhardtii dataset. Each circle represents the number of sequences that were assigned 
GO terms from one of the three categories: BP, CC, or MF. Positions of overlap represent 
sequences which were assigned GO terms from more than one category. 
To qualitatively estimate the specificity of the annotations assigned to the CrPPPs 
for each GO category, the number of sequences assigned a GO term at each BLAST2GO 
level was quantified (Figure 8). The majority of the annotations across many of the GO 
levels are MFs, which is in agreement with the previous observation that more MF terms 





Figure 8. Distribution of annotation levels from each of the three GO categories assigned 
to the C. reinhardtii dataset. Categories, designated by color, are grouped by GO level, 
which is found on the x-axis. The height of each bar reflects the number of sequences that 
were assigned GO terms from a given level.   
To identify the groups of GO terms that were assigned more abundantly to the 
CrPPPs, the distribution of GO terms within each category was determined (Figure 9a-
c).While each of these most abundant terms are useful in a number of different biological 
contexts, and thus are not specific to cell death, that these terms were assigned to the 
CrPPPs may shed light on the mechanisms by which PCD is induced in C. reinhardtii. Of 
the CrPPPs assigned terms from the BPs, a number were assigned terms related to 
oxidation-reduction processes and cell redox homeostasis (Figure 9a). This did not come 
as a surprise, given the important roles that ROS plays during PCD. In addition, several 
BP terms assigned to the CrPPPs were related to signaling and gene regulation (Figure 




signal transduction, intracellular signal transduction, transmembrane transport, and 
protein phosphorylation.  
A number of interesting terms from MFs were assigned to the CrPPPs (Figure 
9b), including those which involved zinc, calcium, and general metal binding.  These 
typically act as cofactors for various enzymes within the cell. Of note, however, is that 
Ca2+ plays a number of roles during PCD.209 A number of biomolecule-binding terms 
were also assigned, including DNA and nucleic acid binding, as well as protein binding. 
Finally, two key signaling  terms, protein kinase activity and oxidoreductase activity were 
also assigned to the CrPPPs. 
The CrPPPs are predicted to localize to a diverse array of subcellular locations 
(Figure 9c). Interestingly, many of the sequences are predicted to be integral 
transmembrane proteins and/or localize to a membrane. In addition, many of the CrPPPs 
were predicted to localize to regions of the cell that are known to be important in the cell 
death, including the nucleus, cytoplasm, mitochondrion, and endoplasmic reticulum. 
Interestingly, 14 CrPPPs are predicted to localize to the chloroplast, which is predicted to 
be involved in several plant-specific subroutines during PCD. These CrPPPs may provide 




Figure 9. Distribution of the most abundant GO terms from each category assigned to the C. reinhardtii dataset. For the sake of 
conciseness, only the 15 most abundant terms are displayed for each category.






Selection of CrPPPs of Interest In order to facilitate future studies seeking to 
characterize PCD in C. reinhardtii, several genes of interest were selected from the list of 
CrPPPs (Table 5). In order to create this list, the file of BLASTp alignments between the 
C. reinhardtii proteome and the PCD database was manually explored. Using prior 
knowledge of the various PCD pathways described in the literature, primarily those 
observed in animals, plants, and yeast, subjects which were recognized as PCD proteins 
were identified. The CrPPPs which aligned with the subject(s) were added to the list of 
CrPPPs of interest.  
Selection of CrPPPs for Further Study From the list of CrPPPs, several entries  
were selected for further study regarding a potential role during C. reinhardtii PCD. 
While no stringent criteria were in place for this selection process, several factors were 
considered. First, as a more robust alignment increases the probability of homologous 
function between two proteins, alignments with higher bitscores, e-values, query 
coverages, and/or percent identities were preferred. Second, as a central premise for the 
use of C. reinhardtii as a model for studies in PCD, it was presented in Chapter 1 that C. 
reinhardtii serves as a model for transitionary stages between distant phylogenetic 
groups. As such, the proteins selected for study were chosen as a mixture of proteins 
which were either conserved between multiple phylogenies, or were limited to a 
subgroup of organisms. Finally, as it was known that the study to follow would utilize 
mutant strains ordered from a mutant library, the last criterion used in the selection of 
CrPPPs to study further was whether a mutant strain with a disrupted allele of the gene 






Predicted contributors to C. reinhardtii PCD 
query bitscore evalue qcovs pident sacc subject name Organism 
Cre01.g004350.t1.2 210 4.37E-56 80 26.63 NP_001158150.1 programmed cell death 6-
interacting protein 
Mus musculus 












Cre01.g050150.t1.1 109 9.16E-26 54 32.889 NP_015154.1 Old yellow enzyme 3 (OYE3) Saccharomyces 
cerevisiae 
Cre01.g052300.t1.1 156 1.09E-41 39 42.439 NP_005216.1 E2F-1 Homo sapiens 
Cre01.g061807.t1.1 147 7.12E-43 84 37.5 NP_062254.2 Bax inhibitor 1 Rattus 
norvegicus  
156 2.37E-46 93 42.5 NP_199523.1 Bax inhibitor 1 Arabidopsis 
thaliana 
Cre02.g085650.t1.1 202 2.05E-61 99 33.943 NP_009498.1 Deoxyribonuclease Tat-D Saccharomyces 
cerevisiae 




Cre02.g108400.t1.2 137 9.91E-43 97 59.813 NP_001335.1 Defender against death 1 (DAD-1) Homo sapiens  
125 5.20E-38 97 51.429 NP_174500.1 Defender against death 1 (DAD-1)  Arabidopsis 
thaliana 








query bitscore evalue qcovs pident sacc subject name Organism 
Cre02.g117500.t1.2 241 2.14E-71 77 31.827 NP_194642.1 Hexokinase 1 Arabidopsis 
thaliana 












Cre03.g153800.t1.1 333 2.90E-111 67 55.797 NP_973794.1 GPI transamidase Arabidopsis 
thaliana 
Cre03.g163500.t1.2 147 6.32E-36 34 40.367 NP_564287.1 Executer 2 Arabidopsis 
thaliana  
133 1.87E-31 27 45.395 NP_849488.1 Executer 1 Arabidopsis 
thaliana 




Cre03.g184700.t1.2 103 1.13E-23 55 42.667 NP_014840.4 Metacaspase-1 Saccharomyces 
cerevisiae  
248 6.95E-78 99 35.16 NP_178051.1 Metacaspase-5 Arabidopsis 
thaliana  
246 3.36E-77 99 36.117 NP_178052.1 Metacaspase-4 Arabidopsis 
thaliana  
162 2.45E-45 78 37.269 NP_173092.1 Metacaspase-8 Arabidopsis 
thaliana  
109 3.35E-26 35 40.667 NP_201229.1 Metacaspase-3 Arabidopsis 
thaliana  
107 3.24E-25 35 37.333 NP_171719.2 Metacaspase-1 Arabidopsis 
thaliana  







query bitscore evalue qcovs pident sacc subject name Organism 
Cre03.g184700.t2.1 206 2.87E-62 98 32.843 NP_178051.1 Metacaspase-5 Arabidopsis 
thaliana  
204 2.82E-61 99 33.333 NP_178052.1 Metacaspase-4 Arabidopsis 
thaliana  
124 2.19E-31 77 33.878 NP_173092.1 Metacaspase-8 Arabidopsis 
thaliana 
Cre03.g206800.t1.1 156 1.03E-40 67 32.242 NP_198006.1 Sugar transport protein 13 Arabidopsis 
thaliana 
Cre03.g209393.t1.1 241 1.51E-74 82 39.25 NP_015154.1 Old yellow enzyme 3 (OYE3) Saccharomyces 
cerevisiae  
240 1.73E-74 79 39.535 NP_012049.1 Old yellow enzyme 2 (OYE2) Saccharomyces 
cerevisiae 
Cre03.g210513.t1.1 245 1.14E-76 86 39.348 NP_015154.1 Old yellow enzyme 3 (OYE3) Saccharomyces 
cerevisiae  
244 4.53E-76 84 39.744 NP_012049.1 Old yellow enzyme 2 (OYE2) Saccharomyces 
cerevisiae 
Cre04.g217922.t1.1 268 4.78E-78 36 38.953 NP_083045.4 Synoviolin Mus musculus 
Cre04.g226850.t1.2 257 1.55E-79 65 47.02 NP_015171.1 Proteinase A Saccharomyces 
cerevisiae 












300 4.20E-103 96 62.343 NP_113791.1 14-3-3 protein epsilon Rattus 
norvegicus  
276 1.24E-93 96 57.917 NP_036611.2 14-3-3 protein gamma Homo sapiens  





query bitscore evalue qcovs pident sacc subject name Organism  
268 3.02E-90 96 57.083 NP_003396.1 14-3-3 protein eta Homo sapiens  
263 2.38E-88 93 58.009 NP_037143.2 14-3-3 protein zeta/delta Rattus 
norvegicus  
258 2.75E-86 91 58.407 NP_037185.1 14-3-3 protein theta Rattus 
norvegicus 




100 1.30E-21 54 27.607 NP_780387.2 Apoptosis-inducing factor 3 
(AIF3) 
Mus musculus 
Cre06.g274500.t1.2 121 2.84E-32 64 45.062 NP_001186793.1 BCL2L2-PABPN1 Homo sapiens 




Cre06.g303900.t1.1 128 1.19E-33 47 37.705 NP_014641.2 ADIPOR-like receptor IZH2 Saccharomyces 
cerevisiae 
Cre08.g362750.t1.2 177 1.81E-51 78 31.933 NP_012327.1 Mitochondrial nuclease (NUC1) Saccharomyces 
cerevisiae 
Cre08.g367650.t1.2 117 4.08E-28 86 29.487 NP_001269876.1 Apoptotic protease-activating 
factor 1 (APAF-1) 
Mus musculus 
 
117 5.94E-28 86 29.487 NP_033814.2 Apoptotic protease-activating 
factor 1 (APAF-1) 
Mus musculus 
Cre08.g367800.t1.2 196 1.63E-60 76 41.736 NP_849368.1 Nudix hydrolase 7 Arabidopsis 
thaliana 
Cre08.g371052.t1.1 265 1.53E-72 42 34.632 NP_001424.3 Inositol-requiring enzyme 1 
(IRE-1) 
Homo sapiens 












query bitscore evalue qcovs pident sacc subject name Organism  
















142 1.62E-35 85 33.051 NP_055271.2 Programmed cell death protein 4 
(PDCD4) 
Homo sapiens 
Cre10.g428750.t1.1 357 6.71E-99 98 26.78 NP_055791.1 Programmed cell death protein 11 
(PDCD11) 
Homo sapiens 
Cre11.g475350.t1.1 134 4.93E-37 91 34.146 NP_064709.2 Anamorsin Homo sapiens 
Cre11.g480060.t1.2 145 1.30E-38 37 36.607 NP_001156411.1 Apoptosis-enhancing nuclease 
(AEN) 
Mus musculus 
Cre12.g483550.t1.2 107 1.75E-24 33 29.339 NP_973794.1 GPI transamidase Arabidopsis 
thaliana 
Cre12.g496650.t1.2 188 1.10E-58 78 43.304 NP_181023.1 Fatty acid 2-hydroxylase 1 (FAH1) Arabidopsis 
thaliana  
176 4.78E-54 80 40.351 NP_193819.1 Fatty acid 2-hydroxylase 2 (FAH2) Arabidopsis 
thaliana 








Cre12.g517451.t1.1 153 9.16E-41 46 36.364 NP_014840.4 Metacaspase-1 Saccharomyces 
cerevisiae  






query bitscore evalue qcovs pident sacc subject name Organism  
236 6.58E-73 55 44.561 NP_171719.2 Metacaspase-1 Arabidopsis 
thaliana  
214 1.90E-64 55 41.319 NP_201229.1 Metacaspase-3 Arabidopsis 
thaliana  
105 6.89E-24 29 39.474 NP_178051.1 Metacaspase-5 Arabidopsis 
thaliana  
102 7.40E-23 29 37.584 NP_178052.1 Metacaspase-4 Arabidopsis 
thaliana 
Cre12.g556228.t1.1 109 2.45E-26 89 31.045 NP_001185625.1 Apoptosis-inducing factor 2 
(AIF2) 
Homo sapiens 
Cre13.g587000.t1.2 116 5.96E-27 77 27.551 NP_062790.1 Apoptosis-antagonizing 
transcription factor 
Mus musculus 
Cre13.g588550.t1.2 231 1.07E-73 98 43.182 NP_190808.1 Syntaxin-122 Arabidopsis 
thaliana 








Cre16.g674050.t1.2 108 1.82E-26 94 30.368 NP_671713.1 p53-induced gene 3 (PIG3) Homo sapiens 








Cre16.g685901.t1.1 670 0.00E+00 99 38.842 NP_076054.1 Exportin-2 Mus musculus 










query bitscore evalue qcovs pident sacc subject name Organism  
158 6.03E-44 97 30.457 NP_012049.1 Old yellow enzyme 2 (OYE2) Saccharomyces 
cerevisiae 




















Note: qseqid = Chlamydomonas query identifier (Phytozome), qcovs = percent of the C. reinhardtii query that is covered by the 
subject, pident = percent identity of the subject to the Chlamydomonas query, sacc = accession number of the subject sequence. 
Alignments are grouped together when either the query sequences are alternative transcripts of the same gene, or when multiple 
proteins from the PCD database aligned with a single C. reinhardtii protein. Bolded alignments represent the C. reinhardtii queries 






Analysis and Discussion of the CrPPPs Selected for Further Study For each of 
the chosen CrPPPs, further predictive analyses were carried out to confirm that the robust 
BLASTp alignments were representative of functional similarities between the C. 
reinhardtii protein and its homologs in other organisms. For each selected C. reinhardtii 
protein, the homologous amino acid sequences from H. sapiens, A. thaliana, and S. 
cerevisiae were retrieved, if present, from the NCBI database. Notably, though a role in 
PCD has been established for the homolog from least one of these organisms, the 
existence of such a role may have yet to be determined in one or more of the homologs 
from other organisms. Such unconfirmed roles will be declared for each sequence in the 
following discussion. All retrieved sequences were imported into the locally-installed 
Geneious software and aligned using the included ClustalW alignment tool.210,211 
Subsequently, the domains, features, and annotations of all sequences were predicted 
using the InterProScan plugin available for Geneious.212,213 To support the prediction that 
the C. reinhardtii protein and its homologs are similar in function, the presence and 
relative locations of the annotations assigned by InterProScan were qualitatively 
compared between sequences. The domains for the sequences were assigned individually, 
and thus independently of the amino acid alignments, for each individual sequence. 
Because the protein domains were predicted independently of the amino acid alignments, 
the shared presence and alignment of the domains between a C. reinhardtii protein and 
one or more of its homologs corroborates the prediction that the protein’s function may 





Bax inhibitor 1 BI-1is an ER transmembrane protein that acts to repress cell 
death in response to a number of different stressors.214 Despite this well-established role, 
little is known regarding the mechanisms by which BI-1 attenuates PCD. BI-1 was 
initially identified by a functional screen in yeast, in which a human cDNA expression 
library was cloned into a Bax-expressing strain of S. cerevisiae.215 Subsequent 
experiments revealed that BI-1 co-immunoprecipitates with the anti-apoptotic BCL-2 and 
BCLXL proteins, linking BI-1 with a critical anti-apoptotic pathway in animals.215 BI-1 is 
also believed to achieve its anti-PCD functions through two additional mechanisms: the 
reduction of Ca2+ levels in the endoplasmic reticulum and the negative regulation of the 
IRE-1 pro-PCD signaling mechanisms.214 
BI-1 is well-conserved in animals, plants, and yeast. In Arabidopsis, ER-mediated 
PCD can be accelerated by disruption of the bi-1 gene, and attenuated by overexpression 
of bi-1.216 In mammalian cells, BI-1 acts early in the early stages of the adaptive response 
to ER stress by directly interacting with the stress sensor IRE-1.217 In plants, BI-1 
expression is controlled by the transcription factor bZIP60.218 As plant IRE-1 mediates 
the transcriptional activity of bZIP60, the activation provides another link between BI-1 
and IRE-1. 
A strong case has been presented for the conserved function of BI-1 in distinct 
lineages. The expression of mammalian Bax in plant and yeast cells rapidly induced 
PCD, whereas the overexpression of BI-1 was sufficient to repress Bax-induced 
death.215,219 When mammalian BI-1 was overexpressed in Bax-expressing plant cells, 
death was repressed.219 Moreover, the co-expression of plant BI-1 with mammalian Bax 




yeast cells expressing either Drosophila or Arabidopsis BI-1 were markedly more 
resistant to PCD induced by both H2O2 and heat stress.221 Taken together, the results of 
these studies are highly indicative of a conserved role for BI-1 in the repression of cell 
death. 
Given the widespread presence of BI-1 in eukaryotic systems, it has the potential 
to serve as an excellent starting point for studying phylogenetically-conserved 
mechanisms of PCD in C. reinhardtii. The alignment of C. reinhardtii BI-1 to its 
homologs in H. sapiens (accession: AAU29521), A. thaliana (accession: AAG35727), 
and S. cerevisiae (accession: P48558.1) is shown in Figure 10. Each of the four 
sequences is predicted to contain cytoplasmic domains, transmembrane domains, and 
non-cytoplasmic, presumably luminal, domains. While each of the aligned BI-1 
homologs possesses four cytoplasmic domains, the BI-1 sequences from C. reinhardtii, 
A. thaliana, and S. cerevisiae are predicted to contain seven transmembrane domains and 
four luminal domains. BI-1 from H. sapiens was only predicted to contain 6 
transmembrane domains and three luminal domains. The biological significance of this 
observation is unknown, but it may indicate a divergence of human BI-1 from the other 
BI-1 proteins. Cumulatively, these results indicate a high degree of conservation between 
C. reinhardtii BI-1 and its homologs from other phyla, suggesting that the anti-PCD 






Figure 10. Alignment and annotation of the BI-1 proteins from C. reinhardtii, plants, humans, and yeast. The graph at the top of the 
figure represents the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved 
residues highlighted in color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation 





Inositol-requiring enzyme 1 IRE-1 is an ER transmembrane protein which acts to 
mediate PCD in response to the accumulation of unfolded or misfolded proteins within 
the ER.222 The accrual of such aberrant proteins is referred to as ER stress, and the cell 
attempts to correct this condition via the unfolded protein response (UPR).223 IRE-1 is 
composed of a luminal region, a transmembrane domain, and a cytosolic region. The 
cytosolic region of IRE-1 contains two functional domains: a serine/threonine kinase 
domain and an endoribonuclease domain.223 Though IRE-1 was initially believed to 
promote cell survival, recent studies have instead demonstrated that IRE-1 acts as a 
molecular switch during ER stress, and can act to either promote cell survival or to 
induce PCD.222  
During the initial phase of ER stress, IRE-1 activates the UPR in an attempt to 
restore protein homeostasis.224 At the onset of stress, IRE-1 monomers dimerize or 
oligomerize within the ER membrane and are activated by trans-autophosphorylation 
events.223 Activated IRE-1 attempts to adapt to the stress by two primary mechanisms, 
which are carried out simultaneously.223 Firstly, IRE-1 initiates a process known as 
Regulated IRE-1-Dependent Decay (RIDD), which selectively degrades the transcripts of 
ER-translocating proteins to reduce the protein-folding demand within the ER.224 
Secondly, the RNase domain of IRE-1 alternatively splices the bZIP transcription factors 
Xpb-1, bZIP60, and Hac1 in animals, plants, and yeast, respectively.223 The activated 
bZIP transcription factor localizes to the nucleus, where it induces the transcription of ER 
quality control components.223 In animals, if the cell is unable to restore ER protein 
homeostasis, the RIDD pathway switches targets and initiates the apoptotic process by 




translation of caspase-2 mRNA.224 This degradation allows for the upregulation of 
caspase-2, which then promotes the activation of the apoptotic program. 
Importantly, recent studies indicate that, even in animals, the IRE-1 signaling 
network remains largely undiscovered, and the IRE-1-caspase-2 axis is likely only one of 
several mechanisms by which IRE-1 can initiate PCD in animal cells.222,223 Further 
clouding the matter is that the pathways by which IRE-1 induces PCD in animals, plants, 
and yeast are likely to have diverged.223 As such, multiple and possibly unique 
mechanisms may underlie IRE-1-mediated cell death in plants and yeast as well.223,224 
As IRE-1 is conserved in eukaryotes, with potentially divergent PCD functions in 
different lineages, C. reinhardtii IRE-1 may represent a transitionary form of the protein. 
As such, the characterization of the role of IRE-1 during C. reinhardtii PCD may 
facilitate the discovery of previously unknown IRE-1 mechanisms in other organisms. 
The alignment of C. reinhardtii IRE-1 to homologous sequences from H. sapiens 
(accession: NP_001424), A. thaliana (accession: NP_565419), and S. cerevisiae 
(accession: NP_011946.1) is shown in Figure 11. Interestingly, several features of C. 
reinhardtii IRE-1 are unique compared to those of its homologs. First, both a 
transmembrane domain and a cytosolic domain are predicted to be present in IRE-1 from 
H. sapiens, A. thaliana, and S. cerevisiae. Neither domains were predicted to be present 
in C. reinhardtii IRE-1. Instead, a non-cytoplasmic domain is predicted to span the entire 
protein. Though the biological implications of this prediction are unknown and somewhat 
puzzling, it may indicate that C. reinhardtii IRE-1 is not a transmembrane protein. 
Characterization of IRE-1 in C. reinhardtii will be necessary to confirm this prediction. 




predicted to possess a zinc finger domain at the C-terminus of the peptide. Also of note is 
that a quinoprotein alcohol dehydrogenase-like domain is predicted to be present in C. 
reinhardtii, humans, and yeast, but not in plants. A search of the literature indicates that a 
role for this domain within IRE-1 has not been described in any of the other species, and 
its function remains unknown. Consistent with the known functions of IRE-1, all 
sequences are predicted to possess kinase and RNase domains. Cumulatively, these 
results indicate that there is a high degree of conservation between C. reinhardtii IRE-1 
and its homologs from other phyla, suggesting that the function of IRE-1 as a mediator of 
PCD may be conserved in C. reinhardtii. Notably, the predictions that 1) C. reinhardtii 
IRE-1 is not a transmembrane protein, and 2) C. reinhardtii IRE-1 possess a unique a 
zinc finger domain at the C-terminal region may indicate additional and novel functions 





Figure 11. Alignment and annotation of the IRE-1 proteins from C. reinhardtii, plants, humans, and yeast. The graph at the top of the 
figure represents the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved 
residues highlighted in color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation 






E2F The E2F family of proteins is conserved in animals and plants. In mammals, 
the E2F family comprises eight genes, e2f1–8, which code for a total of 9 distinct 
proteins.225 The e2f3 gene codes for both E2F3a and E2F3b by the utilization of 
alternative promoters. Traditionally, members of the E2F family are best known for their 
role in the regulation of cell cycle progression. Interestingly, studies demonstrate that one 
family member in particular, E2F1, can act as a key mediator of the apoptotic process. 
Pro-survival signals, such as those from the phosphatidylinositol 3 kinase (PI3K)–protein 
kinase B (Akt) and epidermal- growth-factor receptor (EGFR)–Ras pathways, inhibit 
E2F1-mediated apoptosis, whereas E2F1-mediated apoptosis suppresses such pro-
survival signals. That E2F1 can induce both cell proliferation and apoptosis intuitively 
seems paradoxical, but such a mechanism may represent a centralized control system by 
which the cell decides to live or die when faced with stress.225 
All E2F proteins contain a DNA-binding domain.226 E2F1–5 possess an additional 
transactivation domain that enables activation of gene expression. Also, E2F1-6 contain a 
dimerization domain, through which the interaction with members of the dimerization-
partner (DP) family members is achieved. The interaction with DP-family proteins 
enables these E2F proteins to bind DNA and act as transcriptional regulators.227 E2F7 and 
E2F8 do not interact with DP family members, but bind DNA as either homodimers or 
E2F7-E2F8 heterodimers.225 
The transcriptional activity of E2F family members is mediated by several 
mechanisms. The best understood involves the association of E2F with the 




transactivate, but also causes the recruitment of various chromatin modifiers and 
remodeling factors to the promoter regions of E2F target genes.226 
E2F1 can induce apoptosis in a p53 -dependent or -independent manner.228,229 In 
the p53-dependent manner, E2F1 controls the expression of the p53-activating kinases 
ataxia telangiectasia mutated (ATM) and checkpoint kinase 2 (Chk2).230–232 In addition to 
promoting the activation of p53, E2F1 can also directly promote the expression of p53, as 
well as pro-apoptotic cofactors of p53, such as apoptosis stimulating protein of p53 1 and 
2 (ASSP1-2), junction-mediating and -regulatory protein (JMY), and tumor protein p53-
inducible nuclear protein 1 (TP53INP1).226,233,234 Furthermore, E2F1 is also capable of 
promoting apoptosis independently of its transcriptional abilities by directly binding 
p53.235 
E2F1 can also induce apoptosis independently of p53, primarily by upregulating 
pro-apoptotic genes and suppressing the expression of pro-survival signals. The pro-
apoptotic genes upregulated by E2F include those which code for APAF1, caspases -3, -
7, and -8, the BCL-2 effectors BAK and BOK, the BH3-only proteins BAD and BID, 
PIG8, and the p53 family member p73.225,226,236 The survival signals that are repressed by 
E2F1 during apoptosis include those mediated by the transcription factor nuclear factor- 
kB (NF-kB) or by BCL-2 and its family member myeloid cell leukemia 1 (MCL-1).237 
The mechanisms by which the apoptotic activity of E2F1 is regulated are not well 
understood. Thus far, the only pro-apoptotic cofactor of E2F1 that has been identified is 
JAB1, which interacts with E2F1 via a marked box domain, a domain within E2F1 which 




modulates the apoptotic activity of E2F1 is apoptotic inhibitor 5 (API5), which inhibits 
E2F1-mediated apoptosis.240 
While E2F family members are conserved in some fungal lineages, these proteins 
are absent in yeast.227 Though E2F family members are present in plants, their 
involvement in plant PCD has not been explored in detail. Interestingly, PCD in response 
to the DNA-damaging agent bleomycin is attenuated by E2F overexpression in tobacco, 
suggesting an anti-PCD role for E2F in plant PCD.241 
Because E2F family members are conserved in both animals and plants, 
understanding the role of E2F in C. reinhardtii may aid in identifying features of PCD 
that are conserved between plants and animals. Furthermore, it is also predicted that C. 
reinhardtii E2F may also reveal features of PCD that have diverged from animals. This 
prediction stems from the observation that, in animals, E2F1 is capable of inducing 
apoptosis independently of p53. Of particular interest is the ability of E2F1 to activate 
p53 target genes to induce apoptosis. At least one pro-PCD gene targeted by both p53 and 
E2F1, PIG8, has been identified in both C. reinhardtii and animals. Furthermore, PIG8 
epxpression is upregulated during C. reinhardtii PCD. As an ortholog of p53 has yet to 
be identified in C. reinhardtii, it may be the case that PIG8 is activated by E2F during C. 
reinhardtii PCD. In an even broader sense, we present the possibility that, in the absence 
of p53, C. reinhardtii E2F may act as a central mediator of PCD.  
The alignment of C. reinhardtii E2F with E2F family members from H. sapiens 
(accessions: Q01094, Q14209, O00716, Q16254, Q15329, O75461, Q96AV8, A0AVK6) 
and A. thaliana (accessions: Q9FNY0.1, Q9FV71.1, Q9FV70.1, Q9LFQ9.1, Q8LSZ4.1, 




do little to distinguish family members within the same organism, the two broad classes 
of E2F members become apparent when visualized in this manner. While some family 
members possess a heterodimerization domain for interaction with the DP regulators, 
others do not. H. sapiens possesses two E2F proteins, E2F7 and E2F8, which are not 
predicted to contain this domain, while A. thaliana possesses three such members: E2FD, 
E2FE, and E2FF. C. reinhardtii E2F aligned more robustly with E2F1-6 in humans, 
suggesting similarities to one or more of these proteins. Interestingly, when aligned with 
E2F family members from Arabidopsis, the DP dimerization domain of C. reinhardtii 
E2F did not align with the DP dimerization domain predicted in the A. thaliana E2FA-C. 
The implications of this result, if any, are not known. Cumulatively, these results suggest 
that a high degree of conservation exists between C. reinhardtii E2F and E2F family 
members from animals and plants. Importantly, however, the high degree of conservation 
between the E2F family members renders a more detailed analysis of the results from 





Figure 12. Alignment and annotation of the E2F proteins from C. reinhardtii and humans. The graph at the top of the figure represents 
the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved residues highlighted in 
color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation denotes its source, where 






Figure 13. Alignment and annotation of the E2F proteins from C. reinhardtii and plants. The graph at the top of the figure represents 
the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved residues highlighted in 
color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation denotes its source, where 





Tat-D  TatD was first described in E. coli as a component of the twin arginine 
translocation (TAT) operon242 Unlike TatA, TatB, and TatC, which localize to the 
bacterial plasma membrane to form a complex necessary for the transport of proteins 
from the cytoplasm to the periplasm, TatD was determined to be a cytoplasmic protein 
with Mg2+-dependent single-stranded DNase activity.243,244 Because of this, it was 
proposed that TatD is unlikely to function in protein export with the other components of 
the Tat operon.243  
A search for apoptotic nucleases in Caenorhabditis elegans identified CRN-2, a 
homolog of bacterial TatD.245 Using an RNAi-based approach, repression of crn-2 
expression resulted in a delayed PCD during development, suggesting a potential role for 
CRN-2 in C. elegans PCD. Moreover, knockdown of crn-2 expression in the background 
of a mutation in ced-3, the C. elegans homolog of caspase-9, resulted in a significant 
inhibition of cell death. Interestingly, however, an enhanced TUNEL-positive phenotype, 
a common marker for cell death, was observed when crn-2 was knocked down in a 
background strain harboring a mutation in cps-6, the C. elegans homolog of endoG.245 
Cumulatively, the results of this study may indicate that crn-2 in C. elegans plays a pro-
PCD role during PCD, but additional research into the matter is required. 
In S. cerevisiae, TAT-D was shown to be an endo-/exonuclease which plays dual 
roles in the degradation of genomic DNA.110 TAT-D in S. cerevisiae acts as an 
endonuclease by non-specifically cleaving dsDNA and as an exonuclease by excising 
DNA in the 3’-5’ direction. In agreement with a role for S. cerevisiae TAT-D in PCD, 
yeast strains overexpressing TAT-D exhibited an increased rate apoptosis when treated 




strain lacking functional TAT-D exhibited a resistance to PCD in response to H2O2. 
Interestingly, despite the contrasting survival results, strains of C. elegans and S. 
cerevisiae lacking TAT-D/CRN-2 exhibited an enhancement of TUNEL-positive 
phenotypes.110 
Studies in bacteria revealed that E. coli TatD is a Mg2+-dependent 3’-5’ 
exonuclease.243 In addition, this study also found that E. coli TatD exhibits a strong 
specificity for single-stranded DNA and RNA, and possesses a very low affinity for 
dsDNA, indicating that the endonuclease role for this enzyme in animals and yeast may 
not be conserved in bacteria. Similarly to the results observed in S. cerevisiae, a strain of 
E. coli deficient in TatD was found to be sensitive to treatment with low levels of 
H2O2.243  While this could suggest that TatD may contribute to PCD in bacteria, the 
authors postulate that TatD is a DNA repair enzyme, and that the decreased survival may 
be due to a role for TatD in DNA damage accumulated by exposure to H2O2. 
TAT-D is widely conserved throughout all kingdoms of life, with homologs in 
animals, plants, fungi, and prokaryotes.243 Despite this, little is known regarding the role 
of TatD during PCD. Moreover, investigations of the nuclease in different organisms 
suggest that the function of TAT-D may have diverged between phyla. As such, we 
reasoned that understanding the role of TAT-D during C. reinhardtii PCD may further 
facilitate an understanding of how PCD is carried out in both prokaryotes and eukaryotes. 
The alignment of C. reinhardtii TAT-D to homologs from H. sapiens (accession: 
AAH64964.1), A. thaliana (accession: NP_190807.3), and S. cerevisiae (accession: 
P34220) is shown in Figure 14. Each of the four TAT-D proteins were predicted to be 




degree of conservation between C. reinhardtii TAT-D and its homologs from other phyla, 






Figure 14. Alignment and annotation of the TAT-D proteins from C. reinhardtii, plants, yeast, and humans. The graph at the top of the 
figure represents the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved 
residues highlighted in color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation 





Lesion-stimulating disease 1 Lesion-stimulating disease 1 (LSD-1) is a negative 
regulator of cell death in plants.246 Early studies into LSD-1 revealed that lsd-1 loss-of-
function in Arabidopsis results in a distinctive “runaway” cell death phenotype. This 
phenotype is characterized by the inability of leaf cells to restrict the propagation of cell 
death following an initial stress stimulus.246,247 This uncontrolled death comes about as 
the result of accumulated ROS, including superoxide ions and hydrogen peroxide.88,247–249 
The elevated levels of ROS observed in Arabidopsis lsd-1 mutants are the result of 
lowered antioxidant enzyme activity, suggesting that LSD-1 acts as a positive regulator 
of antioxidant machinery during PCD.  
Despite the long-standing recognition of LSD-1 as an important repressor of PCD 
in plants, the mechanisms by which LSD-1 attenuates PCD have remained largely 
undiscovered.246 The runaway death phenotype of lsd-1 mutants is dependent on 
enhanced disease susceptibility 1 (ESD-1) and phytoalexin deficient 4 (PAD-4), as loss-
of-function mutations in either eds-1 or pad-4 in the lsd-1 mutant strain attenuate the 
runaway cell death phenotype. Moreover, EDS-1 and PAD-4 are believed to function 
antagonistically to LSD-1, as both produce effects which contrast LSD-1 in response to 
stress.249 The LSD-1/EDS-1/PAD-4 regulatory system has been well established, and 
may represent a core mechanism by which PCD is regulated in the cell.249 
LSD-1 contains three zinc(Zn)-finger motifs, which mitigate a protein’s 
interactions between proteins, DNA, and/or RNA. The LSD-1 Zn-finger domains have 
been categorized as C2C2-type, which are distinct for some transcription factors.250 As 




In addition to functioning as a putative transcriptional regulator, a yeast two-
hybrid screen revealed ten distinct proteins with which LSD-1 may interact. At least one 
of these proteins, metacaspase-1, is a positive regulator of plant PCD, and interacts with 
the second and third Zn-finger domains of LSD-1.251 One proposed model postulates that, 
under unstressed conditions, LSD-1 is bound to the inactive metacaspase-1 zymogen, 
suppressing its conversion into the active protease.252 In response to a PCD-inducing 
stress, pro-PCD signaling causes the dissociation of LSD-1 from metacaspase-1, and 
subsequent maturation and activation of metacaspase-1 brings about PCD.252  
In response to the meager understanding of the molecular and cellular functions of 
LSD-1, a very recent study sought to characterize the protein in greater detail.249 While it 
should be noted that this analysis did not examine the role of LSD-1 during PCD, the 
obtained results establish the extraordinarily broad implications of LSD-1 in the plant 
cell. Namely, this study identifies a previously-unpredicted function of LSD-1 as a 
scaffolding protein which interacts with proteins that are engaged in a diverse array of 
molecular pathways. These include methylation, ubiquitination, cell cycle control, cell 
wall formation, gametogenesis, and embryo development. Furthermore, the authors 
demonstrate that the association of LSD-1 with proteins from these pathways is 
dependent on the redox state of the cell, and that oxidative stress has a strong effect on 
the proteins that LSD-1 interacts with. Moreover, this study also confirmed the long-
standing prediction that LSD-1 acts as a transcriptional regulator that translocates from 





As LSD-1 is conserved only in plants, it likely represents a divergent component 
of PCD that is plant-specific. As such, it may prove a useful subject for the study of 
plant-specific PCD processes. Furthermore, the cumulative observations that LSD-1 1) 
interacts with proteins from a number of essential plant PCD processes, 2) interacts with 
a distinct set of proteins during oxidative stress, 3) directly regulates gene transcription, 
and 4) is essential for the control and negative regulation of PCD, may collectively 
implicate LSD-1 as a primary point of integration for pro- and anti-PCD signaling. If 
true, this would allude to LSD-1 as a central mediator of the life and death decision-
making process in plants. In addition, the conservation of LSD-1 in plants and C. 
reinhardtii suggests that the acquisition of LSD-1 was an early event in the evolution of 
plants. Because of this, C. reinhardtii LSD-1 may serve as a prime subject for 
understanding the early divergence of PCD between plants and other eukaryotes.  
The alignment of C. reinhardtii LSD-1 its homolog in A. thaliana (accession: 
OAP01040) is shown in A. Both proteins were predicted to contain LSD-1-type zinc 
finger domains. Perplexingly, the putative LSD-1 protein in C. reinhardtii was predicted 
to be LOL-1. A search of the literature revealed that LSD-1-like 1 (LOL-1) is 
evolutionarily related to LSD-1 and has been implicated to function as a positive 
regulator of PCD in plants.253 Similar to LSD-1, LOL-1 possesses three zinc finger 
domains, indicating that it may also function as a transcriptional regulator. It has been 
proposed that LSD-1 and LOL-1 function antagonistically to regulate plant PCD.253 In 
addition, the discovery of other LOL proteins in plants presents even further possibilities 




When A. thaliana LOL-1 (accession: Q93ZB1.1) was integrated into the 
alignment of LSD-1 from C. reinhardtii (Figure 15B), the C. reinhardtii protein aligned 
more robustly with LSD-1 (42% identity) than with LOL-1 (38% identity). Furthermore, 
InterProScan functional annotation did not annotate the LOL-1 protein as LOL-1, 
indicating that this annotation system may not be sufficient to accurately distinguish 
between the two closely-related proteins. Cumulatively, these results indicate that LSD-1 
is highly conserved between C. reinhardtii and A. thaliana, suggesting that the anti-PCD 
function of LSD-1 may be conserved in C. reinhardtii. However, the possibility that the 







Figure 15. Alignment and annotation of the LSD-1 homologs from C. reinhardtii and plants. A) C. reinhardtii LSD-1 aligned with 
LSD-1 from A. thaliana. B) C. reinhardtii LSD-1 aligned with LSD-1 and LOL-1 from A. thaliana. The graph at the top of each figure 
represents the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved residues 
highlighted in color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation denotes its 






p53-induced gene 3 p53-induced gene 3 (PIG3) was first identified as one of 13 
previously-undiscovered genes that are upregulated by p53 prior to the onset of 
apoptosis.254 In spite of the apparent specificity of p53 to animal lineages, PIG3 is well 
conserved, and orthologs of PIG3 exist in both plants and bacteria.255 Of note, a search of 
the protein databases and literature suggests that PIG3 is not present in yeast. PIG3 is a 
quinone oxidoreductase which catalyzes the reduction of quinone into 
hydroxyquinone.254 Though PIG3 is known to participate in the apoptotic process, the 
mechanisms by which it induces apoptosis are not well-characterized. 
Following the synthesis of PIG3 during apoptosis, the treatment of cells with a 
quinone oxidoreductase inhibitor caused a significant reduction in ROS accumulation, as 
well as an extensive inhibition of apoptosis, suggesting that PIG3 positively regulates the 
apoptotic process by contributing to the accumulation of ROS.254  
In addition to its role in the generation of ROS, PIG3 has also been shown to 
contribute to the apoptotic process by other mechanisms. PIG3 positively regulates 
apoptosis by directly interacting with the p53 inhibitor MDM2.256 This association 
attenuates the MDM2-dependent ubiquination, and subsequent proteasomal degradation 
of, p53. Moreover, the PIG3-MDM2 association promotes the ubiquination and 
subsequent proteasomal degradation of MDM2.256 
The robust BLASTp alignment of a C. reinhardtii protein with human PIG3 
(Table 5) indicates that the two proteins may be homologous. Given that PIG3 is also 
present in plants, a lineage presumed to lack p53, it presents a unique opportunity to 




Furthermore, as PIG3 is present in C. reinhardtii, but not in S. cerevisiae, it may 
represent another aspect of PCD that has been lost in other unicellular lineages.  
The alignment of PIG3 from C. reinhardtii with PIG3 from H. sapiens (Q53FA7) 
and A. thaliana (NP_193889.1) is shown in Figure 16. Several domains are predicted to 
be conserved across all three sequences, including C- and N-terminus-specific alcohol 
dehydrogenase domains and an NAD(P)-binding domain with a Rossman-fold structure. 
In addition, C. reinhardtii PIG3 is predicted to be a quinone oxidoreductase-like. 







Figure 16. Alignment and annotation of the PIG3 proteins from C. reinhardtii, humans, and plants. The graph at the top of the figure 
represents the conservation of amino acids at each residue. Each protein has the results of the alignment, with conserved residues 
highlighted in color, and the annotations that were assigned to the proteins by InterProScan. The color of each annotation denotes its 






Currently, very little is known about the molecular mechanisms by which C. 
reinhardtii initiates and executes PCD. As such, the first aim of this study was to predict 
on a large scale, C. reinhardtii proteins which participate in PCD. To achieve this, the C. 
reinhardtii proteome was aligned with protein sequences from other organisms that were 
annotated to be involved in PCD using BLASTp. After removing the less robust 
alignments from the BLASTp results, 2,389 C. reinhardtii query sequences remained. 
We believe that this list will serve as an excellent starting point for studies which seek to 
characterize the molecular basis of PCD in C. reinhardtii. To further facilitate such 
efforts, we characterized the CrPPPs by assigning predicted GO terms to each of the 
sequences using BLAST2GO. 
The second aim of this study was to select several of the CrPPPs for further 
investigation regarding a role during C. reinhardtii PCD. In order to accomplish this goal, 
the BLASTp alignments of CrPPPs to the annotated PCD sequences was explored 
manually, and the CrPPPs which aligned strongly with a known PCD protein were used 
to create a list of proteins which we believe represent particularly strong candidates for 
further investigation. From this list of CrPPPs of interest, several were selected to be 
studied in this project. To validate that the robust BLASTp alignments represent similar 
characteristics between the known PCD subject proteins and the CrPPPs selected for 
further study, the amino acid sequences of the homologs from H. sapiens, A. thaliana, 
and S. cerevisiae were aligned with one another, the sequences were characterized using 
InterProScan annotations, and the presence/absence and locations of the annotations were 




chosen for further study was predicted to be similar, both in domain composition and 
structure, to its homologs, and thus represent strong candidates for studies seeking to 
elucidate the molecular mechanisms of PCD in C. reinhardtii (Table 6).  
Table 6 
C. reinhardtii proteins selected for further study 
Protein Conservation Predicted PCD Role 
BI-1 Eukaryotes Anti-PCD 
IRE-1 Eukaryotes PCD Mediator 
E2F Animals, plants Pro-PCD 
TAT-D Eukaryotes, prokaryotes Pro-PCD 
LSD-1 Plants Anti-PCD 







Selection and Verification of C. reinhardtii Mutant Strains 
Introduction 
Mutant strains are extremely powerful tools which facilitate the elucidation of 
gene function by examination of the phenotypes that result from the absence of a 
functional gene product. Collections of individual mutant strains are called mutant 
libraries, and can be produced or purchased by researchers interested in studying the 
function of a specific gene or a set of genes. Mutant libraries have revolutionized the 
study of gene function studies in bacteria, yeast, animals, and land plants.257–261 
Though mutant libraries can be generated on a large scale by a number of 
different techniques, one of the most common means of mutant library construction is 
through random insertional mutagenesis, a process by which foreign DNA introduced 
into the cell and non-specifically integrated introduced into the genome. The insertional 
loci are mapped for each transformant by sequencing the genomic sequencing that flank 
either side of the cassette. In addition, a selection marker, such as an antibiotic resistance 
gene, is integrated into the cassette to positively-select for transformant cells, while 
inhibiting the growth of non-transformants, when cultured on growth medium containing 
the antibiotic. 
Historically, reverse genetic studies in C. reinhardtii have been restricted by the 
lack of a comprehensive Chlamydomonas mutant library. In 2016, a commercially-
available library of C. reinhardtii mutant strains was made available for researchers by 
the Chlamydomonas Library Project (CLiP).173 The library was generated by 




4533 of C. reinhardtii. The insertional cassette used to generate the mutants contains a 
gene conferring resistance to paromomycin, an antibiotic to which C. reinhardtii is 
naturally susceptible.262 As such, positive selection of C. reinhardtii transformants 
following mass mutagenesis was achieved by plating the transformation culture onto 
medium containing the antibiototic. Transformants colonies were isolated and organized 
on solid medium in a layout similar to that of a 384-well plate.173 
The insertional locus of each colony was determined using a two-step 
combinatorial super-pooling method, in conjunction with large-scale sequencing.173 The 
first pooling scheme combined all colonies from a single plate. The second pooling 
scheme combined colonies by plate position across all plates. The genomic sequences 
flanking the inserts of all colonies in each pool were identified by two large-scale 
sequencing techniques: Chlamydomonas MmeI-based insertion site sequencing 
(ChlaMmeSeq) and Linear and Exponential Amplification coupled with Paired-end 
Sequencing (LEAP-Seq).173,262 Following the determination of genomic flanking 
sequences within in each pool, deconvolution algorithms were employed to assign the 
detected genomic flanking sequences to each of the individual colonies. Alignment of 
these flanking sequences with the C. reinhardtii genome revealed the insertional locus of 
the cassette for each colony. 
As suggested by the curators of the CLiP library, the reported insertional locus of 
each mutant strain should be individually confirmed prior to using the strains in 
experiments. In the article describing the generation of the mutant library, the authors 
demonstrated that insertion sites mapped by the large-scale methods described above 




the library caution that any culture received by the library may contain a mixture of more 
than one mutant strain. As such, validation of the mapped insertional mutation is a 
necessary prerequisite to experimental utilization of any CLiP mutant strain. 
In previous work, we used a large-scale approach to predict 2,389 C. reinhardtii 
proteins which participate in PCD. From this list of C. reinhardtii predicted PCD 
proteins, several were selected to be examined further for a role in C. reinhardtii PCD. 
The purpose of the current study is twofold. First, for each CrPPP that was previously 
selected for further study, we sought to select a mutant strain of C. reinhardtii with a 
disrupted gene coding for the selected protein. Second, for each of the chosen mutant 
strains, we sought to validate the insertion sites reported by the CLiP library. 
Materials and Methods 
Acquisition of C. reinhardtii Strains and Primers Mutant strains with an insert 
in one particular gene were chosen from the CLiP library (Table 7). To search for strains 
with an insert in the gene of interest, the gene locus was used to query the mutant 
collection from the CLiP website. If, for a given gene, multiple mutant strains were 
available, insertions that were 1) in the coding region of the predicted gene, and/or 2) had 
a high probability of being mapped correctly, were preferentially selected. The C. 
reinhardtii strains arrived by mail as slant cultures of growth medium. Upon the arrival 





Insertional characteristics of C. reinhardtii strains with a mutation in the selected genes. 
gene gene id mutant_ID chromosome side feat. flanking_seq conf 
bi-1 Cre01.g061807 LMJ.RY0402.079236 1 3' 3'UTR GTCTGAGCGTGACTCGAAGGACCTTGTCTC 73% 
 Cre01.g061807 LMJ.RY0402.114320 1 3' intron ATATTCAAGACAGCGCGCTGGCGACTTGCA 95% 
 Cre01.g061807 LMJ.RY0402.114320 1 5' intron GTTGCCTGTGGATGTTGCCCAGCATTGACT 95% 
 Cre01.g061807 LMJ.RY0402.127549 1 3' intron ACACACACCTACACACAAACACACACACAT 73% 
 Cre01.g061807 LMJ.RY0402.147808 1 5' intron CGAGGACGTGACTTGGCAGCTGCAAGTCGC 73% 
ire-1 Cre08.g371052 LMJ.RY0402.058154 8 3' MSVs CAAATCCTTGCACCACGTCAGCAGGTCCCG 73% 
 Cre08.g371052 LMJ.RY0402.079723 8 3' exon TCTCCACGGCGGTCCTGGTTGGCTACGAGC 58% 
 Cre08.g371052 LMJ.RY0402.098795 8 5' intron AGCAAAGCACATGAGGAAAGGGTTACTTAC 58% 
 Cre08.g371052 LMJ.RY0402.122895 8 5' MSVs ATAGGACGGGGGTTGCATGGATTGGTACAG 95% 
 Cre08.g371052 LMJ.RY0402.122895 8 3' MSVs CTGGCTACGCCTCCTCTTCGTTTCTAATGA 95% 
 Cre08.g371052 LMJ.RY0402.209343 8 3' MSVs GGGTGAGTGAGAGCGTGTGTTTGAGTGTGT 73% 
e2f Cre01.g052300 LMJ.RY0402.074518 1 5' exon GGTCCTGGTCGTCGGGGTCCGCTCCCCGGT 95% 
 Cre01.g052300 LMJ.RY0402.074518 1 3' exon CTACGGTGGAGGGGACGAGGACGACGAGG 95% 
 Cre01.g052300 LMJ.RY0402.087995 1 5' 3'UTR GCCCTCTCCCCACTCCATGACTTGCATCTC 95% 
 Cre01.g052300 LMJ.RY0402.087995 1 5' 3'UTR CAGGATTTTAGTGGGTAGCAGTCGTAAAGT 95% 
 Cre01.g052300 LMJ.RY0402.128436 1 3' intron GCGCGTGCGAAACCCCTCGCTACATGGGAA 95% 
 Cre01.g052300 LMJ.RY0402.128436 1 5' intron CACCATGCAAGGCTCACCTCAACCTTCCCT 95% 
 Cre01.g052300 LMJ.RY0402.135078 1 3' 3'UTR TGGCTGGGTTGATAACGACCTTTTCCTGCC 58% 






gene gene id mutant_ID chromosome side feat. flanking_seq conf 
 Cre01.g052300 LMJ.RY0402.190878 1 5' 3'UTR CACCACCACACTAACACCGTGTAACGACTC 95% 
 Cre01.g052300 LMJ.RY0402.190878 1 3' 3'UTR GTCATGGAGTGGGGAGAGGGCTGATCAAAC 95% 
tat-d Cre02.g085650 LMJ.RY0402.046580 2 5' intron CATGCACCACTCACATGGGTAGGCCCGACT 58% 
 Cre02.g085650 LMJ.RY0402.146555 2 5' exon CCGCTTGTACTGCACCGTGGGGTGTCACCC 73% 
 Cre02.g085650 LMJ.RY0402.192095 2 3' exon CGCCACGGCCTCCAGGTCCGTTCTCCCCTT 95% 
 Cre02.g085650 LMJ.RY0402.192095 2 5' exon TCTTCGGCAACACCGAGCGAATGTTCTTTC 95% 
 Cre02.g085650 LMJ.RY0402.195934 2 3' exon TCCTTGCACCGAGTGGGGTGACACCCCACG 95% 
 Cre02.g085650 LMJ.RY0402.195934 2 5' exon GTTCGAGGACCACCCGGGGGGACCGGAAGC 95% 
 Cre12.g517350 LMJ.RY0402.076546 12 3' 3'UTR GCGATGATGGGCCAAGGAGCGATAGGGACA 73% 
lsd-1 Cre12.g517350 LMJ.RY0402.114954 12 3' exon GGCACCCGGCACCCGTTGCACACGATTTGG 73% 
 Cre12.g517350 LMJ.RY0402.131712 12 5' 3'UTR CTCCTCTGCATCTCATCATACCAGCGTCAC 95% 
 Cre12.g517350 LMJ.RY0402.131712 12 5' 3'UTR ATGGGTACCAGCTATTCCATGTTGTGTAGG 95% 
 Cre12.g517350 LMJ.RY0402.198243 12 5' exon GGCTCCATGGCCCCGCCTTCTCAAAGCCAC 73% 
 Cre12.g517350 LMJ.RY0402.208237 12 3' 5'UTR AGTGTGAAGCTAATCGCGCAGGGGCTACAA 73% 
pig3 Cre16.g674050 LMJ.RY0402.061331 16 5' exon CATCATGTAGGAGCCCCTGCAGGCAGGCAG 95% 
 Cre16.g674050 LMJ.RY0402.061331 16 3' exon GTTTGGCCAGGGCAAGCTGCGCGTGGAGGT 95% 
 Cre16.g674050 LMJ.RY0402.167637 16 3' intron TGGCCCCGGCCACTCGGTTCAGTGTCCATT 58% 
 Cre16.g674050 LMJ.RY0402.197441 16 3' exon GTGGCCACTTGGCCGAAGCGCGTGCGCAGG 58% 
NOTE: Bolded entries designate strains that were selected for further study. Each row represents a side of the cassette that was 
mapped by the CLiP library. As each inserted cassette has a genomic sequence flanking either side, a single mutant strain should have 
two rows: one for each side of the cassette inserted into the genome. An exception to this is the lsd-1 mutant strain, in which only one 
side of the cassette was mapped. MSVs = multiple splice variants. Table adapted from the “basic mutant data table” file from the CLiP 





For each mutant strain, the CLiP library suggests genomic primers to use for 
verification of the insertional locus. The library also provides the primer sequences which 
bind the insertional cassette and face outward towards the genome. Notably, these same 
primers were used to map the genomic flanking sequences. The suggested genomic 
primer sequences for each locus of interest, as well as the sequences for the cassette 
primers, were retrieved from the CLiP website (Table 8). All primers were ordered from 
Thermo Fisher. The genomic primers were rehydrated to a concentration of 20 M, and 
the cassette primers were rehydrated to a concentration of 10 M.  
Table 8.  
Cassette and genomic primers used for verification of the mutant strains. 
Primer Name Primer sequence (5’ to 3’) 
bi-1 G1 AACCTATCACAATCCGCTGG 
bi-1 G2 CCCAACAGAACAAGCGGTAT 
ire-1 G1 CAACAGTTGCGTAGCGTTGT 
ire-1 G2 GGATTGTGGTTTCAGAGCGT 
e2f G1 CGCAGCTGTACCATCACTCA 
e2f G2 CCTGAACACACATGCCAAAC 
tat-d G1 GCTCAGGGGGTAGAATGTCA 
tat-d G2 GCTCTGGGGTAAGGGTAAGG 
lsd-1 G1 TGCATAGTGTGCATGCGTAA 
lsd-1 G2 AGAGGCGTGCTTGTGAAGAT 
pig3 G1 TGGAAATAGCTGTCGCTGTG 
pig3 G2 CTTGCCCTGCACACAATCTA 
Cassette Primer (C1) GCACCAATCATGTCAAGCCT 





Verification of Mutant Strains As recommended by the curators of CLiP 
library, the verification of each mutant strain consisted of four steps: 1) procuration of 
individual colonies from the slant culture received to produce a clonal culture of cells, 2) 
PCR amplification of the insertional locus reported by the CLiP library using genomic 
primers targeting either side of the insertional locus, 3) PCR amplification of both 
cassette-genome junctions using the locus-specific genomic primers in combination with 
the cassette primers, and 4) sequencing of the cassette-genome junction PCR products.  
Obtaining Clonal Populations In order to obtain a single colony from each strain, 
an inoculating loop was used to transfer a small number of cells from the stock slant to a 
fresh TAP plate, where an isolation streak was performed. The plates were allowed to 
incubate for three days. For each strain, five unique and well-isolated colonies were 
selected. Each of the selected colonies was picked onto a fresh TAP plate, where they 
were individually streaked to obtain small lawns of growth. 
Extraction of Crude Genomic DNA For each strain, a small loopful of cells was 
taken from a single lawn and transferred into a PCR tube containing 50 L of freshly-
prepared 10 mM EDTA, pH 8.0. The tubes were vortexed for ten seconds. The samples 
were then boiled in a thermocycler at 100C for 10 minutes, then cooled at 4 C for 1 
minute. The samples were vortexed for 10 seconds and subsequently centrifuged at 1000 
x g for 1 minute. The resulting supernatant, containing the crude genomic DNA, was 
aliquoted into fresh 1.5 mL centrifuge tubes.  
PCR Amplification of Insertion Sites 
Prediction of Amplicon Sizes Using Genomic Primers The predicted binding sites 




align the G1 and G2 primer sequences recommended for each strain (Table 8) with the C. 
reinhardtii genome (v5.5). For each pair of genomic primers, the predicted amplicon size 
was calculated by taking the difference, in base pairs, of the genomic sites to which the 
primers aligned.  
Laboratory Methods The PCR reactions were prepared as described by the CLiP 
website, with some modifications. Primer mixes of G1/G2 primers were prepared for 
each of the insertional loci by combining 50 L of 20 M G1 primer, 50 L of 20 M G2 
primer, and 100 L sterile water. A stock “PCR Solution” was prepared by mixing 
DMSO and sterile water in a 1.25:20.25 ratio.  
For each pair of genomic primers, two separate PCR reactions were carried out. In 
one reaction, genomic DNA from the corresponding mutant strain was used as a 
template. In the other reaction, genomic DNA from the wild-type strain was used as a 
template. The PCR reactions were prepared by adding 21.5 L PCR Solution, 2.5 L 
G1/G2 primer mix, and 1 L of the appropriate genomic DNA into an Illustra PuReTaq 
Ready-To-Go PCR Bead (GE Healthcare). The PCR reactions were carried out as 
described in Table 9.  
Table 9. 
PCR conditions for amplification of insertional loci and cassette-genome junctions 
Number of Repetitions Temperature (C) Time 
Once 95 5 minutes 
40 Cycles 95 30 seconds 
 58 45 seconds 





Number of Repetitions Temperature (C) Time 
Once 72 10 minutes 
Once 10 Hold 
 
The PCR products were immediately subjected to electrophoresis on a 1% 
agarose gel made with TAE and 0.00002% SYBR Safe (Thermo-Fisher). Electrophoresis 
was performed at 120V for 30 minutes, and the bands were visualized using the 
ChemiDoc XRS+ (Bio-Rad) imaging system, which had been outfitted with the 
XcitaBlue conversion screen (Bio-Rad) for compatibility with SYBR Safe.  
PCR Amplification of the Cassette-Genome Junctions 
Determination of the Cassette Primer Binding Sites In order to amplify the 
cassette-genome junctions, the CLiP library provides primer sequences designed to bind 
either side of the cassette and face outwards towards the genome. However, the binding 
sites of the cassette primers on the cassette are not provided. As a portion of the cassette 
will be included in the PCR product of each cassette-genome junction, the binding sites 
of the cassette primers are necessary to accurately predict the size of the cassette-genome 
amplicons. In addition, knowledge of the cassette side that each primer binds is necessary 
to determine the proper cassette/genome primer combinations to use when amplifying the 
cassette-genome junctions.  
The nucleotide sequence of the CIB1 cassette was retrieved from the CLiP 
website. The cassette sequence, along with the C1 and C2 primer sequences, were 
imported into the Geneious (v10.1.2) software. The binding sites of the C1 and C2 




Determination of Necessary Genomic/Cassette Primer Combinations The CLiP 
website provides a document titled “Instructions for characterizing insertion sites by 
PCR” (https://www.chlamylibrary.org/help). The authors of this document provide an 
example of a PCR-based method to confirm that an insert was mapped correctly. In this 
example, the cassette-genome junctions were amplified using the cassette primer C1 in 
conjunction with the genomic primer G1, and the cassette primer C2 in conjunction with 
the genomic primer G2. Of note, the cassette can insert into the genome in one of two 
orientations: sense or antisense. In the example provided, however, a single mutant strain, 
and thus only one cassette orientation, was used.  
In this study, when designing the PCR reactions to amplify the cassette-genome 
junctions, it was unclear if the orientation of the cassette would alter the combination of 
cassette/genome primers to be used. As such, for each mutant strain, the orientation of the 
cassette was determined. The orientation of the cassette, in conjunction with the binding 
locations of the cassette primers, were used to determine the appropriate combination of 
genomic and cassette primers to use.  
For each mutant strain, the genomic sequences reported to flank each side of the 
cassette (Table 7) were aligned with the C. reinhardtii genome using the BLASTn feature 
on the Phytozome webpage. The location of the genomic flanking sequences relative to 
one another revealed the orientation of the insert in each strain. For each of the strains, 
the cassette orientation and the predicted binding sites of the genomic primers were used 
to determine the necessary cassette/genome primer combination needed to amplify the 




Prediction of Cassette-Genome Amplicon Sizes Amplification of any cassette-
genome junction would consist of two parts: the base-pairs contributed by the genome 
and the base-pairs contributed by the cassette. To determine the size of the genomic 
portion of the cassette-genome amplicons, the difference, in bp, of each flanking 
sequence location and the binding site of its corresponding genomic primer was 
calculated. The portion of the cassette-genome junction amplicon contributed by the 
cassette was determined by taking the difference of the cassette primer binding site and 
the terminal residue of the cassette. Finally, in order to predict the total size of each 
cassette-genome junction amplicon, the portion of the amplicon contributed by the 
genome and the portion of the amplicon contributed by the cassette were summed 
together.  
Laboratory Methods Primer mixes of G1/C1 and G2/C2 were prepared by adding 
100 L of 10 M cassette primer, 50 L of 20 M genomic primer, and 50 L of water 
to a sterile 1.5 mL microcentrifuge tube. The PCR reactions were prepared by adding 
21.5 L PCR Solution, 2.5 L G1/G2 primer mix, and 1 L of the appropriate genomic 
DNA into a PCR tube containing a Ready-To-Go bead. The PCR reactions were allowed 
to proceed under the previous conditions (Table 9). Agarose electrophoresis and imaging 
of the PCR products were carried out as described above.  
Sequencing The PCR products resulting from the amplification of the cassette-
genome junction were sent to Lone Star labs (http://www.lslabs.com) for sequencing. The 
G1/C1 products were sequenced using the C1 primer, while the G2/C2 products were 




Results and Discussion 
Verification of Mutant Strains  
Prediction of the Cassette Primer Binding Sites It was reported by the CLiP 
website that the cassette primers C1 and C2 bind opposite sides of the cassette and face 
outward towards the genome. To determine where each primer binds the cassette, the 
primer sequences were aligned to the cassette sequence using Geneious (Figure 17). 
These results confirmed that the C1 and C2 primers bind to opposite sides of the cassette 
and are oriented such that the 3’ end of each primer faces the genome.  
As the amplification of the cassette-genome junctions utilizes a primer that binds 
the cassette, a portion of that cassette will be included in the resulting PCR product. As 
such, in order to accurately predict the size of the expected PCR product, it is necessary 
to determine the number of base pairs that the cassette will contribute to the amplicon. To 
determine the number of base pairs from the cassette that would be included in the 
cassette-genome junction amplicons, the distance between the most interior residue of the 
cassette primer binding site and the most exterior residue of the cassette was determined. 
It was found that the innermost  residue of the C1 primer binding site is 123 bp from the 
end of the cassette. Similarly, the most interior residue of the C2 primer binding site was 
found to be 134 bp from the side of the cassette that it binds to (Figure 17). These 
findings were used to accurately predict the expected amplicon sizes of the cassette-
genome junction PCR products.  
Determination of the Cassette-Genome Primer Combinations Because it was 
unclear if the orientation of the cassette in the genome would alter the genomic/cassette 




combination of primers necessary to amplify the cassette-genome junction was 
determined for each strain. This was achieved by deductively piecing together several 
pieces of information.  
First, the relative locations of the suggested genomic primers revealed which 
genomic primer binds the genome upstream of the insertion site and which genomic 
primer binds the genome downstream of the insertion site. This indicated which primer 
would act as the forward primer during PCR, and which primer would as the reverse 
primer.  
Second, the relative locations of the genomic sequences that flank each side of the 
insert were determined. At this point, it should be noted that the CLiP library informs 
users of the library which side of the cassette that each cassette primer binds (Table 7). 
However, the nomenclature system that is used labels one side of the cassette as the “5’ 
side” and the other side of the cassette as the “3’ side”. In light of the fact that the cassette 
can insert into the genome in an inverse manner, thus causing the “5’ side” to be oriented 
downstream of the “3’ side”, this nomenclature was found to be confusing. While such 
terminologies were not used while conducting the experiments herein, the knowledge that 
the genomic sequence flanking the so-called “5’ side” of the cassette was obtained using 
the C1 primer and that the genomic sequence flanking the so-called “3’ side” was 





Figure 17. CIB1 Cassette with C1 and C2 Primer binding sites shown. The C1 primer one side of the cassette, while the C2 primer 







Figure 18. The effect of cassette orientation on the cassette primer positioning and 
elongation direction. With regard to the orientation of the cassette, two scanrios are 
possible: A) The cassette is not inverted during insertion to the C. reinhardtii genome. B) 
The cassette is inverted during insertion into the C. reinhardtii genome. Genomic 
sequences flanking either side of the cassette are shown in light blue.  
Using the relative locations of the genomic sequences flanking the insert, in 
combination with the knowledge of which cassette primer was used to produce each 
flanking sequence (Table 7), the locations of the cassette primers relative to one another, 
and thus the orientation of the overall cassette, could be determined for each mutant 
strain. Understanding the location and directionality of each cassette primer allowed for 
determination of the proper cassette/genomic primer combinations to use for 
amplification of the cassette-genome junctions. For each of the mutant strains, regardless 
of the cassette orientation, it was found that the primer combinations G1/C1 and G2/C2 





Figure 19. The effect of cassette orientation on the binding sites and elongation direction 
of the suggested genomic primers. Genomic sequences flanking either side of the cassette 
are shown in light blue.  
 
Prediction of PCR Results 
Qualitative Predictions If the insertion loci of the mutant strains were mapped 
correctly by the CLiP library, several results were expected following PCR. First, 
amplification of the insertional loci using genomic primers G1/G2 would yield products 
of the expected size in the WT strain only. No products were expected to be present in the 
mutant strains, as the size of the insert was predicted to cause the reaction to fail. Second, 
amplification of the cassette-genome junctions using primer combinations G1/C1 and 
G2/C2 would yield products in the mutant strain only. No products were expected to be 
present in the WT strain, as the cassette primers would have no cassette to bind.  
Quantitative Predictions of Amplicon Sizes The predicted sizes of all PCR 
products were determined. The expected amplicon sizes of the G1/G2 products were 
determined by taking the difference, in nucleotides, of the predicted binding sites of each 
primer. The expected amplicon sizes of the cassette-genome junctions, using the primer 
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combinations G1/C1 and G2/C2, were determined by 1) calculating the difference, in 
nucleotides, of the genomic primer binding site and the genomic sequence flanking the 
cassette in order to determine number of nucleotides contributed to the product by the 
genome, and 2) adding the nucleotides contributed to the amplicon by the cassette (Figure 
17) to the expected size of the PCR product (Figure 20). 
 
Figure 20. Visualization of the components of the two cassette-genome amplicons. For 
each PCR reaction, base pairs originating from both the cassette and the genome 
contribute to the overall size of the expected PCR product.  
 
Validation of Insert Mapping By Sequencing Observing products of the expected 
sizes in a mutant strain which are absent in the WT strain gives strong evidence for the 
claim that insert has been mapped correctly by the CLiP library. However, this method is 
not entirely conclusive, as it only demonstrates that the products are of the expected size; 
it does not establish that the products observed are the cassette-genome amplicons. 
In order to show that the sequences obtained by amplifying the cassette-genome 
junctions are the same nucleotide sequences that compose the cassette-genome junction, 
the products from these PCR reactions were sent off for sequencing. The cassette primer 
that was used to amplify the cassette-genome junction was also used to sequence the PCR 
products. After the sequencing products were obtained, they were aligned with a 
simulation of the insertion site. This simulation was created for each mutant strain by 
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obtaining the gene sequence from Phytozome, the CIB1 cassette sequence from the CLiP 
library (https://www.chlamylibrary.org/showCassette?cassette=CIB1), and inserting the 
CIB1 sequence into the reported loci within the Geneious software. The sequencing 
products from cassette-genome junction were also imported into Geneious and were 
aligned with the simulation of the disrupted gene using discontiguous BLASTn. It was 
expected that, if the amplification of the cassette-genome junctions was successful, the 
sequencing products would align with their respective cassette-genome junctions in the 
simulated insertion.  
Verification of Insertion Sites in Each Mutant Strain In the following 
paragraphs, the results of the mutant verification experiments will be presented and 
discussed for each of the mutant strains.  
Verification of the bi-1 Mutant Strain Based on the alignment of the bi-1 G1 and 
bi-1 G2 primers with the C. reinhardtii genome, it was predicted that PCR amplification 
of the bi-1 locus would yield a product of 1,420 bp using WT template DNA (Figure 
21A). This prediction was supported, as a product slightly smaller than 1,500 bp was 
observed (Figure 21C). Furthermore, it was expected that PCR amplification would not 
yield a product in the bi-1 mutant strain. This prediction was also supported, as no 
product was visible in the bi-1 mutant lane (Figure 21C). 
With regard to the cassette-genome junctions, it was predicted that PCR 
amplification using the bi-1 G1/C1 and bi-1 G2/C2 primer combinations would give 
products of 896 bp and 766 bp, respectively. (Figure 21B). Both of these predictions were 
supported, as PCR performed using bi-1 mutant genomic DNA as the template yielded 
products of the expected size with either the bi-1 G1/C1 or the bi-1 G2/C2 primer 
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combinations (Figure 21D). It was also predicted that PCR performed using the bi-1 
G1/C1 or the bi-1 G2/C2 primer combinations would not produce a product when 
template DNA from the WT strain is used. As no product was visible in the WT lane, 
these predictions were also supported (Figure 21D). 
Sequencing results of the cassette-genome junction PCR products from the bi-1 
mutant strain were only able to partially confirm the mapped insertional locus reported 
for the bi-1 mutant strain (Figure 21E). While the sequenced bi-1 G1/C1 product aligned 
well with the simulated insertion site in the bi-1 gene, the sequencing reaction failed to 





C)  D)  
E)  
Figure 21. Verification of the bi-1 mutant strain. A) Predicted binding sites and 
elongation direction of genomic primers bi-1 G1 and bi-1 G2 on WT genomic DNA 
based on the alignment of the primer sequences with the C. reinhardtii genome. These 
binding sites allowed for the prediction of the amplicon size when PCR is performed 
using WT genomic DNA. B) The genomic sequences reported to flank either side of the 
cassette (shown in light blue), the binding sites and elongation direction of all cassette 
and genomic primers, and the expected amplicon sizes when PCR is performed with bi-1 
G1/C1 and bi-1 G2/C2 primer combinations with bi-1 mutant genomic DNA. A 500 bp 
ladder is included for reference.  C) Results of PCR using the primer combination bi-1 
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G1 and bi-1 G2 on both bi-1 mutant (M) and WT genomic DNA. A 500 bp ladder is 
included for reference. D) Results of PCR using the primer combinations bi-1 G1/C1 and 
bi-1 G2/C2 on both bi-1 mutant (M) and WT genomic DNA. A 500 bp ladder is also 
shown for reference. E) Alignment of the sequencing results from the bi-1 mutant strain 
cassette-genome junctions with a simulation of the insertion site. The C. reinhardtii bi-1 
gene is shown in blue, the inserted CIB1 cassette is shown in red, the binding sites of 
both the genomic and the cassette primers are shown in green, and the sequencing 
product(s) is shown in gold.  
Verification of the ire-1 Mutant Strain Based on the alignment of the ire-1 G1 
and ire-1 G2 primers with the C. reinhardtii genome, it was predicted that PCR 
amplification of the ire-1 locus would give a product of 1,457 bp in the WT strain (Figure 
22A). Though a product was visible in the WT lane, the weak signal intensity indicates 
poor amplification (Figure 22C). Additionally, it was expected that PCR amplification 
would not yield a product in the ire-1 mutant strain. This prediction was also supported, 
as no product was visible in the ire-1 mutant lane (Figure 22C). 
It was also predicted that amplification of the cassette-genome junctions using 
ire-1 G1/C1 and ire-1 G2/C2 would give products of 1,049 bp and 649 bp, respectively, 
in the ire-1 mutant strain (Figure 22B). Both of these predictions were supported, as PCR 
performed using ire-1 mutant genomic DNA as the template yielded products of the 
expected size with either the ire-1 G1/C1 or the ire-1 G2/C2 primer combinations (Figure 
22D). It was also predicted that PCR performed using the ire-1 G1/C1 or the ire-1 G2/C2 
primer combinations would not produce a product when template DNA from the WT 
strain is used, as no cassette would be present for the cassette primers to bind. As no 
product was visible in the WT lane, these predictions were also supported (Figure 22D). 
Sequencing results of the cassette-genome junction PCR products from the ire-1 
mutant strain were only able to partially confirm the mapped insertional locus reported 
for the ire-1 mutant strain (Figure 21E). While the sequenced ire-1 G2/C2 product 
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aligned well with the simulated insertion site in the ire-1 gene, the sequencing reaction 
failed to obtain a sequence for the ire-1 G1/C1 products. 
A) 
B) 
C)  D)  
E) 
Figure 22. Verification of the ire-1 mutant strain. A) Predicted binding sites and 
elongation direction of genomic primers ire-1 G1 and ire-1 G2 on WT genomic DNA 
based on the alignment of the primer sequences with the C. reinhardtii genome. These 
binding sites allowed for the prediction of the amplicon size when PCR is performed 
using WT genomic DNA. B) The genomic sequences reported to flank either side of the 
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cassette (shown in light blue), the binding sites and elongation direction of all cassette 
and genomic primers, and the expected amplicon sizes when PCR is performed with ire-1 
G1/C1 and ire-1 G2/C2 primer combinations with ire-1 mutant genomic DNA. A 500 bp 
ladder is included for reference. C) Results of PCR using the primer combination ire-1 
G1 and ire-1 G2 on both ire-1 mutant (M) and WT genomic DNA. A 500 bp ladder is 
included for reference. D) Results of PCR using the primer combinations ire-1 G1/C1 
and ire-1 G2/C2 on both ire-1 mutant (M) and WT genomic DNA. A 500 bp ladder is 
also shown for reference. E) Alignment of the sequencing results from the ire-1 mutant 
strain cassette-genome junctions with a simulation of the insertion site. The C. reinhardtii 
ire-1 gene is shown in blue, the inserted CIB1 cassette is shown in red, the binding sites 
of both the genomic and the cassette primers are shown in green, and the sequencing 
product(s) is shown in gold. 
 
Verification of the e2f Mutant Strain Based on the alignment of the e2f G1 and  
G2 primers with the C. reinhardtii genome, it was predicted that PCR amplification of 
the e2f locus would give a product of 1,380 bp in the WT strain (Figure 23A). This 
prediction was supported, as a product between 1,000 and 1,500 bp was observed (Figure 
23C). Additionally, it was expected that PCR amplification would not yield a product in 
the e2f mutant strain. This prediction was also supported, as no product was visible in the 
e2f mutant lane (Figure 23C). 
It was also predicted that amplification of the cassette-genome junctions using e2f 
G1/C1 and e2f G2/C2 would give products of 636 bp and 991 bp, respectively, in the e2f 
mutant strain (Figure 23B). Both of these predictions were supported, as PCR performed 
using e2f mutant genomic DNA as the template yielded products of the expected size 
with either the e2f G1/C1 or the e2f G2/C2 primer combinations (Figure 23D). It was also 
predicted that PCR performed using the e2f G1/C1 or the e2f G2/C2 primer combinations 
would not produce a product when template DNA from the WT strain is used, as no 
cassette would be present for the cassette primers to bind. As no product was visible in 
the WT lane, these predictions were also supported (Figure 23D). 
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Sequencing results of the cassette-genome junction PCR products from the e2f 
mutant strain were only able to confirm the mapped insertional locus reported for the e2f 
mutant strain (Figure 21E). The sequences obtained from the e2f G1/C1 and e2f G2/C2 





C)  D)  
E)  
Figure 23. Verification of the e2f mutant strain. A) Predicted binding sites and elongation 
direction of genomic primers e2f G1 and e2f G2 on WT genomic DNA based on the 
alignment of the primer sequences with the C. reinhardtii genome. These binding sites 
allowed for the prediction of the amplicon size when PCR is performed using WT 
genomic DNA. B) The genomic sequences reported to flank either of the cassette (shown 
in light blue), the binding sites and elongation direction of all cassette and genomic 
primers, and the expected amplicon sizes when PCR is performed with e2f G1/C1 and e2f 
G2/C2 primer combinations with e2f mutant genomic DNA. C) Results of PCR using the 
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primer combination e2f G1 and e2f G2 on both e2f mutant (M) and WT genomic DNA. A 
500 bp ladder is included for reference. A 500 bp ladder is also shown for reference. D) 
Results of PCR using the primer combinations e2f G1/C1 and e2f G2/C2 on both e2f 
mutant (M) and WT genomic DNA. A 500 bp ladder is also shown for reference. E) 
Alignment of the sequencing results from the e2f mutant strain cassette-genome junctions 
with a simulation of the insertion site. The C. reinhardtii e2f gene is shown in blue, the 
inserted CIB1 cassette is shown in red, the binding sites of both the genomic and the 
cassette primers are shown in green, and the sequencing product(s) are shown in gold. 
Verification of the tat-d Mutant Strain Based on the alignment of the tat-d G1 
and tat-d G2 primers with the C. reinhardtii genome, it was predicted that PCR 
amplification of the tat-d locus would give a product of 1,410 bp in the WT strain (Figure 
24A). This prediction was supported, as a product slightly smaller than 1,500 bp was 
observed (Figure 24C). Additionally, it was expected that PCR amplification would not 
yield a product in the tat-d mutant strain. This prediction was also supported, as no 
product was visible in the tat-d mutant lane (Figure 24C). 
It was also predicted that amplification of the cassette-genome junctions using tat-
d G1/C1 and tat-d G2/C2 would give products of 1,082 bp and 577 bp, respectively, in 
the tat-d mutant strain (Figure 24B). Both of these predictions were supported, as PCR 
performed using tat-d mutant genomic DNA as the template yielded products of the 
expected size with either the tat-d G1/C1 or the tat-d G2/C2 primer combinations (Figure 
24D). It was also predicted that PCR performed using the tat-d G1/C1 or the tat-d G2/C2 
primer combinations would not produce a product when template DNA from the WT 
strain is used, as no cassette would be present for the cassette primers to bind. As no 
product was visible in the WT lane, these predictions were also supported (Figure 24D). 
Sequencing results of the cassette-genome junction PCR products from the tat-d 
mutant strain were only able to partially confirm the mapped insertional locus reported 
for the tat-d mutant strain (Figure 21E). While the sequenced tat-d G1/C1 product 
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aligned well with the simulated insertion site in the tat-d gene, the sequencing reaction 








C)  D)  
E)  
Figure 24. Verification of the tat-d mutant strain. A) Predicted binding sites and 
elongation direction of genomic primers tat-d G1 and tat-d G2 on WT genomic DNA 
based on the alignment of the primer sequences with the C. reinhardtii genome. These 
binding sites allowed for the prediction of the amplicon size when PCR is performed 
using WT genomic DNA. B) The genomic sequences reported to flank either side of the 
cassette (shown in light blue), the binding sites and elongation direction of all cassette 
and genomic primers, and the expected amplicon sizes when PCR is performed with tat-d 
G1/C1 and tat-d G2/C2 primer combinations with tat-d mutant genomic DNA. A 500 bp 
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ladder is included for reference.  C) Results of PCR using the primer combination tat-d 
G1 and tat-d G2 on both tat-d mutant (M) and WT genomic DNA. A 500 bp ladder is 
included for reference. D) Results of PCR using the primer combinations tat-d G1/C1 and 
tat-d G2/C2 on both tat-d mutant (M) and WT genomic DNA. A 500 bp ladder is also 
shown for reference. E) Alignment of the sequencing results from the tat-d mutant strain 
cassette-genome junctions with a simulation of the insertion site. The C. reinhardtii e2f 
gene is shown in blue, the inserted CIB1 cassette is shown in red, the binding sites of 
both the genomic and the cassette primers are shown in green, and the sequencing 
product(s) are shown in gold. 
Verification of the lsd-1 Mutant Strain Based on the alignment of the lsd-1 G1 
and lsd-1 G2 primers with the C. reinhardtii genome, it was predicted that PCR 
amplification of the lsd-1 locus would give a product of 1,941 bp in the WT strain 
(Figure 25A). This prediction was supported, as a product slightly smaller than 2,000 bp 
was observed (Figure 25C). Additionally, it was expected that PCR amplification would 
not yield a product in the lsd-1 mutant strain. This prediction was also supported, as no 
product was visible in the lsd-1 mutant lane (Figure 25C). 
It was also predicted that amplification of the cassette-genome junctions using 
lsd-1 G1/C1 would yield a product of 1,122 bp in the lsd-1 mutant strain (Figure 25B). 
This prediction was supported, as PCR performed using lsd-1 mutant genomic DNA as 
the template yielded products of the expected size with the lsd-1 G1/C1 primer 
combination (Figure 25D). It was also predicted that PCR performed using the lsd-1 
G1/C1 or the lsd-1 G2/C2 primer combinations would not produce a product when 
template DNA from the WT strain is used, as no cassette would be present for the 
cassette primers to bind. No product was visible in the WT lane, indicating that this 
prediction was also supported (Figure 25D). 
For the amplification of the cassette-genome junctions, the lsd-1 mutant strain 
represents a unique instance. For this particular strain, only one of the genomic sequences 
predicted to flank the cassette was reported (Table 7). This indicates that the CLiP library 
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were unable to produce the genomic sequence which flanks the other side of the cassette. 
With regards to the verification of the insertion site in the lsd-1 mutant strain, the lack of 
a genomic flanking sequence for this side of the cassette renders the prediction of the 
expected product size problematic. It could be assumed that the CLiP sequencing reaction 
for this side of the cassette simply failed. If this were the case, the product size of the 
amplicon could be predicted by assuming that the genomic sequence adjacent to the other 
flanking sequence flanked this side of the cassette. 
Sequencing results of the cassette-genome junction PCR products from the lsd-1 
mutant strain were not able to confirm the presence of the insert in the lsd-1 mutant 







C)  D)  
E)  
Figure 25. Verification of the lsd-1 mutant strain. A) Predicted binding sites and 
elongation direction of genomic primers lsd-1 G1 and lsd-1 G2 on WT genomic DNA 
based on the alignment of the primer sequences with the C. reinhardtii genome. These 
binding sites allowed for the prediction of the amplicon size when PCR is performed 
using WT genomic DNA. B) The genomic sequences reported to flank either side of the 
cassette (shown in light blue), the binding sites and elongation direction of all cassette 
and genomic primers, and the expected amplicon sizes when PCR is performed with lsd-1 
G1/C1 and lsd-1 G2/C2 primer combinations with lsd-1 mutant genomic DNA. C) 
Results of PCR using the primer combination lsd-1 G1 and lsd-1 G2 on both lsd-1 mutant 
(M) and WT genomic DNA. A 500 bp ladder is included for reference. D) Results of 
PCR using the primer combinations lsd-1 G1/C1 and lsd-1 G2/C2 on both lsd-1 mutant 
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(M) and WT genomic DNA. A 500 bp ladder is also shown for reference. E) Alignment 
of the sequencing results from the tat-d mutant strain cassette-genome junctions with a 
simulation of the insertion site. The C. reinhardtii e2f gene is shown in blue, the inserted 
CIB1 cassette is shown in red, the binding sites of both the genomic and the cassette 
primers are shown in green, and the sequencing product(s) are shown in gold. 
 
Verification of the pig3 Mutant Strain Based on the alignment of the pig3 G1 
and pig3 G2 primers with the C. reinhardtii genome, it was predicted that PCR 
amplification of the pig3 locus would give a product of 1,517 bp in the WT strain (Figure 
26A). This prediction was supported, as a product slightly smaller than 1,500 bp was 
observed (Figure 26C). Additionally, it was expected that PCR amplification would not 
yield a product in the pig3 mutant strain. This prediction was also supported, as no 
product was visible in the pig3 mutant lane (Figure 26C). 
It was also predicted that amplification of the cassette-genome junctions using 
pig3 G1/C1 and pig3 G2/C2 would give products of 846 bp and 880 bp, respectively, in 
the pig3 mutant strain (Figure 26B). Both of these predictions were supported, as PCR 
performed using pig3 mutant genomic DNA as the template yielded products of the 
expected size with either the pig3 G1/C1 or the pig3 G2/C2 primer combinations (Figure 
26D). It was also predicted that PCR performed using the pig3 G1/C1 or the pig3 G2/C2 
primer combinations would not produce a product when template DNA from the WT 
strain is used, as no cassette would be present for the cassette primers to bind. As no 
product was visible in the WT lane, these predictions were also supported (Figure 26D). 
Sequencing results of the cassette-genome junction PCR products from the pig3 
mutant strain were only able to partially confirm the mapped insertional locus reported 
for the pig3 mutant strain (Figure 21E). While the sequenced pig3 G2/C2 product aligned 
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well with the simulated insertion site in the pig3 gene, the sequencing reaction failed to 




C)  D)  
E) 
Figure 26. Verification of the pig3 mutant strain. A) Predicted binding sites and 
elongation direction of genomic primers pig3 G1 and pig3 G2 on WT genomic DNA 
based on the alignment of the primer sequences with the C. reinhardtii genome. These 
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binding sites allowed for the prediction of the amplicon size when PCR is performed 
using WT genomic DNA. B) The genomic sequences reported to flank either side of the 
cassette (shown in light blue), the binding sites and elongation direction of all cassette 
and genomic primers, and the expected amplicon sizes when PCR is performed with pig3 
G1/C1 and pig3 G2/C2 primer combinations with pig3 mutant genomic DNA. C) Results 
of PCR using the primer combination pig3 G1 and pig3 G2 on both pig3 mutant (M) and 
WT genomic DNA. A 500 bp ladder is included for reference. D) Results of PCR using 
the primer combinations pig3 G1/C1 and pig3 G2/C2 on both pig3 mutant (M) and WT 
genomic DNA. A 500 bp ladder is also shown for reference. E) Alignment of the 
sequencing results from the tat-d mutant strain cassette-genome junctions with a 
simulation of the insertion site. The C. reinhardtii e2f gene is shown in blue, the inserted 
CIB1 cassette is shown in red, the binding sites of both the genomic and the cassette 
primers are shown in green, and the sequencing product(s) are shown in gold. 
 
Summary 
In the present work, strains of C. reinhardtii, each with an insertional cassette 
disrupting a selected protein-coding gene, were selected for further study regarding a 
predicted role in C. reinhardtii PCD. To validate the insertion sites mapped by the CLiP 
library, a three-fold, PCR-based approach was used. First, genomic primers designed to 
bind the genome ~1,000 bp upstream and downstream of the insertion site were used to 
amplify each putative insertional locus in both the corresponding mutant strain and the 
WT strain. Given that the size of the cassette should prohibit the PCR reaction from 
completing, it was predicted that a PCR product of the expected size would be present in 
the WT strain, but not in the mutant strain.  
Second, the two cassette-genome junctions in each of the mutant strains were 
amplified by PCR. Each junction was amplified using one of the cassette primers and its 
corresponding genomic primer. It was expected that these reactions would yield products 
of the expected sizes in the mutant strains, but not in the WT strain, as no cassette would 
be present for the cassette primers to bind.  
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Finally, to confirm that the PCR products from the amplification of the cassette-
genome junctions were sent off for sequencing to confirm that the observed products 
were indeed from the cassette genome-genome junctions. To confirm that the sequenced 
products from the G1/C1 and G2/C2 PCR reactions were of the cassette-genome 
junctions, a simulation of the insertion was created for each of the strains by inserting the 
CIB1 cassette nucleotide sequence, in its determined orientation, into the insertion site 
reported by the CLiP library. For each mutant strain, the sequences obtained from PCR 
amplification of the cassette-genome junctions, if any, were aligned with the simulated 
insertion site. 
Table 10.  
Summary of results obtained during verification of mutant strains. 
 Amplify Insertion 
Site with G1/G2 
primers? 
Amplify Cassette-Genome 
Junctions? Sequencing Results 

















bi-1 Yes No No Yes No Yes Yes Failed 
ire-1 No No No Yes No No Failed Yes 
e2f Yes No No Yes No Yes Yes Yes 
tat-d Yes No No Yes No Yes Yes Failed 
lsd-1 Yes No No No No Yes Failed Failed 
pig3 Yes No No Yes No Yes Failed Yes 
NOTE: “Failed” denotes instances where no sequence was obtained from the sequencing 








Assessment of PCD Phenotypes in Mutant Strains of C. reinhardtii 
Introduction 
Characteristics of PCD As discussed in Chapter 1, cells which have undergone 
PCD, or are in the process of undergoing PCD, exhibit a number of characteristics which 
distinguish them from non-PCD cells.  
Metabolic Activity The cessation of life is a rudimentary way by which death may 
be defined. Thus, the death of the cell is accompanied by the loss of features that are 
characteristic of living cells. As such, a classic method of distinguishing between live and 
dead cells is to assay for the presence of metabolic activity. In general, assays that test for 
the presence of metabolic activity utilize a probe that is cleaved by an enzyme, or class of 
enzymes, that can be used to indicate metabolic activity.263 The probe is designed such 
that, when cleaved by the target enzyme(s), the resulting product is detectable by either 
fluorescence or colorimetric methods.95 
Plasma Membrane Integrity The plasma membrane (PM) is a universal feature of 
prokaryotic and eukaryotic cells. The PM functions as a physical barrier to separate the 
intracellular and extracellular environments. The PM is said to be intact when this barrier 
is preserved. The maintenance of PM integrity requires the input of energy. During PCD, 
the cessation of metabolic activity results in the termination of metabolic processes, 
which, in turn, causes the loss of PM integrity. Once compromised, the integrity of the 
PM cannot be restored, so this feature is useful as an indicator of cell death. Methods for 
detecting PM integrity generally rely on the use of exclusionary dyes that are not retained 
by cells possessing an intact plasma membrane. Such probes are generally either 
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colorimetric or fluorescent, and the intracellular accumulation of the probe can be 
determined using the appropriate detection method. In the case of fluorescent probes, the 
dye often will fluoresce under specific conditions. For example, the most often used 
indicator of PM integrity, propidium iodide, is a DNA intercalating agent that emits a 
signal that is enhanced significantly when bound to DNA.  
Phosphatidylserine Externalization Phospholipids are a primary component of 
the plasma membrane. Under normal cellular conditions, PM phospholipids are 
distributed asymmetrically across the lipid bilayer; phosphatidylserine (PS) and 
phosphatidylethanolamine (PE) reside within the inner leaflet of the membrane, while 
phosphatidylcholine (PC) and sphingomyelin (SM) exist primarily in the outer leaflet of 
the PM.264,265 Phospholipids are translocated from one layer of the PM to the other by 
enzymes known as phospholipid translocases. Phospholipid translocases come in three 
varieties: scramblases non-specifically and bi-directionally move phospholipids between 
the lipid layers, flippases specifically transport PS and PE from the outer leaflet to the 
inner leaflet, and floppases are believed to move PC from the inner to the outer leaflet of 
the PM.266,267 The asymmetric nature of the phospholipid distribution across the PM is 
maintained primarily by the antagonistic actions of flippases/floppases and 
scramblases.267 
Many instances of PCD are accompanied by the externalization of PS.268–271 As 
such, PS externalization has long been used as a marker of PCD.272 PS exposure serves to 
facilitate the elimination of dead or dying cells via macrophages, which possess PS 
receptors that facilitate the recognition of apoptotic cells.48 The binding of PS to the PS 
receptor causes the engulfment and destruction of the apoptotic cell by the macrophage.48 
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The molecular mechanisms that lead to the externalization of PS have only 
recently begun to be explored in detail. As such, the signaling pathways that underlie PS 
externalization remain largely uncharacterized.273 However, recent evidence indicates 
that PS exposure during PCD in animal systems may be result of the direct destruction of 
flippases and the activation of scramblases by activated caspase-3.267 
Accumulation of Reactive Oxygen Species The accumulation of reactive oxygen 
species (ROS) is a characteristic of PCD that is observed in all branches of life.274,275 
Small quantities of ROS are produced in cells as byproducts of normal metabolic 
processes, such as the production of ATP. Aside from being a byproduct of cellular 
metabolism, ROS also play important roles in various signaling pathways, such as those 
involved with transduction, phagocytosis and cell growth. However, as the name implies, 
ROS exhibit a tendency to react with a number of intracellular biomolecules, including 
proteins, lipids, and nucleic acids.276–278 As the alteration of these biomolecules results in 
massive, and sometimes irreversible, cellular damage, elevated levels of ROS are highly 
deleterious to the cell. Cells utilize two primary strategies to circumvent the detrimental 
effects associated with high concentrations of ROS. First, intracellular ROS levels are 
tightly controlled via the synthesis of antioxidant enzymes, which serve to counteract the 
harmful effects of ROS.279 Secondly, cellular processes that generate large amounts of 
ROS are localized to specific organelles, such as the mitochondrion, chloroplast, and 
endoplasmic reticulum, which function as sites of containment for ROS.280 
The accumulation of ROS is a key attribute of PCD, and the accrual of these 
damaging compounds is, in part, what contributes to the destruction of the intracellular 
components during PCD.280 PCD-associated accumulation of ROS occurs by two primary 
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mechanisms: the repression of antioxidant enzyme activities, and the release of ROS 
from localized intracellular regions. In light of the fact that accumulation of ROS is a 
universally-observed characteristic of PCD, this feature has been monitored extensively 
in PCD studies. 
Colony Growth The process of cell division requires energetic input. The 
termination of metabolic activity at the onset of cell death results in the absence of energy 
sources required for cell division. Consequently, the inability to divide is one way by 
which cell death may be assessed.95 Given that individual cells are not visible to the 
naked eye, the amount of observable growth on solid medium is an approach that is 
commonly used to assess cell death. A number of different techniques can be used to 
assess cell viability by this approach, including the quantitation of colony forming units 
or, in instances where individual colonies cannot be distinguished, the assessment of 
growth density.105,281–285 
DNA Laddering Fragmentation of genomic DNA is a hallmark characteristic of 
PCD. DNA fragmentation is achieved through the activities of a number of different 
nucleases.286 Perhaps the most well-known nuclease that participates in the apoptotic 
process is caspase-activated DNase (CAD). Under normal conditions, CAD is inhibited 
via the binding of its repressor, inhibitor of CAD (iCAD).286 Initiation of the apoptotic 
program is accompanied by the activation of caspases -3 and -7, which target and cleave 
iCAD. Following the degradation of its inhibitor, activated CAD promotes the 
degradation of genomic DNA.286 CAD-mediated DNA fragmentation is a progressive 
phenotype that proceeds through two primary stages. First, chromosomal DNA is 
fragmented into larger (50-100 kb) fragments.286 Following this initial degradation, DNA 
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is cleaved at inter-nucleosomal regions, resulting in the formation of smaller fragments, 
approximately 180 bp in size.287 Though CAD is the most-characterized nuclease 
associated with apoptosis, other nucleases that participate in the fragmentation of 
genomic DNA during PCD are endonuclease G, DNase II, DNase , and AIF.288,288 
A classic technique for visualization of the early stages of DNA fragmentation 
during apoptosis is the DNA laddering assay, in which extracted genomic DNA is run on 
an agarose gel.287 Following electrophoretic separation, distinct bands, a result of 
genomic cleavage between nucleosomes, are visible on the gel. The fragmentation pattern 
resembles the rungs of a ladder when visualized in this manner and, as such, is referred to 
as DNA “laddering”. 
Characteristics of PCD in C. reinhardtii When subjected to PCD-inducing 
conditions, C. reinhardtii cells exhibit many of the same characteristics observed in 
animal cells that are undergoing PCD. Despite the presence of phenotypic commonalities 
between animal PCD and C. reinhardtii PCD, the detailed mechanisms by which C. 
reinhardtii initiates and executes PCD have yet to be explored in detail. 
In previous work, we utilized bioinformatics methods to predict C. reinhardtii 
proteins that participate in PCD on a large scale. We then selected several predicted C. 
reinhardtii gene products that, based on homology to known PCD proteins, we 
hypothesized to participate in C. reinhardtii PCD, either as facilitators or inhibitors 
(Table 6). We then selected several C. reinhardtii mutant strains from a library generated 
by random insertional mutagenesis. For each of the chosen mutant strains, the CLiP 
library reported that the insertion site of the cassette was located within the coding region 
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of one of the selected protein-coding genes. To validate this, we confirmed the reported 
insertion site in each mutant strain using PCR-based methods. 
The purpose of this study is to utilize a reverse genetics approach to explore the 
potential roles(s) that the proteins of interest may play during C. reinhardtii PCD. Using 
time-course methodologies, we examined PCD phenotypes exhibited by each of the 
mutant strains and compared the results to those observed in the parent WT strain. We 
expected that, if a selected C. reinhardtii protein contributes to PCD, the disruption of the 
protein-coding gene would result in an altered PCD program in the mutant strain. 
Furthermore, we predicted that disruption of the PCD program may provide insight into 
the molecular role of the gene product during heat-induced PCD in C. reinhardtii. 
Materials and Methods 
Culture Conditions All C. reinhardtii cultures were maintained at a constant 
temperature of 25C in an illuminated incubator set to a 14/10 hour light/dark cycle. 
Stock cultures were maintained on slants of solid TAP medium (20.0 x 10-3 M Tris, 7.00 
x 10-3 M NH4Cl, 8.30 x 10-4 M MgSO4  7H2O, 4.50 x 10-4 M CaCl2  2H2O, 1.65 x 10-3 
M K2HPO4, 1.05 x 10-3 M KH2PO4, 1.34 x 10-4 M Na2EDTA  2H2O, 1.36 x 10-4 M 
ZnSO4  7H2O, 1.84 x 10-4 M H3BO3, 4.00 x 10-5 M MnCl2  4H2O, 3.29 x 10-5 M FeSO4 
 7H2O, 1.23 x 10-5 M CoCl2  6H2O, 1.00 x 10-5 M CoCl2  6H2O, 4.44 x 10-6 M 
(NH4)6MoO3, 0.001% (v/v) CH3COOH, 1.7% (w/v) agar). In order to maintain a 
sufficient number of cells to use for experiments, subcultures of the slant stocks were 
maintained on solid TAP plates. All subcultures were passaged a maximum of three 
times, after which a new subculture was streaked from the stock slant. Liquid cultures 
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were inoculated using cells obtained from a subcultured plate and gently agitated by 
constant aeration for 2-4 days prior to use. 
Analysis of Mutant Strains Under Normal Conditions To identify strains with 
abnormalities which could interfere with the subsequent PCD experiments, unstressed 
cells were analyzed for irregularities in morphology and growth rate.   
Morphological Analysis Liquid cultures of all strains were inoculated in R 
medium (1.6 x 10-4 M H3BO3, 3.5 x 10-5 M ZnSO4•7H2O, 1.8 x 10-6 M MnSO4  H2O, 8.4 
x 10-7 M CoCl2  6H2O, 8.3 x 10-7 M, Na2MoO4  2H2O, 2.8 x 10-7 M CuSO4  5H2O, 1.7 
x 10-3 M Na Citrate  2H2O, 3.7 x 10-5 M FeCl3  6H2O, 3.6 x 10-4 M CaCl2  2H2O, 1.2 x 
10-3 M MgSO4  7H2O, 3.7 x 10-3 M NH4NO3, 1.5 x 10-3 M KH2PO4, pH to 6.8 with 10% 
K2HPO4  3H2O, and 0.022 M CH3COONa) and allowed to incubate under normal 
culturing conditions, as described above. After two days, samples of each strain were 
taken. To observe the morphologies of individual, unstressed cells, the samples were 
visualized using phase-contrast microscopy at 400X magnification. Additionally, the 
cells were qualitatively analyzed for differences in size, shape, and motility relative to the 
parent WT strain.  
Growth Curve Analysis In order to compare the rate of growth between the 
mutant strains and the parent WT strain, 500 mL Erlenmeyer flasks containing 300 mL of 
liquid R medium were inoculated with cells taken from a plate subculture. Once a day, at 
the time of inoculation, a 500 L aliquot was removed from each culture. Lugol’s iodine 
was added to each of the samples at a 1:1 ratio and pipetted to mix. Hemacytometer 
counts were performed to determine the densities of the cultures at each time point.  
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Analysis of Mutant Strains Under PCD-inducing Conditions 
Induction of PCD by Heat Stress Several days prior to the beginning of an 
experiment, liquid cultures of all strains to be used were started in a 250 mL Erlenmeyer 
flask containing 125 mL of liquid R medium. The flasks were allowed to incubate under 
normal culturing conditions, as described above. After several days, the cell density of 
each culture was estimated by hemacytometer counts. The volume of each culture needed 
to produce 5 mL of culture at a density of 4.0 x 106 cells/mL was calculated, and the 
appropriate volume of culture was aliquoted into a 15 mL conical tube. Cells were 
pelleted by centrifugation at 3,200 x g for 5 minutes. The supernatant was immediately 
decanted, and fresh R medium was added to each tube to the 5 mL mark. To resuspend 
the pellets, and also to allow the cells to acclimate to the new conditions, the tubes were 
allowed to incubate on a rotating shaker for 30-60 minutes on the benchtop under 
ambient light. Following this, 1 mL aliquots were placed into 1.5 mL microcentrifuge 
tubes. 
To induce PCD, heat stress was applied to the experimental groups by 
submergence in a 42C water bath for two hours. The control groups were left to incubate 
on the benchtop for the same period of time. In some cases, sampling was conducted after 
completion of the heat stress. In these situations, the heat stress tubes were removed from 
the water bath and placed with the control tubes until sampling was completed. The 
overhead lighting in the room was turned off and all cultures were illuminated by an 
overhead table lamp equipped with a 14W (60W equivalent) Soft White fluorescent bulb 
(Great Value). At the times specified for each experiment, samples were removed from 
all groups.  
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Imaging All images from the microscopy assays were obtained using an 
AMScope MU140-CCD camera. For each sample, 5 L of cells was loaded onto a 
hemacytometer. The entire grid and the surrounding area was visualized with a Nikon 
Eclipse E400 microscope at 40X magnification. Images of this field of view were 
captured using brightfield and epifluorescence microscopy using the AMLite software 
(AMScope, version 1.0.8718). 
Metabolic Activity Assay To identify cells with metabolic activity, the fluorescent 
dye fluorescein diacetate (FDA) was utilized to measure esterase activity. A heat stress 
was applied to cells as described above. Samples were taken at 30 minute intervals for 3 
hours. At each sampling, 1 L of 2.4 mM FDA was added to 100 L of cells. The tubes 
were inverted several times to mix, and allowed to incubate in the dark at room 
temperature for 1 minute. Cells were loaded onto a hemacytometer, visualized, and 
imaged as described above. 
Plasma Membrane Integrity Assay To identify cells that had lost plasma 
membrane integrity, the fluorescent dye SYTOX Green (Life Technologies) was utilized.  
A heat stress was carried out as described above. Samples were taken at 30 
minute intervals for 3 hours. At each sampling, 1 L SYTOX Green was added to 100 L 
of culture. The tubes were allowed to incubate in the dark at room temperature for 2 
minutes. Following the incubation period, cells were loaded onto a hemacytometer, 
visualized, and imaged as described above. 
Phosphatidylserine Externalization Assay To identify cells displaying 
externalized phosphatidylserine, the Alexa Fluor AnnexinV/Dead Cell Apoptosis Kit 
(Thermo Fisher) was utilized.  
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A heat stress was carried out as described above. Samples were taken at 60 
minute intervals for 4 hours. During sampling, 100 L of cells from each culture were 
aliquoted into 1.5 mL microcentrifuge tubes containing 100 L ice-cold PBS. The 
samples were centrifuged at 16,100 x g for 30 seconds, and the supernatant was aspirated. 
The cells were then resuspended in 100 L 1X AnnexinV binding buffer, and 25 L from 
each tube was aliquoted into a fresh 1.5 mL microcentrifuge tube. To this, 2.5 L of 
AnnexinV was added. The samples were allowed to incubate at room temperature for 15 
minutes, whilst covered in aluminum foil to protect the cells from ambient light. 
Following the incubation period, cells were loaded onto a hemacytometer, visualized, and 
imaged as described above. 
ROS Accumulation Assay To identify cells which had accumulated reactive 
oxygen species, the fluorescent probe 5-(and 6)-chloromethyl-2’7-
dichlorodihydrofluorescein diacetate acetyl ester (CM-H2CFDA; Thermo-Fisher) was 
used. Prior to the induction of PCD, 10 L of CM-H2DCFDA was added to each culture. 
A heat stress was carried out, as described above. Samples were taken at 30 minute 
intervals for 2 hours. At the time of sampling, 20 L of cells were removed from each 
tube and placed into a 1.5 L microcentrifuge tube containing 1 mL of fresh R medium. 
The cells were centrifuged at 16,100 x g for 30 seconds, and the supernatant was 
aspirated until approximately 20 L of liquid remained, along with the pellet. The cells 
were gently resuspended in the remaining liquid. From this, cells were loaded onto a 
hemacytometer and imaged as described above.  
Plating Assay To assess the growth capabilities of each strain throughout the PCD 
process, cells were plated at different times. A heat stress was performed, as described 
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above. Samples were taken at 30 minute intervals for 3 hours. During sampling, 75 L of 
each culture was taken, added to a sterile 1.5 mL microcentrifuge tube containing 75 L 
fresh medium, and inverted several times to mix. The 150 L suspension was plated onto 
solid TAP medium. The plates were allowed to incubate for 3 weeks. Following this, the 
plates were individually imaged using the ChemiDoc XRS+ (Bio-Rad) imaging system, 
which had been outfitted with the VersaDoc conversion plate (Bio-Rad).  
DNA Laddering Assay To qualitatively determine the presence and extent of 
DNA laddering, genomic DNA was extracted using the DNeasy Plant Mini Kit (Qiagen) 
at designated time points throughout a heat stress. DNA laddering was visualized 
simultaneously in all samples using agarose gel electrophoresis. 
A heat stress was carried out as described above, with some modifications.180 It 
was previously determined that 20 mL of stationary phase culture is necessary to obtain 
quantities of DNA sufficient for the visualization of laddering on an agarose gel (data not 
shown). Additionally, a preliminary examination of the modified DNeasy protocol 
indicated that between forty-five and sixty minutes should be allotted to complete a 
single extraction from start to finish. The lengthy nature of this process added a 
complicating factor to the timeframe of the experiment, as samples were to be collected 
every thirty minutes. As such, the experiment was designed such that 1) each strain 
would be sampled at thirty minute intervals for the duration of the two hour heat stress, 
and 2) all samples could be collected and processed simultaneously.  
Each culture was resuspended to 100 mL at a density of 1.0 x 107 cells/mL in 
fresh R medium. The resuspended cultures were distributed evenly into five 50 mL 
conical tubes, such that the culture volume in each tube was 20 mL. Each of the five 
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conical tubes was labeled with the time that the cells were to be heat-stressed: 0, 30, 60, 
90, and 120 minutes. A timer was set for two hours, and the samples to be heat stressed 
for two hours were submerged in a 42C water bath. At thirty minute increments, the 
tubes to be subjected to a heat-stress for the amount of time remaining on the timer were 
submerged in the hot water bath (e.g. samples to be heat-stressed for 90 minutes were 
submerged 30 minutes after the first samples were submerged, etc.). After two hours, all 
tubes were removed from the water bath. 
Following the heat stress, genomic DNA was extracted from each of the samples 
using the Plant DNeasy kit according the manufacturer’s instructions, with some 
modifications. The samples were centrifuged at 3,200 x g for 5 minutes, and the 
supernatant was decanted. Each pellet was resuspended in 400 L of API buffer, 
containing 4 L 100mg/mL RNase A, 20 L 10% SDS, and 4 mg Proteinase K. The cells 
were gently pipetted to mix and transferred to a 15 mL conical tube. The cells were 
placed into a heating block set to 65C for 10 minutes. Subsequently, 130 L of Buffer 
P3 was added, and the tube was inverted to mix. The cells were placed in an ice bath for 
5 minutes, then centrifuged for 5 minutes at 13,400 x g. The supernatant was transferred 
into the provided column within a 2 mL collection tube. After centrifugation at 16,100 x 
g for two minutes, the supernatant of the flow through was transferred to a fresh 1.5 mL 
microcentrifuge tube. The volume of the sample was determined, and 1.5 volumes Buffer 
AW1 were added. Next, 650 L was transferred into the DNeasy Mini spin column 
within a 2 mL collection tube and centrifuged at 5,900 x g for one minute. This was 
repeated until all volume from the Buffer AW1 step was depleted. The column was 
transferred into a fresh collection tube and 500 L of Buffer AW2 was added to the 
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column. The apparatus was centrifuged at 16,100 x g for two minutes. The column was 
transferred to a fresh 1.5 mL microcentrifuge tube. Fifty microliters of Buffer AE was 
pipetted onto the membrane of the column. After allowing to incubate on the benchtop 
for 5 minutes, the apparatus was centrifuged at 5,900 x g for 1 minute. To extract any 
remaining DNA from the column, another 50 L Buffer AE was added to the membrane, 
allowed to incubate for 5 minutes, and centrifuged at 5,900 x g for 1 minute. The flow-
through, containing the purified genomic DNA, was stored at -20C when not in use.  
The concentration of DNA in each sample was determined using a Qubit 2.0 
(Thermo-Fisher), in conjunction with the Qubit dsDNA High Sensitivity (HS) Assay Kit 
according to the manufacturer’s instructions. The 200X dsDNA HS Reagent was diluted 
to the working concentration using dsDNA HS buffer at a 1:200 ratio. A two-point 
calibration curve was made using the standards included in the dsDNA HS kit; ten 
microliters of each standard was diluted into 190 L of 1X dsDNA HS Reagent to 
calibrate the standard curve for samples between 0 and 500 ng/mL For each sample of C. 
reinhardtii genomic DNA from the heat stress experiment, 5 L of sample was diluted 
into 195 L of 1X dsDNA HS Reagent, and the concentration of dsDNA was determined 
using the Qubit 2.0.  
Following the quantification of dsDNA in each of the samples, a 1% agarose gel 
was prepared using 1X TAE and 0.00002% 10,000X SybrSafe (Invitrogen). To 
accurately assess the extent of DNA laddering, the quantity of DNA loaded into each of 
the wells needed be the same. In order to load the gel with the maximum amount of DNA 
possible, the sample with the lowest DNA concentration was identified. The maximum 
volume of the wells was predetermined to be approximately 30 L. Thus, the quantity of 
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DNA from each sample that was added to the gel was equivalent to the quantity of DNA 
present in 30 L of the least concentrated sample. 
Post-Acquisition Processing and Analysis of Images All image analysis was 
performed using ImageJ. Any image processing was carried out in either ImageJ or 
Adobe Photoshop Lightroom 5.  
Microscopy Assays For each sample, a brightfield and fluorescence image of the 
same field of view was captured. The following steps were repeated for all image pairs. 
First, the brightfield and fluorescent images were non-destructively overlaid and cropped 
to include only the hemacytometer grid. The two resulting cropped images were saved as 
separate files. The number of particles in the cropped brightfield and fluorescent images 
were determined automatically using custom macros. The macros were written such that, 
for each image that was automatically scored, another image was created, in which the 
particles that were scored were overlaid with an outline. This allowed for the 
visualization of the particles that were scored by the automated counts. Each image was 
then manually verified to ensure that the automated scoring of the fluorescent and 
brightfield images was accurate. To validate the automated counts of the brightfield 
images, the brightfield image overlaid with particle outlines was examined. Cells which 
were not recognized as particles were scored, and this number was added to the 
automated count for the brightfield image. Non-cell particles which were scored were 
also identified, and this number was subtracted from the automated count for that image.  
To validate the automated counts of the fluorescence field of view, an additional 
step was added. Because some images contained a fair amount of background 
fluorescence, it was difficult to determine by looking at a fluorescent image alone if a 
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fluorescent spot was originating from a cell, or was merely background. To address this 
issue, the automatically-scored fluorescent image, overlaid with the particle outlines, was 
overlaid with the brightfield image. This allowed for the visualization and manual scoring 
of 1) fluorescent spots originating from a cell, but which had not been scored by the 
automated methods, and 2) background fluorescent spots which had been scored as a 
fluorescent cell. Both of these instances were scored, and either added or subtracted from 
the automated particle counts for the fluorescent image. 
For each pair of brightfield and fluorescent images, the corrected counts were 
then used to determine the percentage of fluorescent cells in each field of view.  
Plating Assay An automated macro was written to determine the relative area that 
was occupied by visible growth on each plate after three weeks of growth. On plates 
where contamination was present, the contaminant colonies were removed, if possible, 
using the Spot Removal tool in Adobe Photoshop Lightroom 5. This method of removal 
was not possible in all instances of contamination, however, as contaminant growth 
overlapped with C. reinhardtii growth on some of the plates. 
DNA Laddering Assay The gel image from the DNA laddering assay was altered 
in order to better visualize the bands. For the sake of consistency, all transformations 
were applied to the entire image rather than to specific portions of the gel. First, the black 
and white pixels of the gel were inverted in ImageLab (v5.2). The image was then 
exported as a TIFF file, which was subsequently imported into Adobe Photoshop 
Lightroom 5. The exposure, contrast, highlights, shadows, whites, blacks, and clarity 
settings were altered across the entire image until the DNA bands were most prominent. 
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Statistical Analysis To determine if there was a significant effect of strain and/or 
time on the measured variable amongst the heat-stressed strains, the data from the 
microscopy and plating assays were analyzed using two-factor repeated measures 
analysis of variance (ANOVA) tests. Because there was interest as to whether there was a 
difference in the measured variable between each of the mutant strains and the parent WT 
strain at each time point throughout the heat stress, multiple comparison post-hoc 
contrasts were also performed between each mutant strain and the parent WT strain at 
each time point. The p-values reported from the post-hoc tests were adjusted by Holm’s 
method, a variant of the Bonferroni correction.289 While the Bonferroni method is used to 
minimize the rate of Type I (false positive) errors that are prone to occur when testing 
multiple hypotheses, it is more likely to generate Type II (false negative) errors when 
applied to many tests simultaneously. Holm's corrective method was developed to 
minimize the Type I error rate associated with testing multiple hypotheses simultaneously 
while also minimizing the Type II error rate associated with the Bonferroni correction.290 
Results and Discussion 
Analysis of Unstressed Cells 
Prior to analysis of the mutant strains during PCD, the cells were first analyzed 
under non-stress conditions.  
Morphological Analysis Visualization of each mutant strain by phase-contrast 
microscopy revealed that the e2f, tat-d, and lsd-1 mutant strains exhibited a tendency to 
form palmelloids under unstressed conditions (Figure 27C-E). Attempts to disrupt the 
structures by either mechanical force or resuspension in 10 mM Hepes for 1 hour were 
unsuccessful in disturbing the aggregates. Furthermore, the initial formation of 
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palmelloids could not be prevented by culturing the cells in either TAP or R medium. 
Interestingly, not all cells in these cultures were integrated into palmelloids. Based on the 
qualitative assessment of morphological features of non-palmelloid cells from these 
strains, individual cells could be broadly categorized into one of two classes: cells that 
appeared normal, in terms of behavior, size and morphology, relative to the parent WT 
strain (Figure 27A), and so-called “giant” cells, which exhibited a size substantially 
larger than that of WT cells. Furthermore, these giant cells also displayed a degree of 
variation with regard to ciliary presence/number, as some cells were aciliate, while as 
many as six cilia were counted on some of the ciliated giant cells. Anecdotally, cells of 
the e2f mutant strain tended to form palmelloids with neat exclusivity. Very few 
individual cells were noted in this strain, and only the occasional giant cell was observed. 
In contrast, many of the observed non-palmelloid cells of the tat-d and lsd-1 mutant 
strains displayed the giant phenotype. 
At the time that these observations were made, it was known that the majority of 
the assays performed in this study would require cell scoring under low-magnification 
brightfield microscopy. As these assays mandated the ability to differentiate individual 
cells, and because discerning individual cells comprising a palmelloid is difficult and 
time-consuming to carry out by these methods, the e2f, tat-d, and lsd-1 mutant strains 
were excluded from the remainder of the experiments in this study. On the other hand, 
the bi-1, ire-1, and pig3 mutant cells appeared identical to the parent WT strain, in terms 
of morphology, size, and behavior, as determined by phase-contrast microscopy (Figure 
27B,C,F). As visualization of the bi-1, ire-1, and pig3 strains by microscopy indicated an 
absence of obvious physical abnormalities at the cellular level, these strains met the 
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requirements for further analysis under normal conditions. Importantly, the "normal" 
appearance of cells in these strains does not, in and of itself, exclude the possibility of an 
unintended effect of mutagenesis, as such an effect could be present without manifesting 




B)  C)  
D)  E)  
F)  G)  
Figure 27. Morphologies of the C. reinhardtii strains utilized in this study. A) WT strain, 
B) bi-1  mutant strain, C) ire-1 mutant strain, D) e2f mutant strain, E) tat-d mutant strain, 
F) lsd-1 mutant strain, G) pig3 mutant strain. 
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Growth Curve Analysis With this experiment, we sought to determine if the loss 
of bi-1, ire-1, or pig3 would have an effect on the ability of C. reinhardtii to grow under 
normal culturing conditions. Though statistical analysis indicates that time had a 
significant effect on the mean cell density (p = 5.84 x 10-15), no significant difference in 
the mean daily cell density was observed between the parent WT strain and the bi-1, ire-
1, and pig3 mutant strains (p > 0.05). These results indicate that the rate of cell division in 
each of the mutant strains was approximately equivalent to that of the parent WT strain 
under normal culturing conditions (Figure 28). We interpret these results to suggest that 
the growth of C. reinhardtii is unaffected by the disruption of bi-1, ire-1, or pig3 genes, 
implying that no metabolic pathways essential for cell division under mixotrophic 
conditions were affected by the disruption of these genes. Future studies utilizing these 
strains may wish to validate that the growth rate of each mutant strain is unaffected by the 





Figure 28. Growth curves of the bi-1, ire-1, and pig3 mutant strains and parent WT strain. 
Plotted points represent the mean cell density of each strain at each time point (n=3). 
Error bars represent the  standard error of each of the plotted points. Statistically 
significant differences were not detected between any of the mutant strains and the parent 
WT strain across all time points. 
 
Analysis of Strains Under PCD-Inducing Conditions 
Metabolic Activity Assay The probe fluorescein diacetate (FDA) is one of the 
most frequently-used methods of identifying metabolically-active cells, particularly in 
microbial cells. Specifically, FDA enables the detection of cells exhibiting esterase 
activity, which is inferred to indicate metabolic activity. Following its entry into the cell, 
the acetate groups of FDA are non-specifically hydrolyzed by intracellular esterases, 
producing a standalone fluorescein.291 This product can be detected using fluorescent 
methods, and can be visualized in individual cells using fluorescence microscopy. As 
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such, a cell that has accumulated a fluorescent product is inferred to be metabolically 
active.   
With this experiment, we sought to determine if the loss of BI-1, IRE-1, or PIG3 
would have an effect on the loss of metabolic activity that occurs during PCD (Figure 
29). Across all strains subjected to heat stress, the most drastic decrease in the percentage 
of FDA-positive cells occurred between 30 and 90 minutes. In all heat-treated strains, 
very few members of the population exhibited fluorescence at 120 minutes. 
Statistical analysis indicated that time had a significant effect on the observed 
percentage of FDA-positive cells (p < 2 x 10-16). While the overall kinetics of the 
percentage of FDA-positive cells were similar for each the four strains throughout the 
heat stress procedure, there were several time points at which the percentage of 
fluorescent cells in one or more of the mutant strains was found to be significantly 
different than that of the parent WT strain. In particular, the percentage of fluorescent 
cells in the bi-1 mutant strain was found to be significantly lower than that of the parent 
WT strain at 30 minutes (p = 1.27 x 10-8) and significantly higher at 90 minutes (p = 4.10 
x 10-12). Additionally, in the ire-1 mutant strain, the percentage of fluorescent cells was 
significantly lower than that of the parent WT strain at 60 minutes (p = 1.12 x 10-6).  
Taken together, the results indicate that the overall kinetics of the decrease in the 
percentage of metabolically-active cells are not drastically altered in the absence of BI-1, 
IRE-1, or PIG3. In the parent WT strain, only a slight decrease in the percentage of 
fluorescent cells was observed after 30 minutes of heat stress; a very small portion of the 
population ceases metabolic activity at the onset of heat stress. The loss of IRE-1 or PIG3 
did not exhibit a noticeable effect on this feature, though the more drastic decrease in the 
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percentage of metabolically-active cells in the bi-1 mutant strain suggests that the loss of 
BI-1 may accelerate the cessation of metabolic activity during the initial response to heat 
stress. Furthermore, the steep decrease in the percentage of FDA-positive cells in all 
strains between 30 and 90 minutes suggests that the vast majority of the population halts 
metabolic activities during this time frame. Though this effect was enhanced in the ire-1 
mutant strain at 90 minutes, the lack of a statistical difference in the percentage of 
fluorescent cells between either the bi-1 or the ire-1 mutant strains and theparent  wild 
type strain at 120 minutes suggests that the loss of either of these genes does not affect 
the percentage of the population exhibiting metabolic activity at the conclusion of the two 
hour heat stress. 
 
Figure 29. Stress-induced loss of metabolic activity in the bi-1, ire-1, and pig3 mutant 
strains compared to the parent WT strain. Plotted points represent the mean percentage of 
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fluorescent cells in each strain at each time point (n=3). Error bars represent the ± 
standard error of each strain at each time point. Statistical analysis was carried out using a 
two-way repeated measures analysis of variance (ANOVA). Post-hoc contrasts were 
carried out for each time point, wherein each mutant strain was compared to the parent 
WT strain. Statistical significance is denoted according to p-value; “***” indicates a 
significant difference when p < 0.001. 
Plasma Membrane Integrity Assay Here, the fluorescent probe SYTOX Green 
was used to visualize cells with compromised plasma membranes during PCD. SYTOX 
Green is a DNA intercalating agent which exhibits a >500 fold increase in fluorescence 
intensity when bound to DNA.292,293 Because SYTOX Green is impermeable to cells with 
intact plasma membranes, living cells exclude the dye completely and are not stained.293 
Upon the loss of plasma membrane integrity at death, SYTOX enters the cell and binds 
DNA, resulting in a detectable fluorescent emission.294 Thus, a cell which fluoresces is 
inferred to have lost plasma membrane integrity.  
With this study, we sought to determine if the loss of bi-1, ire-1, or pig3 would 
have an effect on the loss of plasma membrane integrity that occurs during PCD (Figure 
30). The kinetics of the percentage of SYTOX Green-positive cells were similar between 
all four strains during the first 90 minutes of heat stress. After 90 minutes, the percentage 
of fluorescent cells continued to increase in the parent WT strain. In the ire-1 and pig3 
mutant strains, the percentage of fluorescent cells increased only slightly between 90 and 
120 minutes, then stayed relatively stable between 120 and 180 minutes. Intriguingly, the 
percentage of fluorescent cells in the bi-1 mutant strain decreased dramatically after 90 
minutes. One potential explanation for the decrease in the percentage of fluorescent cells 
could be that, because SYTOX Green binds DNA, and because DNA is being rapidly 
degraded in PCD (and potentially even more so in the bi-1 strain), there is an insufficient 
quantity of DNA for SYTOX Green to bind.  
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Statistical analysis indicated that the percentage of SYTOX-positive cells was 
significantly affected by strain (p = 1.06 x 10-14), time (p < 2 x 10-16) and the interaction 
between strain and time (p = 1.18 x 10-12). Though the kinetics of the percentage of 
fluorescent cells were similar between all strains within the first 90 minutes of heat stress, 
there were several time points at which the percentage of fluorescent cells in one or more 
of the mutant strains was found to be significantly different than that of the parent WT 
strain. The percentage of fluorescent cells in the pig3 mutant strain was significantly 
lower than that of the parent WT strain at 60 minutes (p = 2.24 x 10-5). The bi-1 mutant 
strain showed a significantly lower percentage of fluorescent cells than the parent WT 
strain at 120 minutes (p < 2 x 10-16), 150 minutes (p < 2 x 10-16), and 180 minutes (p < 2 
x 10-16). The ire-1 mutant strain showed a significantly lower percentage of fluorescent 
cells than the parent WT strain at 120 minutes (p = 7.7 x 10-4), 150 minutes (p = 1.01 x 
10-12), and 180 minutes (p < 2 x 10-16). Finally, the pig3 mutant strain showed a 
significantly lower percentage of fluorescent cells than the parent WT strain at 120 





Figure 30. Loss of plasma membrane integrity in the bi-1, ire-1, and pig3 mutant strains 
and parent WT strain during PCD. Plotted points represent the mean percentage of 
fluorescent cells in each strain at each time point (n=3). Error bars represent the ± 
standard error of each strain at each time point. Statistical analysis was carried out using a 
two-way repeated measures analysis of variance (ANOVA). Post-hoc contrasts were 
carried out for each time point, wherein each mutant strain was compared to the parent 
WT strain. Statistical significance is denoted according to p-value;  “***” indicates a 
significant difference when p < 0.001. 
 
The percentage of the population in the parent WT strain exhibiting a loss of 
plasma membrane integrity increased steadily during the first 30 minutes of heat stress. 
This rate of increase was slowed, but not stopped, by the removal of cells from heat stress 
conditions slowed this rate of increase. 
The loss of BI-1 did have an effect on the loss of plasma membrane integrity, as 
the percentage of the fluorescent cells in the bi-1 mutant strain was lower than that of the 
parent WT strain from 60 minutes onward. Unexpectedly, a drastic decrease in the 
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percentage of fluorescent cells was observed in the bi-1 mutant strain at 120, 150, and 
180 minutes, though the implications of this decrease are unknown. Of potential 
importance, the observed decrease was observed to begin prior to the removal the cells 
from the heat stress. 
The loss of IRE-1 also appeared to have an effect of the loss of plasma membrane 
integrity, as the percentage of fluorescent cells in the ire-1 mutant strain was slightly 
lower than that of parent WT strain in the early time points and significantly lower than 
the parent WT strain at later time points. Following the removal of the sample from heat 
stress conditions, the percentage of fluorescent cells decrease slightly. 
The loss of PIG3 also appeared to have an effect on the loss of plasma membrane 
activity, as the percentage of fluorescent cells in the pig3 mutant strain was lower than 
that of the parent WT strain across all time points. Furthermore, the rate of increase in the 
percentage of fluorescent cells in the pig3 mutant strain was not as rapid as any of the 
other strains. Interestingly, as was observed in the parent WT strain, the percentage of 
fluorescent cells in the pig3 mutant strain continued to increase following the removal 
from heat stress conditions, though began to decrease soon thereafter.  
Taken together, it is not entirely clear what the results of this assay indicate with 
regards to plasma membrane integrity. In particular, the decrease in the percentage of 
fluorescent cells, most notable in the bi-1 strain, is inconsistent with the current 
understanding of PCD processes in other organisms. Generally speaking, the loss of 
plasma membrane integrity is one of the few PCD features that reliably indicates the 
death of the cell. If the intracellular presence of a DNA-intercalating, membrane 
impermeable, dye indicates death, and if the percentage of cells that exhibit the presence 
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of that dye decreases at later time points, a direct interpretation of the results would 
indicate that, during the stress, fewer cells in the population are dead at the later time 
points compared to the early time points. Given that the current understanding of PCD 
indicates that a cell, once dead, cannot regain characteristics of life, this possibility is 
rejected here. Instead, it is thought that some other variable, unaccounted for in the 
experimental design, better explains the observed results. Specifically, we suspect that the 
fragmentation of the biomolecule to which SYTOX Green binds, DNA, may cause the 
observed decrease in the percentage of fluorescent cells at later time points. This is 
primarily based on the reasoning that, if the detectable fluorescence of SYTOX green is 
dependent on its ability to bind DNA, and the PCD process effects the DNA binding sites 
of SYTOX (because DNA is degraded during PCD), then the ability of SYTOX to 
reliably indicate cell death may be limited to the stages of cell death in which DNA has 
not yet been extensively fragmented. 
Phosphatidylserine Externalization Assay The probe Annexin V was used to 
visualize cells displaying externalized phosphatidylserine to the outer leaflet of the 
plasma membrane. Annexin V is a cellular protein that binds phosphatidylserine 
directly.295,296 The conjugation of Annexin V to a fluorophore, in this case 
AlexaFluor488, facilitates the visualization of cells bound by Annexin V by fluorescence 
microscopy.62,272 As such, fluorescing cells are inferred to have externalized 
phosphatidylserine.  
In this experiment, we sought to determine if the loss of BI-1, IRE-1, or PIG3 
would affect phosphatidylserine exposure observed during PCD. At 60 minutes, nearly 
all cells were fluorescing, and no statistically-significant difference was detected between 
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the parent WT and any of the mutant strains. In all four strains, the percentage of 
fluorescent cells decreased after the 60 minute time point (Figure 31). Statistical analysis 
indicated that the percentage of Annexin V-positive cells was significantly affected by 
strain (p = 1.83 x 10-4), time (p = 7.33 x 10-11) and the interaction between strain and time 
(p = 6.98 x 10-3). The bi-1 mutant strain showed a significantly lower percentage of 
fluorescent cells than the parent WT strain at 120 minutes (p = 2.40 x 10-14), 180 minutes 
(p < 2 x 10-16), and 240 minutes (p < 2 x 10-16). The ire-1 mutant strain showed a 
significantly lower percentage of fluorescent cells than the parent WT strain at 180 
minutes (p = 3.53 x 10-6) and 240 minutes (p = 3.81 x 10-8). Finally, the pig3 mutant 
strain showed a significantly lower percentage of fluorescent cells than the parent WT 





Figure 31. Phosphatidylserine externalization in the bi-1, ire-1, and pig3 mutant strains 
compared to the parent WT strain during PCD. Plotted points represent the mean 
percentage of fluorescent cells in each strain at each time point (n=3). Error bars 
represent the ± standard error of each strain at each time point. Statistical analysis was 
carried out using a two-way repeated measures analysis of variance (ANOVA). Post-hoc 
contrasts were carried out for each time point, wherein each mutant strain was compared 
to the parent WT strain. Statistical significance is denoted according to p-value: “**” 
indicates a significant difference when p < 0.01. 
Taken together, these results demonstrate a nearly population-wide 
externalization of phosphatidylserine in all strains within the first hour of heat stress, 
indicating that this initial onset of PS externalization is not effected by the loss of BI-1, 
IRE-1, or PIG3. As, the first sampling was not carried out until 60 minutes into the stress, 
future studies may seek to determine if the initial rate of increase of in the percentage of 
Annexin V positive cells is affected in the absence of BI-1, IRE-1, or PIG3. Strikingly, 
the percentage of Annexin V-positive cells decreases in all strains at subsequent time 
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points, indicating that the loss of BI-1, IRE-1, or PIG3 do not prevent this observed 
decrease. Furthermore, the rate of decrease in the percentage of fluorescent cells is 
significantly enhanced in the bi-1, ire-1, and pig3 mutant strains, suggesting that the loss 
of these genes somehow accelerated this rate of decrease. 
The biological implications for the results of the Annexin V assay are unclear. 
The observed decrease in the percentage of fluorescent cells indicates that, by some 
unknown mechanism, Annexin V is unable to bind externalized phosphatidylserine at the 
later time points. 
ROS Accumulation Assay In this study, we utilized the fluorescent probe CM-
H2DCFDA to identify cells which have accumulated ROS during a PCD-inducing heat 
stress. CM-H2DCFDA is a chloromethyl and acetate derivative of 
dihydrodichlorofluorescein (H2DCFDA), a widely-used compound for the detection of 
intracellular reactive oxygen species. Thanks to the presence of lipophilic acetate groups, 
H2DCFDA is able to freely enter the cell by passive diffusion.297 Once in the cytosol, the 
acetate groups of H2DCFDA are hydrolyzed nonspecifically by intracellular esterases, 
yielding the product  2',7' dichlorodihydrofluorescein (H2DCF).298 H2DCF is oxidized to 
form the radical HDCF•, which is further oxidized to form the fluorescent product 
dichlorofluorescein DCF.299 This study utilizes a variant of H2DCFDA, CM-H2DCFDA. 
The addition of two chloromethyl groups results in the final product of its intracellular 
processing to be CM-DCF, a fluorescent compound reported to possess higher retention 
levels in the cell compared to DCF by reducing the ability of the compound to diffuse 
passively into the extracellular space.300  
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In the context of the percentage of fluorescent cells, the kinetics between the 
mutant strains and the parent WT were substantially different (Figure 32). The parent WT 
strain displayed the highest percentage of fluorescent cells at 30 minutes, at which point 
~90% of the cells were fluorescing. The percentage of fluorescent cells decreased at later 
time points in the parent WT strain. In contrast, only half of the cells were fluorescing at 
30 minutes in the bi-1 mutant strain, and ~25-30% of the cells were fluorescing in the ire-
1 and pig3 mutant strains. In the bi-1 mutant strain, the highest percentage of cells, 
~70%, was observed at 90 minutes. In the ire-1 and pig3 mutant strains, the highest 
percentage of fluorescent cells, ~65-70%, was observed at 60 minutes. For each of the 
four strains, the percentage of fluorescent cells was drastically reduced at the 120 minute 
time point. 
Statistical analysis indicated that the percentage of CM-H2DCFDA -positive cells 
was significantly affected by time (p = 7.05 x 10-9) and the interaction between strain and 
time (p = 1.2 x 10-3). Several statistically-significant differences in the percentage of 
fluorescent cells were noted between the parent WT strain and one or more of the mutant 
strains throughout the heat stress. The bi-1 mutant strain showed a significantly lower 
percentage of fluorescent cells than the parent WT strain at 30 minutes (p < 2 x 10-16) and 
a significantly higher percentage of fluorescent cells than the parent WT strain at 90 
minutes (p < 2 x 10-16). The ire-1 mutant strain showed a significantly lower percentage 
of fluorescent cells than the parent WT strain at 30 minutes (p < 2 x 10-16) and a 
significantly higher percentage of fluorescent cells than the parent WT strain at 90 
minutes (p < 2 x 10-16).  The pig3 mutant strain showed a significantly lower percentage 
of fluorescent cells than the parent WT strain at 30 minutes (p < 2 x 10-16) and a 
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significantly higher percentage of fluorescent cells than the parent WT strain at 90 
minutes (p < 2 x 10-16). In the parent WT strain, the highest increase in the percentage of 
fluorescent cells occurred between 0 and 30 minutes following heat stress. This is also 
when the highest percentage of the population exhibiting ROS (90%) was observed in 
this strain. Between 30 and 60 minutes, the percentage of cells exhibiting accumulated 
ROS dropped dramatically. The loss of the bi-1, ire-1, or pig3 genes had similar effects 
on the percentage of fluorescent cells with regards to both the rate at which the 
percentage of fluorescent cells increased, but also in terms of the maximum percentage of 
the population that exhibited the accumulation of ROS. The initial accumulation of ROS 
observed in the parent WT strain was attenuated in each of the three mutant strains (more 
so in the ire-1 and pig3 mutant strains than the bi-1 mutant strain). Furthermore, while 
the percentage of the parent WT population exhibiting accumulated ROS decreased after 
the 30 minute time point, the percentage of the ire-1 and pig3 mutant populations that 
exhibited accumulated ROS did not peak until 60 minutes. In the bi-1 mutant strain, the 
percentage of cells exhibiting ROS accumulation did not reach its maximum until the 90 




Figure 32. ROS accumulation in the bi-1, ire-1, and pig3 mutant strains compared to the 
WT strain during PCD. Plotted points represent the mean percentage of fluorescent cells 
in each strain at each time point (n=3). Error bars represent the ± standard error of each 
strain at each time point. Statistical analysis was carried out using a two-way repeated 
measures analysis of variance (ANOVA). Post-hoc contrasts were carried out for each 
time point, wherein each mutant strain was compared to the parent WT strain. Statistical 
significance is denoted according to p-value; “***” indicates a significant difference 
when p < 0.001. 
Regardless, at 120 minutes, the percentage of fluorescent cells in each of the 
strains dropped below 20%. Together, these results indicate that the loss of either BI-1, 
IRE-1, or PIG3 significantly reduced the capability to accumulate ROS in the cell, both in 
terms of timing and the percentage of cells exhibiting the accumulation of ROS. 
Plating Assay With this experiment, we sought to determine if the loss of either 
the bi-1, ire-1, or pig3 genes would affect the area of vegetative growth on solid medium 
throughout and following a PCD-inducing heat stress.  
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In each of the four strains, the most drastic decrease in growth area occurred 
within the first 60 minutes of heat stress (Figure 33). Statistical analysis indicated that the 
growth area was significantly affected by time (p < 2 x 10-16) and the interaction between 
strain and time (p = 1.29 x 10-4). At only the 30 minute time point was there a significant 
difference between the growth area of the parent WT strain and one of the mutant strains. 
At 30 minutes, both the bi-1 (p = 7.72 x 10-7) and pig3 (p < 2 x 10-16) mutant strains 
showed a significantly greater growth area than that of the parent WT strain. Though the 
mean measured area of the ire-1 mutant strain was higher than parent WT strain at 30 
minutes, the difference was not statistically significant.  
Of note, the mean area of the pig3 mutant strain was higher than that observed in 
the parent WT strain between 30-120 minutes. Additionally, the mean growth area of the 
bi-1 mutant strain was higher than that of the parent WT strain between 30-90 minutes. 
Finally, the mean area of the ire-1 mutant strain was higher than the parent WT strain 






Figure 33. Relative growth area of the bi-1, ire-1, and pig3 mutant strains during PCD. This boxplot depicts the relative growth areas 
measured for each strain at each time point throughout the heat stress (n=3). The boxes represent data between the 25th and 75th 
percentiles, solid horizontal line within each of the boxes represents the median, and the whiskers represent the minimum and 
maximum values. Statistical analysis was carried out using a two-way repeated measures analysis of variance (ANOVA). Post-hoc 
contrasts were carried out for each time point, wherein each mutant strain was compared to the parent WT strain. Statistical 




DNA Laddering Assay In this experiment, we sought to determine if the loss of 
either BI-1, IRE-1, or PIG3 would affect either the timing or intensity of DNA laddering 
during PCD (Figure 34). In all three mutant strains, DNA laddering appeared more 
prominent than in the parent WT strain, suggesting that genomic fragmentation is 
enhanced in the absence of BI-1, IRE-1, or PIG3. The patterns of genomic DNA 
fragmentation were similar between the ire-1 mutant strain and parent WT strain in that 
genomic fragmentation was not clearly present until 120 minutes. However, the laddering 
in the ire-1 mutant strain was more prominent than that observed in the parent WT strain 
at the 120 minute time point. This could potentially indicate that the absence of IRE-1 
enhances the occurrence of DNA fragmentation without expediting the process. In the bi-
1 and pig3 mutant strains, the onset of DNA fragmentation occurred rapidly between the 
60 and 90 minute time points, potentially indicating that the absence of BI-1 or PIG3 
enhances both the rate and occurrence of DNA fragmentation in C. reinhardtii.  Notably, 







Figure 34. DNA laddering in the bi-1, ire-1, and pig3 mutant strains during PCD. Each lane contains purified genomic DNA from a 







In previous studies, C. reinhardtii proteins that participate in PCD were predicted 
using a large-scale, homology-based, approach. From this list of C. reinhardtii predicted 
PCD proteins (CrPPPs), we selected several proteins to investigate further for a role in C. 
reinhardtii PCD. We hypothesized that each of these selected proteins participates in C. 
reinhardtii PCD, and we sought to test this hypothesis utilizing a reverse genetics 
approach. To this end, mutant strains of C. reinhardtii, each harboring an insertional 
mutation in one of the selected protein-coding genes, were ordered from the CLiP library 
and the reported insertion site was validated for each strain. 
The purpose of this study was to test the hypothesis that each of these proteins 
participates in PCD in C. reinhardtii. To accomplish this, a reverse genetics approach 
was utilized, wherein we assayed for typical PCD features in each of the mutant strains 
following exposure to a PCD-inducing heat stress. We predicted that C. reinhardtii 
strains deficient in a single selected protein would exhibit an alteration of one or more 
PCD phenotypes relative to the parent WT strain. Notably, morphological analysis of the 
e2f, tat-d, and lsd-1 mutant strains exposed a tendency of these strains to form 
multicellular aggregates known as palmelloids under normal culturing conditions. As 
such structures are not conducive for the manual scoring of cells by microscopy, these 
strains were excluded from the study. A summary of the results for the bi-1, ire-1, and 








Comparison of PCD features in each mutant strain to the parent WT strain. 
Feature bi-1 Mutant Strain ire-1 Mutant Strain pig3 Mutant Strain 
Loss of Metabolic Activity 
(Figure 29) 
Altered Altered Approximately the 
same 
Loss of Plasma Membrane 
Integrity (Figure 30) 
Attenuated after 120 
minutes 
Attenuated after 120 
minutes 
Attenuated after 60 
minutes 
PS Externalization  
(Figure 31) 
Attenuated after 120 
minutes 
Attenuated after 180 
minutes 
Attenuated after 120 
minutes 








Cell Division Ability  
(Figure 33) 




Greater area at 30 
minutes 
DNA Laddering  
(Figure 34) 
More rapid, enhanced Delayed Enhanced 
 
bi-1 Mutant Strain Bax inhibitor-1 (BI-1) is a conserved ER-transmembrane 
protein that acts to repress PCD in distinct phylogenetic clades. Given the anti-PCD 
functions of BI-1 in other organisms, it was expected that enhanced PCD features would 
be observed in a C. reinhardtii strain lacking functional BI-1 (Table 6).  
Of the experiments performed in this study, only the DNA laddering assay 
provided strong support for the prediction that a C. reinhardtii strain lacking functional 
BI-1 would exhibit enhanced PCD features (Figure 34). That DNA laddering in the bi-1 
mutant strain was observed to be more prominent at 90 minutes than the parent WT strain 
at any of the time points, suggests that DNA laddering is enhanced in the absence of BI-
1. Additionally, DNA laddering in the bi-1 mutant strain is less prominent at 120 minutes 
compared to 90 minutes, suggesting that the DNA fragmentation process as a whole may 




The other results obtained from this study were either inconclusive or did not 
support the prediction that the bi-1 mutant strain would exhibit enhanced PCD features. 
While a greater decrease in the percentage of metabolically active cells was observed in 
the bi-1 mutant strain after 30 minutes of heat stress, this trend was not observed at later 
time points. In fact, a greater percentage of cells in the bi-1 mutant strain was observed to 
be metabolically active at both the 90 and 120 minute time points relative to the parent 
WT strain (Figure 29). Unexpectedly, the percentage of bi-1 mutant cells exhibiting a 
loss of plasma membrane integrity was slightly lower than that of the parent WT strain 
within the first 90 minutes of heat stress (Figure 30). Perplexingly, a prominent decrease 
in the percentage of SYTOX Green-positive cells was observed in the bi-1 mutant strain 
after 90 minutes of heat stress. Intuitively, it seems unlikely that cells regain plasma 
membrane integrity, as this feature is thought to be irreversible and has been proposed to 
be one of the most reliable marker for cell death.95 Given that DNA intercalating agents 
such as SYTOX Green bind DNA, we predict that the observed decrease in the 
percentage of fluorescent cells may be due to the extensive fragmentation of DNA at 
these later time points. Importantly, this prediction is consistent with the extensive DNA 
fragmentation observed in the bi-1 mutant strain from the results of the DNA laddering 
assay (Figure 34). If true, this explanation of the SYTOX Green results would be in 
agreement with the prediction that the loss of BI-1 would augment PCD in C. reinhardtii, 
though it would simultaneously call into question the efficacy of SYTOX green as an 
indicator of membrane permeability in the presence of extensive DNA degradation. 
Unexpectedly, ROS accumulation in the bi-1 mutant strain was attenuated during heat-




contributor to the ROS accumulation observed during apoptosis, it was expected that that 
the absence of BI-1 would result in a more robust accumulation of ROS during PCD. 
Also surprisingly, a larger growth area was observed for the bi-1 mutant strain compared 
to the parent WT strain at 30, 60, and 90 minutes, suggesting a higher number of viable 
cells at these time points (Figure 33). 
ire-1 Mutant Strain Inositol-requiring enzyme 1 (IRE-1) is a phylogenetically-
conserved ER transmembrane protein that acts as both a stress sensor and primary 
regulator of PCD. In light of the PCD-modulating role of IRE-1 in other organisms, it 
was expected that attenuated PCD features would be observed in a C. reinhardtii strain 
lacking functional IRE-1 (Table 6). 
Of the experimental results obtained in this study, some were consistent with the 
prediction that a C. reinhardtii strain lacking functional IRE-1 would exhibit attenuated 
PCD features. A lower percentage of cells exhibiting a loss of plasma membrane integrity 
was observed in the ire-1 mutant strain relative to the parent WT strain at 120, 150, and 
180 minutes following subjection to heat stress (Figure 30). Additionally, ROS 
accumulation in the ire-1 mutant strain is both delayed and decreased relative to the 
parent WT strain (Figure 32). Finally, when plated at various time points during the heat 
stress, the area of growth in the ire-1 mutant strain was greater than that of the parent WT 
strain at all times assayed, with the exception of the 60 minute time point (Figure 33).  
The results of the other experiments performed were either inconclusive or did not 
support the prediction that PCD would be attenuated in the ire-1 mutant strain. Namely, 
the percentage of metabolically-active cells was only slightly reduced in the ire-1 mutant 




(Figure 29). Whether these differences are relevant in a biological context is unclear. 
Additionally, the results of the DNA laddering assay suggest that DNA fragmentation 
may be enhanced in the absence of IRE-1, as the DNA laddering observed in the ire-1 
mutant strain is more prominent at 120 minutes than any of the parent WT lanes (Figure 
34). Unexpectedly, however, DNA laddering in the ire-1 mutant strain was not visible at 
90 minutes. As faint DNA laddering is visible in the parent WT strain at this time, the 
results of this experiment may indicate that DNA laddering is delayed in the absence of 
IRE-1.  
pig3 Mutant Strain p53-induced gene 3 (PIG3) is a quinone oxidoreductase that 
is conserved in plants and animals. In mammals, PIG3 expression is activated by the 
apoptotic regulator, p53. In light of the pro-PCD functions of PIG3 in animals, it was 
expected that attenuated PCD features would be observed in a C. reinhardtii strain 
lacking functional PIG3 (Table 6). 
Of the experiments performed in this study, some of the results obtained were in 
agreement with the prediction that a C. reinhardtii strain lacking functional PIG3 would 
exhibit diminished PCD features. The percentage of cells exhibiting a loss of plasma 
membrane integrity was lower in the pig3 mutant strain relative to the parent WT strain 
across all time points (Figure 30). Moreover, the percentage of cells exhibiting ROS 
accumulation was both delayed and diminished in the pig3 mutant strain relative to the 
parent WT strain (Figure 32). Additionally, when cells were plated at various time points 
during and after the heat stress, the mean area of growth observed in the pig3 mutant 




Some of the experiments carried out in this study either did not support the 
prediction that PCD features would be attenuated in the pig3 mutant strain or were 
inconclusive. The percentage of cells exhibiting metabolic activity in the pig3 mutant 
strain was slightly less than that of the parent WT strain during the first 90 minutes of 
heat stress (Figure 29). Whether this observation is relevant in a biological context is 
unknown. DNA laddering was more prominent in the pig3 mutant strain than in the 
parent WT mutant strain at both 90 and 120 minutes, suggesting that the loss of PIG3 






Project Summary, Study Limitations, and Future Studies 
Project Summary 
In a broad sense, the preceding work was carried out in order to elucidate some of 
the molecular mechanisms that underlie programmed cell death (PCD) in 
Chlamydomonas reinhardtii. An understanding of PCD in C. reinhardtii is beneficial for 
two primary reasons. First, despite the fact that PCD processes are observed throughout 
the tree of life, exceedingly little is known regarding the molecular foundations of PCD 
in non-animal organisms. The poor characterization of such a widespread and 
fundamental process limits our understanding of basic biological processes, both at the 
cellular and organismal level. We argue that an understanding of PCD in unicellular 
organisms, many of which are widely regarded to represent ancestral life forms, is crucial 
to understanding PCD processes in other organisms. This is because 1) at least some 
aspects of PCD may be conserved between a given multicellular organism and the 
unicellular ancestor, and 2) as speciation of unicellular organisms gave rise to the vast 
array of biological diversity observed today, findings in unicellular organisms can often 
be translated to higher organisms of common descent.  
As a second benefit of understanding PCD in C. reinhardtii, we present that C. 
reinhardtii is an ideal organism in which to study conserved aspects of PCD, as the 
relatedness of C. reinhardtii to both animals and higher plants makes findings in this 
organism likely relevant to these systems. In this way, Chlamydomonas is set apart from 




C. reinhardtii for industrial use means that understanding PCD in this organism is highly 
likely to benefit the areas of industry in which it is utilized, such as biofuel and nutrition.   
The purpose of this chapter is to summarize the work that was described in 
previous sections of this thesis, discuss potential limitations to these experiments, and 
present future studies for consideration.  
Prediction and Selection of Putative PCD Proteins in C. reinhardtii The goals 
of this work were to 1) use computational methods to predict proteins in C. reinhardtii 
that participate in PCD on a large scale, and 2) select several proteins for further 
investigation regarding a role in C. reinhardtii PCD. The results of these experiments are 
summarized in Table 5 and Table 6, and suggest that some mechanisms of PCD in other 
organisms may be conserved in C. reinhardtii. 
Selection and Verification of C. reinhardtii Mutant Strains In order to 
investigate a role for the selected gene products during C. reinhardtii PCD, we sought to 
employ a reverse-genetics approach, in which mutant strains of C. reinhardtii, each 
deficient in one of the selected proteins, would be utilized. We ordered the mutant strains, 
one for each selected CrPPP (Table 6), from the Chlamydomonas Library Project (CLiP) 
library of mutant strains. Prior to experimental utilization of the selected strains, the 
reported insertional locus was verified for each strain using methods recommended by the 
CLiP library. This process consisted of three steps, the results of which are summarized 
in Table 11. 
Finally, to confirm that the PCR products from the amplification of the cassette-
genome junctions were sent off for sequencing to confirm that the observed products 




products from the G1/C1 and G2/C2 PCR reactions were of the cassette-genome 
junctions, a simulation of the insertion was created for each of the strains by inserting the 
CIB1 cassette nucleotide sequence, in its determined orientation, into the insertion site 
reported by the CLiP library. For each mutant strain, the sequences obtained from PCR 
amplification of the cassette-genome junctions, if any, were aligned with the simulated 
insertion site. 
Comparative Analysis of PCD Features in C. reinhardtii Mutant Strains 
Following the verification procedures for the mutant strains, we tested the hypotheses 
that each of the selected proteins participates in C. reinhardtii PCD. To this end, a reverse 
genetics approach was utilized, wherein each of the mutant strains was assayed for 
typical PCD features in response to a PCD-inducing heat stress. It was predicted that C. 
reinhardtii strains deficient in a single selected protein would exhibit an alteration in one 
or more of the PCD phenotypes measured relative to the parent WT strain. A synopsis of 
the results for the bi-1, ire-1, and pig3 mutant strains is shown in Table 11. To 
summarize, the results obtained in this study demonstrate that each of the mutant strains 
exhibited one or more PCD phenotypes which were distinct from that of the parent WT 
strain. These findings suggest that BI-1, IRE-1, and PIG3 may participate in PCD C. 
reinhardtii.  
Limitations and Future Studies 
Database Construction Not all proteins that are involved in PCD were included 
in the database used to predict PCD proteins in C. reinhardtii. Given that the molecular 
bases for recently-discovered forms of PCD, such as pyroptosis or ferroptosis, are poorly 




database. When the underlying molecular pathways for these processes are characterized 
in more detail, future studies might attempt to integrate these forms of PCD into the 
prediction of PCD participants in C. reinhardtii.  
We also opted to exclude amino acid sequences of non-eukaryotic origin from the 
database, as the total number of eukaryotic sequences alone exceeded 90,000 search 
results. Given the possibility that some aspects of PCD in non-eukaryotic organisms may 
be conserved in C. reinhardtii, future studies that seek to further elucidate the molecular 
basis of C. reinhardtii may construct a database using amino acid sequences of bacterial, 
archaeal, and/or viral origin.  
It should also be noted that some of the sequences included in the PCD database 
may not actually participate in PCD. A keyword search from the NCBI webpage returns 
all amino acid sequences from the searched databases that contain the keyword in the 
entry's GenPept page. However, the presence of a keyword in a GenPept entry does not 
guarantee the involvement of the protein in that process. Hence, it is conceivable that a 
protein, which is not involved in PCD, contains one of the search terms in its GenPept 
entry. However, because the filtered BLASTp results consisted of over 100,000 
alignments between the CrPPPs and the database proteins, manual confirmation of a role 
in PCD for every subject sequence was not feasible. One reason we suspect that the 
database in this study may contain superfluous entries is that, in searches of the RefSeq 
database, we opted to include search results from all eukaryotic organisms in the 
database. The basis of PCD in many of these organisms remains largely uncharacterized, 
indicating that the annotations assigned to such organisms may be predictive only. Thus, 




results seemed advantageous because of the extensive nature of the resulting database, we 
suspect that this comprehensiveness may have come at the cost of stringency with regard 
to a verified role during PCD for the amino acid sequences that originated from 
uncharacterized genomes. As an alternative approach, it may be beneficial to construct 
future databases using only sequences from organisms in which PCD has been 
extensively characterized.  
In light of the limitations discussed above, we propose that the UniProt database 
may be more suitable than the RefSeq database for exploratory studies such as this.301,302 
The UnitProt webpage (www.uniprot.org) provides descriptive titles for each entry, 
including all known synonyms and alternative names. In addition, the user-friendly 
webpage also possesses extensive search capabilities, which allows the user to perform a 
keyword search using a number of different parameters, and subsequently filter the 
search results using those same parameters. As an additional feature, the UniProt 
webpage provides the Gene Ontology terms accompanying each entry, along with the 
associated annotation score, allowing the user to assess the robustness of the annotation 
based on the evidence used to assign the term. Together, these features of the UniProt 
database may be a great benefit to future studies which seek to 1) create a more 
customized database, and 2) quickly and efficiently analyze individual entries.  
Prediction of PCD Proteins in C. reinhardtii The computational strategy used to 
predict the C. reinhardtii proteins that participate in PCD utilized the BLASTp alignment 





Methods of Detecting Similarity Other tools, which utilize distinct algorithms to 
detect sequential similarity, may be utilized as an alternative to BLASTp. One of the 
most recent tools that have been developed for the detection of sequence similarities is 
Hmmer, which uses an approach known as probabilistic modeling to detect subtle 
signatures that are shared between a query amino acid sequence and individual protein 
families.303,304 In some ways, this technique offers a sensitivity that is superior to methods 
that utilize a one-to-one approach of sequence alignment, as it allows for the detection of 
residues conserved within protein families, which may not be detectable by traditional 
pairwise alignment methods. Until recently, a limitation of computational abilities and 
the complex calculations associated with probabilistic modeling restricted the suitability 
of Hmmer to the analysis of only a few sequences.305 However, the rapid advancements 
in the capacities of computational systems, in conjunction with the performance 
improvements seen in the latest version, Hmmer3, have expanded the usage of this tool to 
larger datasets.305 
Another alignment tool, PSI-BLAST, utilizes an approach that is somewhat 
similar to Hmmer to detect distantly-related sequences. To detect such homologies, PSI-
BLAST utilizes an iterative alignment strategy, wherein the user designates meaningful 
alignments following each iteration.306 Aligned positions are subsequently used to query 
the database a second time, following which the user again designates  alignments that 
are deemed to be meaningful. This process is repeated until no new subjects emerge in 
the alignments. One disadvantage of PSI-BLAST is that, because of the requirement for 
manual designation of meaningful alignments, it is not suitable for the analysis of more 




human error, as the tedious nature of denoting meaningful alignments has the potential to 
result in the misidentification of a meaningful alignment. This will, in turn, affect the 
alignments that are reported in subsequent iterations of the BLASTp procedure. 
Sequential and Functional Similarity of Amino Acid Sequences Alignment tools 
are, alone, unable to accurately predict functional similarities between two amino acid 
sequences. Many examples exist of proteins that, despite homology, perform vastly 
different functions in distinct organisms.201 As such, the alignment of a query protein to a 
subject protein does not, in and of itself, guarantee similar functions and/or characteristics 
for the two proteins.201  Secondly, many instances of unrelated proteins that share similar 
or identical functions in the cell have also been described. Therefore, the lack of an 
alignment between query and subject sequences cannot be used to infer that the two 
proteins are functionally dissimiliar.201 Given the limitations of sequence alignment tools, 
further comparative bioinformatics analyses, such as the comparison of domain 
composition/location, should be utilized to supplement the results of an alignment 
between two amino acid sequences.  
Elucidation of Conserved Pathways In light of the apparent role of the selected 
CrPPPs during C. reinhardtii PCD, it stands to reason that other components of the PCD 
pathways in which these proteins participate may also be conserved in C. reinhardtii. 
Future studies seeking to identify conserved aspects of PCD in C. reinhardtii may wish to 
take a predictive computational approach to addressing this question. One bioinformatics 
resource that may be useful in identifying conserved aspects of PCD in C. reinhardtii is 
through functional association networks. Tools such as the Search Tool for the Retrieval 




such purposes.307 STRING is a web-based database of known and predicted protein-
protein interactions. To use the database, the user produces the name(s) or amino acid 
sequence(s) of one or more proteins and specifies the source organism in which to search 
for interactions. From this, STRING produces an interaction network of the predicted and 
known proteins with which the searched protein interacts. Proteins are represented as 
nodes, and associations between proteins are designated by strings that connect two 
nodes.  
Using one of the CrPPPs from this study as an example, it can be supposed that a 
future study might wish to identify components of the IRE-1 PCD pathways that are 
conserved in C. reinhardtii. First, known interactors of IRE-1 in another organism, 
suppose Homo sapiens, can be identified using the STRING database. Importantly, IRE-1 
participates in processes other than PCD, and it is likely that not all proteins that interact 
with IRE-1 in H. sapiens will be of relevance to PCD. As such, PCD roles for these 
interactors should be confirmed at some point. Once proteins that interact with IRE-1 in 
H. sapiens have been identified, these amino acid sequences can be used to query the C. 
reinhardtii proteome. This will yield C. reinhardtii homologs of proteins that interact 
with IRE-1 in H. sapiens. If, in H. sapiens, these proteins participate in PCD, the C. 
reinhardtii homologs may serve as candidate proteins to study further in C. reinhardtii 
PCD. Moreover, if a C. reinhardtii homolog of the IRE-1 interactor is found to 
participate in PCD, further studies could be conducted to determine if the interaction 
between the two proteins is conserved in C. reinhardtii.  
Verification of CLiP Mutant Strains In this study, mutant strains generated by 




as recommended by the curators of the CLiP library, were utilized to confirm the 
insertional locus reported for each strain. 
Analysis of Unexpected Results In the instance where one or more unexpected 
results are obtained during the validation of CLiP mutant strains, an integrated analysis of 
all results is necessary to accurately predict the underlying cause for the unexpected 
results. As an example, the amplification of the ire-1 insertional locus was unsuccessful 
when WT genomic DNA was supplied as the template for PCR amplification (Figure 
22C). Given that PCR reactions performed subsequently relied on at least one component 
from this reaction, the results of these experiments may be useful to deduce the causative 
agent responsible for this failure. Indeed, the amplification of the cassette-genome 
junctions of the ire-1 mutant strain indicates that cassette-genome junction amplified by 
the ire-1 G1/ C1 primer combination was also unsuccessful (Figure 22D).  
Taking into consideration the failure of both reactions that utilized ire-1 G1 
primer, we suspect that the ire-1 G1 primer may be the cause for the failure of both PCR 
reactions. This prediction can be further supported by ruling out other possible 
explanations. One such explanation for this result might be that the template genomic 
DNA from the ire-1 mutant strain was of poor quality. However, the successful 
amplification of the other cassette-genome junction in the ire-1 mutant strain suggests 
genomic DNA of reasonable quality. An alternative explanation might employ the 
reasoning that the inability to amplify the ire-1 G1/C1 cassette-genome junctions may be 
a result of the cassette primer. However, other PCR reactions that also utilized the C1 
primer were successful in almost all instances. Moreover, the only other instance in 




mutant strain; Figure 25D) was correlated with the lack of a reported genomic sequence 
flanking the C1 side of the cassette by the CLiP library (Table 7). These observations 
suggest that, in the case of the lsd-1 mutant strain utilized for this study, the unsuccessful 
amplification of the G1/C1 cassette-genome junction can potentially be attributed to a 
truncation of the cassette during insertion, which may have resulted in the loss of the C1 
primer binding site. However, a flanking sequence was reported by the CLiP library for 
the ire-1 mutant strain, indicating that such a truncation did not occur in the ire-1 mutant 
strain.  
With alternative explanations for the failure to amplify the ire-1 G1/C1 cassette-
genome junction in the ire-1 mutant strain ruled out, the hypothesis that the ire-1 G1 
primer was the reason for the failed PCR reactions seems reasonable. In this way, the 
results of the individual validation experiments, in conjunction with the insertional 
information reported for the strain, may potentially explain the unexpected results of one 
or more PCR reactions. 
Comparative Analysis of PCD Features in Mutant Strains In this study, a 
reverse genetics approach was taken to determine if the loss of a selected protein-coding 
gene would cause an alteration of PCD phenotypes in C. reinhardtii. To achieve this, 
strains of C. reinhardtii were subjected to a PCD-inducing heat stress, and PCD features 
of mutant strains lacking one of the selected proteins were compared to the phenotypes of 
the parent WT strain. 
Unintended Effects of Mutagenesis In a general sense, the implicit logic that 
underlies the utilization of mutant strains to elucidate gene function is that, if a gene 




process in one way or another. If the gene product positively or negatively regulates the 
process, the loss of the gene should attenuate or augment the process, respectively. Given 
that even the simplest biological systems are exceptionally complex, a rudimentary “if 
this, then that” logic is, in and of itself, an oversimplified way of interpreting the results 
obtained from mutant strains. There are a number of factors that may confound the results 
obtained from mutant strains. In particular, a primary concern to consider when utilizing 
mutant strains is that changes in the observed phenotype may not necessarily indicate a 
role for the disrupted gene in PCD.  
The expression of “off-target effects” is a phrase commonly used in molecular 
biology and refers collectively to any and all unintended consequences of a method or 
treatment. It is unclear whether this term can be applied to a strain generated by random 
mutagenesis, as such a technique, by definition, lacks a specific target. Nevertheless, any 
effects that were unintended by the creators of the strain(s) are factors that have the 
potential to alter the measured phenotype of a mutant strain. As such, these unintended 
effects, as they are referred to here, require consideration by anyone utilizing such strains. 
Several plausible unintended effects are discussed below.  
Pleiotropic Genes The first confounding factor in the use of mutant strains stems 
from the pleiotropic nature of certain genes. A gene is said to be pleiotropic when it has 
an effect on multiple phenotypes. As such, the alteration and/or disruption of a 
pleiotropic gene might effect a phenotype in indirect and unpredictable ways.  
As an example of how this notion might play out, consider the mitochondrial 
protein cytochrome c. As outlined in Chapter 1, cytochrome c plays an important role in 




cytochrome c is a completely uncharacterized protein, with the exception of some recent 
evidence which indicates that cytochrome c may play a role in positively-regulating 
apoptosis. Given only this information, one might hypothesize that murine cells deficient 
in cytochrome c will exhibit an extended lifespan as a result of an attenuated apoptotic 
process. To test this hypothesis, a researcher examines the lifespan of murine cells 
lacking cytochrome c and finds that, contrary to what was predicted, cells lacking 
cytochrome c instead exhibit a lifespan that is significantly shortened. Furthermore, when 
mouse embryos are engineered to express a non-functional variant of cytochrome c, the 
animals die prematurely during embryonic development. Based solely on these results, 
the researcher might conclude that cytochrome c may not positively-regulate apoptosis, 
as was previously predicted. Instead, the observation that cells which lack cytochrome c 
are more susceptible to undergoing apoptosis suggests that cytochrome c may actually 
function as an anti-apoptotic factor.  
Abandoning the hypothetical example, the current knowledge of the apoptotic 
process indicates that the conclusion reached by the researcher is incorrect. It is known 
that cytochrome c is a pleiotropic gene which acts not only as a positive regulator of 
apoptosis, but also plays a well-established role in oxidative phosphorylation during the 
synthesis of ATP.308 In fact, the metabolic role of cytochrome c was established long 
before the discovery that cytochrome c also plays a role in apoptosis. However, given that 
the researcher in the example above is not aware of cytochrome c's participation in 
oxidative phosphorylation, the conclusion that the scientist reaches is not an illogical one.  
This example is actually an extensively-adapted account of a study which 




apoptosis.309 In the real study, because the metabolic role of cytochrome c was already 
very well-known, it was not difficult for the authors to deduce that the premature death of 
cytochrome c-deficient embryos could likely be attributed to defective oxidative 
phosphorylation, rather than an anti-apoptotic role for cytochrome c in PCD.  
 The purpose of the example was to demonstrate, in the context of PCD, that 
phenotypes exhibited by mutant strains harboring an altered gene are not always a 
reliable indicator of the gene’s function in the process under investigation. This notion is 
of particular importance in the context of pleiotropic genes. In the case of cytochrome c, 
an alternative explanation for a result which seemed to contrast the hypothesis was 
readily available. This represents an entirely different scenario than the current study, as 
the function(s) of disrupted genes are largely or entirely uncharacterized in C. reinhardtii. 
Similarly to the fictionalized cytochrome c example, some or all of the selected C. 
reinhardtii gene products may play roles in normal cellular processes. As such, it is not 
known if the hypothetical non-PCD roles for these gene products were disrupted by the 
insertional mutation. Though the growth curves of the bi-1, ire-1, and pig3 mutant strains 
did not indicate the presence of any metabolic defects in these strains (Figure 28), the 
plausibility of a non-PCD role for these genes cannot be ruled out by this assay alone. 
The possibility of pleiotropic genes is an important factor to consider, as the disruption of 
a non-PCD pathway might have an indirect effect on the PCD phenotypes. 
Gene Deletion and Genome Mutation A recent study in S. cerevisiae 
demonstrated that the loss of a single gene may result in the evolution of other portions of 
the genome.310 Notably, this phenomenon is not unique to yeast mutant strains, but has 




mutation, termed a driver mutation, increases the likelihood of additional mutations, 
termed passenger mutations, developing at other genomic locations.311,312  
As this study utilized mutant strains of C. reinhardtii, it seems appropriate to note 
the observations made in S. cerevisiae. The occurrence of such passenger mutations in 
mutant C. reinhardtii strains has yet to be explored. However, if the principle that an 
initial mutation drives genome evolution can be generalized to apply to all organisms, 
genome evolution may present a confounding factor to studies that utilize mutant strains 
of C. reinhardtii, as this evolution may generate strains that are divergent from the parent 
WT strain in multiple genes.313 Given that the degree of genomic variation in C. 
reinhardtii lab strains suggests that the baseline rate of evolution for this organism may 
be relatively high to begin with, an initial mutation could conceivably exacerbate the 
evolutionary propensity for C. reinhardtii even further.314,315   
Cassette Cleavage and Integration Transformation in C. reinhardtii is a 
notoriously difficult task.167 The complications that arise during the transformation of C. 
reinhardtii have been primarily attributed to the abundance of nucleases that are present 
in Chlamydomonas cells. These nucleases target exogenous genetic material with high 
efficiency, making the insertion of an intact cassette into the C. reinhardtii genome a 
challenging endeavor.262 Cleavage of the construct may result in a truncated cassette, 
which may or may not effectively disrupt the gene in which the cassette inserts.173 
Additionally, because the cleavage of the construct causes fragmentation of the cassette, 
nuclease activity might also result in the insertion of a cassette fragment into another 
region of the genome. This additional insertion could conceivably have an effect on PCD 




additional cassette fragment present in the genome, it might not be detected by the large-
scale mapping methods used by the CLiP library, as this strategy requires the presence of 
the primer binding site.173  
Detecting Unintended Effects of Mutagenesis Given the potential unintended 
effects that may be present in C. reinhardtii mutant strains, future studies that utilize such 
strains should seek to accomplish two primary goals. First, to rule out additional factors 
that may alter the phenotypes exhibited by a mutant strain, it should be determined that 
the mutagenesis technique, as well as the mutation itself, are absent of unintended 
genomic effects. Second, to confirm that the observed phenotypes are due to the 
disruption of the gene of interest, it should also be demonstrated that the phenotypes 
observed in the mutant strain are linked to the disrupted allele. 
Whole-genome sequencing is likely the most direct method for identifying 
unintended genomic effects of mutagenesis.162 Sequencing the genome of the mutant 
strain in question and comparing it to the genome of the parent WT strain would allow 
the researcher to 1) identify regions of the mutant genome which have diverged from the 
parent WT strain, and 2) identify and map any fragments of the cassette which may have 
inserted elsewhere in the genome of the mutant strain.  
As an alternative to whole genome sequencing, Southern blotting may be utilized 
to detect the presence of cassette fragments that have inserted into the genome.316 To 
utilize a Southern blot for this purpose, nucleotide probes, conjugated to a detectable 
reporter, should be designed for various regions of the insertional cassette. The genome 
of the mutant strain would then be fragmented with specified combinations of restriction 




agarose gel and transferred to a membrane, which would be treated with the pre-designed 
cassette probes. The target cassette sequences would be visualized using a reporter 
conjugated to the cassette probe.317 Given that the genome is fragmented randomly, it 
would be expected that, if a cassette fragment was inserted into a different portion of the 
genome than the mapped cassette, it would be likely be located within a fragment of a 
different molecular weight than that of the mapped cassette. Thus, if a given target 
sequence is present in more than one portion of the genome, it would be expected that 
multiple bands for the target sequence would be visualized on the blot.317 
The downside of this approach compared to whole genome sequencing is that, 
because the probes are specific to only a portion of the cassette, several probes would 
need to be designed and validated for specificity to the cassette. Moreover, the Southern 
blot is only useful for the detection of additional cassette sequences that have not been 
mapped by the CLiP library and does not address the possibility of genomic mutation as a 
result of the insertion. Thus, whole genome sequencing may represent a more thorough 
approach to detecting unintended effects of mutagenesis, as both unmapped insertion 
sites and genomic evolution might be detected by this method.  
Linking the Mutant Phenotype to the Disrupted Gene To validate that a phenotype 
observed in the mutant strain is a result of the disrupted gene, and not an unintended 
effect of the mutagenesis, a useful strategy might be to correlate the presence of the 
mutant allele to the altered phenotype. 
One characteristic of C. reinhardtii that makes it particularly suitable for genetic 
studies is its ability to alternate between haploid and diploid states.318 Under standard 




division. When specific conditions are met, C. reinhardtii cells may undergo sexual 
reproduction. Importantly, Chlamydomonas cells may be classified by their mating type, 
either + or -, and sexual reproduction can only occur between two cells of opposite 
mating type.318 To summarize the process, sexual reproduction involves fusion of the two 
parental strains to form the zygospore, a diploid cell encased in a thick cell wall. The 
zygospore can be induced to meiotically germinate, which results in four haploid 
progeny. The daughter cells exist as a closely-oriented cluster for a brief period of time, 
termed a tetrad, and physical separation of these progeny with a precise instrument 
facilitates the formation of four clonal colonies that are distinct from one another.318 
This characteristic of C. reinhardtii can be utilized to correlate the presence of a 
mutant allele to an altered phenotype.318,319 In the case where a mutant strain exhibits a 
phenotype that is different than that of the parent WT strain, crossing the mutant strain 
with the WT strain of the opposite mating type will produce four progeny strains, which 
can be described as X+, X-, Y+, and Y-, where "X" and "Y" denote the two allelic variants 
of the gene of interest, and "+" and "-" denote the mating type. Using this study as an 
example, the CLiP mutant strains were generated in a – mating type background strain. 
Therefore, mating a CLiP mutant with a + mating type strain would, as an end product, 
produce the mutant allele in both the + and – genetic backgrounds. The differential 
phenotype that was detected in the initial mutant strain can be assayed again, this time 
using all progeny of the cross. If the differential phenotype is the result the mutant allele, 
this phenotype should be present in all strains which possess this allele and not present in 




performed in order to confirm that the altered phenotype follows the mutant allele 
through several generations.319 
Another method that can be used to link the disruption of a gene to a particular 
phenotype is to use multiple mutant strains for the same gene of interest.95 One can obtain 
multiple mutant strains with different mutations in the same gene and determine if these 
strains exhibit similar results for the phenotype in question. As is true of the backcross 
experiments, this strategy seeks to establish a correlation between the disruption of a 
specific gene and the presence of an altered phenotype. 
An additional technique, called the mutant rescue, is another way by which a 
mutant allele and altered phenotype can be correlated.320 This strategy seeks to link the 
disrupted allele to the mutant phenotype by demonstrating that a normal version of the 
gene prevents the occurrence of the altered phenotype. With this technique, the WT allele 
of the disrupted gene is expressed in the mutant strain.321 If the altered phenotype is 
caused by the disrupted gene, the expression of the WT allele should restore the WT 
phenotype, thus "rescuing" the WT phenotype.322 
General Comments on the Assessment of PCD in C. reinhardtii 
Validation of Fluorescent Probes Though the fluorescent probes used in this 
study have been previously utilized to assess PCD in C. reinhardtii, many have yet to be 
validated as accurate indicators of the presumed phenotype in this system. Attributing the 
signal of a probe to the purported phenotype in the cell would require direct validation by 
detailed biochemical experiments. An alternative approach which might facilitate the 
validation of individual probes is the combinatorial use of fluorescent probes that test for 




specifically indicates a particular phenotype, it would demonstrate that distinct probes, 
which possess unique chemical compositions but test for the same phenotype, cause the 
same cells to fluoresce.  
Scoring of Fluorescent Cells The assays which utilized fluorescent probes were 
carried out by manually scoring cells which were recognized as fluorescent under a 
hemacytometer. Though this method was useful for determining the percentage of 
fluorescent cells within the population, the time-consuming nature of the imaging process 
reduced the sampling frequency possible within a given period of time. Additionally, the 
analysis of captured images was also an approach with low throughput. The 
determination of the percentage of fluorescent cells within a population might be 
expedited by use of an automated system, such as a flow cytometer.  
As an alternative to determining the percentage of fluorescent cells within a 
sample, a fluorescence plate reader could be used to measure the total fluorescence 
emitted by a sample. This approach may be particularly useful for preliminarily 
determining the overall kinetics of a phenotype of interest. The resulting data might then 
be used to determine the optimal times to measure that particular phenotype. One 
drawback to this approach is that changes in the total fluorescence intensity in a sample  
cannot necessarily be attributed to an increase in the percentage of fluorescent cells 
within the population, as brighter fluorescence from a select subpopulation could also 
cause a stronger signal. 
Population-Level Analysis Of importance, the experiments conducted in this study 
utilized a population-level approach to assess PCD in C. reinhardtii. In the assays that 




detected fluorescence on a cell-to-cell basis using a binary "fluorescent/not fluorescent" 
scoring methods, 2) calculated the percentage of the cells in the sample that were 
fluorescing, and 3) compared the percentage of fluorescent cells in each mutant strain to 
the percentage of fluorescent cells in the parent WT strain for each time point in order to 
determine if the loss of a selected protein had an effect on the detected phenotype. The 
assays that did not use fluorescent probes also took a population approach to assessing 
PCD in C. reinhardtii. Genomic fragmentation was determined by qualitative assessment 
of DNA laddering of all cells in a sample. Additionally, the viability assay assessed the 
capacity for cell division by measuring the total area of all colonies present on each plate.  
An alternative strategy by which PCD features might be assessed is by the 
analysis of individual cells rather than the population as a whole. For the studies that 
utilize fluorescent probes, quantitative fluorescence microscopy might be used to 
determine if a treatment has an effect on the intensity of fluorescence emitted from 
individual cells. Also, genomic fragmentation can be assessed in individual cells by 
methods utilizing fluorescence microscopy, such as the comet or TUNEL assays. Finally, 
the viability assay can be performed by scoring the number of colony-forming units, 
rather than measuring the total growth area of the population.  
Discussion of Results from the Annexin V Assay One experiment, the 
phosphatidylserine externalization assay, yielded results that  were somewhat ambiguous 
(Figure 31). Somewhat unsurprisingly, the maximum percentage of the population 
exhibiting PS externalization peaked within the first sixty minutes of heat stress for each 
of the strains. Unexpectedly, however, was that the percentage of fluorescent cells 




percentage of Annexin V-positive cells was detected between the mutant strains and the 
parent WT strain at these later time points, indicating that the observed differences may 
be relevant in a biological context. A search of the literature did not provide a precedence 
for these results, and the only instances in which Annexin V staining is described to be 
reversible are those in which the cell, having not yet committed to PCD, returns to a 
metabolically-active and proliferative state.323  
The decrease in the percentage of Annexin V-positive cells appears to begin at 
some point between one and two hours, during which time the cells remain subjected to 
heat stress. Intuitively, the notion that the cells would return to a metabolically-active 
state during persistent exposure to such adverse environmental conditions seems an 
unlikely possibility. The results of the other experiments performed in this study, when 
taken together, are also not indicative of a return to metabolic activity during the PCD-
inducing stress (Figure 29, Figure 33). Furthermore, the observation that the decrease in 
the percentage of Annexin V-positive cells occurs at around the same time as changes in 
other PCD features indicates that this decrease may be relevant in the context of PCD. 
Consistent with this observation, the results of the metabolic activity (Figure 29), PM 
integrity (Figure 30), and viability (Figure 33) assays indicate that, at the population 
level, some pro-death event may be occurring between thirty and ninety minutes of heat 
stress.  
Using these observations, we postulated that, as an alternative explanation to the 
reacquisition of metabolic activity, the observed decrease in the percentage of Annexin V 
positive cells may be a result of PS degradation during C. reinhardtii PCD, such that it is 




immediately return studies that report the occurrence of such a phenomenon during PCD, 
several observations may support this prediction. 
Phosphatidylserine Decarboxylases and PCD First, we inquired if a precedence 
for PS degradation is documented in the literature. We found that PS is regularly 
synthesized and degraded as a part of normal cellular metabolism.265 Though the 
mechanisms of these processes appear to differ slightly between animals and yeast, the 
degradation of PS in both organisms is carried out by PS decarboxylase (PSD) enzymes. 
Notably, PSDs are localized to specific organelles within the cell; animal PSDs reside in 
the mitochondrial intermembrane space, anchored to the inner mitochondrial membrane, 
while PSDs in yeast localize to the mitochondrial and Golgi complex/vacuole 
membranes.265  
From these findings, we reasoned that, since PCD involves the non-specific 
degradation of intracellular components, a subsequent release of PSDs from the 
associated organelle(s) may explain the decreased percentage of PS-externalizing cells 
observed at later time points during C. reinhardtii PCD. Alternatively, we also reasoned 
that, if a PSD in C. reinhardtii was localized to the mitochondrial intermembrane space, 
the formation of the mitochondrial permeability transition pore (MPTP) might be an 
another mechanism by which the PSD could be delocalized. 
To corroborate the plausibility of an involvement of a C. reinhardtii PSD in the 
observed decrease in Annexin V-positive cells, we sought to determine if a PSD is 
predicted to be present in the C. reinhardtii proteome. To this end, a BLASTp search was 
carried out within the Phytozome webpage, wherein the amino acid sequences of PSDs 




to query the predicted C. reinhardtii proteome (v5.5). A single predicted PSD in C. 
reinhardtii (Cre02.g119600.t1.1) was returned as a hit (results not shown). The 
possibility that this C. reinhardtii protein is responsible for the decrease in the percentage 
of Annexin V-positive cells at later stages of heat stress may be an avenue for future 
studies to investigate. 
Autophagy and Autophagic Cell Death Of note, our research into PSDs led us to 
an another intriguing discovery: that PSDs catalyze the conversion of PS to another 
phospholipid, phosphatidylethanolamine (PE). While we initially predicted that this 
conversion might itself explain the decrease in Annexin V-positive cells, a study using 
artificial lipid bilayers demonstrated that Annexin V also possesses a high affinity for PE 
within the plasma membrane.324 Given that Annexin V binds both PS and PE with high 
efficacies, we reasoned that the observed decrease in the percentage of Annexin V-
positive cells likely cannot be explained solely by the intermembrane conversion of PS to 
PE. Importantly, however, a search of the literature for a role of PSDs during PCD led us 
to discover that high intracellular levels of PE are required for a process known as 
autophagy in both yeast and animal cells.325  
As a brief overview, the term autophagy broadly refers to several distinct 
physiological processes that result in the degradation of unnecessary cytosolic 
components within the lysosome.326 In this discussion, the term autophagy will be used in 
reference to macroautophagy, a specific type of autophagy. As a point of clarification, 
other forms of autophagy, such as chaperone-mediated autophagy and microautophagy, 
do exist.327 These alternative variants of autophagy should not be confused with 




Autophagy plays an integral part of everyday cellular function, primarily by 
ensuring the protection of the cell from the detrimental consequences of normal 
metabolism, such as damaged mitochondria or aggregated proteins.326 Autophagy is also 
important in the cellular response to non-metabolic stressors. In the early response to 
perturbations of cellular homeostasis, lysosomal degradation of autophagic substrates 
increases. In this context, autophagy plays a crucial cytoprotective role in promoting the 
adaptive recovery of homeostasis and ultimate survival of the cell during stress.327 
Intriguingly, the participants of autophagy do not act solely in a cytoprotective manner. 
In a contrasting role to that observed in the initial cellular stress response, autophagic 
components can also mediate the death of the cell. Consequently, such forms of PCD are 
referred to as "autophagic cell death".327 
Importantly, the contrasting roles of autophagy during stress can be distinguished 
by the pharmacogenic intervention of autophagic machinery.47 Such an inhibition 
promotes cell death in instances where autophagy acts in cytoprotection, while the 
impedance of cell death by pharmacogenic intervention of autophagy indicates a pro-
PCD role for autophagy.48 This approach might be utilized to test the hypothesis that 
autophagic machinery plays a role in C. reinhardtii PCD.  
Tentative Models for Heat-Induced PCD in C. reinhardtii The evidence presented 
in the preceding discussions suggests that several possible mechanisms may explain the 
decrease in the percentage of Annexin V positive cells observed in this study.  
In the first model, the execution of PCD causes the degradation of intracellular 
organelles. This results in the subsequent delocalization of PSDs, which then convert 




the degradation of organelles, but rather by the formation of the MPTP, which causes the 
release of mitochondrial intermembrane space components into the cytosol. As each of 
these scenarios take place during the execution stage of PCD, both models implicate the 
execution of PCD as the cause of the decrease in the percentage of Annexin V-positive 
cells. 
An additional model can also be conceived, in which the decrease in the 
percentage of Annexin V-positive cells is indicative of a switch between the pro-survival 
functions of autophagy and the pro-death mechanisms of autophagic cell death. Under 
this model, C. reinhardtii cells initiate autophagy in the early stages of heat stress and 
maintain metabolic activity (Figure 29) and plasma membrane integrity during this period 
(Figure 30). PS is externalized during this initial response to the heat stress and may 
eventually be converted into PE. Given that Annexin V has a high affinity for both PS 
and PE, this conversion could very well remain undetected by the methods utilized in this 
study. The reversal of Annexin V-positivity at later time points might be explained by the 
translocation of PE into the intracellular space. However, given that 1) intracellular PE 
participates in autophagy, a pro-survival process, and 2) the decrease in the percentage of 
Annexin V-positive cells occurs within approximately the same time frame as PCD 
phenotypes in the other assays performed, this prediction may not hold true.  
Concluding Remarks 
We conducted the preceding work with the intention to shed light on the 
molecular mechanisms by which PCD occurs in C. reinhardtii. As an ancillary benefit, 
we deem that this work will also facilitate additional studies into the molecular basis C. 




reinhardtii proteins that may participate in PCD. The presence of homologs in C. 
reinhardtii to PCD proteins of diverse lineages has strong implications for the evolution 
of PCD in higher organisms, as it is in agreement with the hypothesis that some aspects 
of PCD have been conserved throughout evolutionary history. As a result, the results of 
this work may aid in the establishment of C. reinhardtii as a novel system in which to 
study PCD. Though we consider this work to be merely a drop in the proverbial bucket, 
the findings obtained from these studies generate many new biological questions..  
While differences in PCD phenotypes were detected between each of the C. 
reinhardtii mutant strains and the parental WT strain, the implications of these findings 
with respect to PCD at the cellular level have yet to be fully determined. Although the 
purpose of this study was to determine some of the molecular basis of PCD in C. 
reinhardtii, a more detailed understanding of this process at the cellular level may help to 
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Computational Methods Used to Retrieve and Analyze Subject Sequences for 
BLASTp 
 
All computations were performed using a mid 2015 MacBook Pro Retina running 
macOS Sierra (version 10.12.5) and equipped with a 2.2 GHz Intel Core i7 processor and 
16GB 1600 MHz DDR3 memory.  
 
KEY: 
Any clarifying remarks that were "commented out" of the code are denoted by red text. 
Commands within a blue box were carried out in the bash shell (Terminal). 
 
“$” at the beginning of a line designates a new Terminal command: 
“mattbreuer$” denotes a command from my local system 




Text within a grey box describe non-code methods that were carried out. 
 
 
Retrieve Sequences for Database 
Three independent keyword searches were carried out within the NCBI 
Entrez Webpage. 
 
The keywords used were 
 “apoptosis” 
 “necrosis” 
“programmed cell death” 
 
The results from each search were saved locally as three separate multi-
FASTA files. 
 
Parse accession numbers from multi-FASTA files 
$ sed -n '/>[a-zA-Z0-9]/p' 
/Volumes/Transcend/Research_for_Dr_Gaillard/Thesis/bioinformatics_files/1-
sequence_retrieval/1_searchresults_apoptosis.faa| awk -v col=1 '{print $col}' | sed 's/>//g' > 
3_searchresults_apoptosis_accessions.txt 
 
$ sed -n '/>[a-zA-Z0-9]/p' 
/Volumes/Transcend/Research_for_Dr_Gaillard/Thesis/bioinformatics_files/1-






$ sed -n '/>[a-zA-Z0-9]/p' 
/Volumes/Transcend/Research_for_Dr_Gaillard/Thesis/bioinformatics_files/1-
sequence_retrieval/1_searchresults_pcd.faa | awk -v col=1 '{print $col}' | sed 's/>//g' > 
3_searchresults_pcd_accessions.txt 
 
Combine the three files of search results (accessions) into a single file 
$ cat 3_searchresults_apoptosis_accessions.txt 3_searchresults_necrosis_accessions.txt 
1_searchresults_pcd.faa > 4_searchresults_apop_necro_pcd_accessions_raw.txt 
 
Determine the proteins which appeared in more than one keyword search 
















# identify the overlapping entries between the search results and assign the 




















# load package VennDiagram 
library(VennDiagram) 
 
# list assigns each list a label which will be added to the final image. fill 
designates a color for each circle. cex is the size of the text. filename gives 






Remove duplicate accession numbers from the file of combined search results 
# count the number of lines in the combined list of search results 
mattbreuer$ wc 4_searchresults_apop_necro_pcd_accessions_raw.txt 
91687 
 
# remove duplicate accessions from the combined list 
mattbreuer$ sort 4_searchresults_apop_necro_pcd_accessions_raw.txt -n | uniq > 
5_searchresults_apop_necro_pcd_accessions_no_dups.txt 
 
# count the number of lines in the combined list of accessions after removal of 
duplicate entries 
mattbreuer$ wc 5_searchresults_apop_necro_pcd_accessions_no_dups.txt 
85656 
 
Confirm the appropriate number of entries were removed from the combined file 
Number of lines in the raw file - number of lines in the no_dups file: 91687 - 
85656 = 6,031 lines removed.  
 
Sum of the repeated values from venn_search_results.png: 866 + 5112 + 9 
+ 22(2) = 6,031 total duplicate entries. 
 
Retrieve the non-redundant search results as sequences in FASTA format 
# install E-Direct locally  
$  perl -MNet::FTP -e \ 
>     '$ftp = new Net::FTP("ftp.ncbi.nlm.nih.gov", Passive => 1); 
>      $ftp->login; $ftp->binary; 
>      $ftp->get("/entrez/entrezdirect/edirect.tar.gz");' 
$   gunzip -c edirect.tar.gz | tar xf - 
$   rm edirect.tar.gz 






# script (6_get_fasta_script.sh) which uses E-Direct to fetch the sequence(s), in FASTA 
format, given an accession number(s) as the input: 
 
#!/usr/bin/bash 
while read id 
 do 
 efetch -db protein -id "$id [uid]" -format fasta < /dev/null 
 done  
 
# first, take the unique accession numbers and strip the “.version” from the end of each 
accession. then, fetch each of the sequences in fasta format by executing 
6_get_fasta_script.sh from the command line. 
$ sed 's/\.[[:digit:]]//g' /Volumes/Transcend/Thesis/bioinformatics_files/1-
sequence_retrieval/5_searchresults_apop_necro_pcd_accessions_no_dups.txt | bash 
6_get_fasta_script.sh > 7_searchresults_apop_necro_pcd_fasta_no_dups.faa 
 
# count the number of sequences that are retrieved to confirm that all 85656 
sequences are accounted for. 
$ grep ">" 7_searchresults_apop_necro_pcd_fasta_no_dups.faa -c 
85656 
 
Retrieve taxonomic classification of the source organism for all unique search 
results 
# script (9_get_taxonomy_script.sh) which uses e-direct to fetch taxonomic 
classification of the source organism for each of the accession numbers 
 
#!/usr/bin/bash 
while read id 
 do 
 efetch -db protein -id "$id [uid]" -format gpc < /dev/null | 




# first, take the unique accession numbers from 
5_searchresults_apop_necro_pcd_accessions_no_dups.txt and strip the “.version” 
from the end of each accession. then, fetch the taxonomic classification of the source 
organism using 9_get_taxonomy_script.sh. 
$ sed 's/\.[[:digit:]]//g' /Volumes/Transcend/Thesis/bioinformatics_files/1-
sequence_retrieval/5_searchresults_apop_necro_pcd_accessions_no_dups.txt | bash 
10_get_taxonomy_script.sh > 11_search_results_taxonomy.txt 
 
# confirm that all 85656 entries are in the output file 
$ wc 11_search_results_taxonomy.txt 
85656 
 
Reformat the taxonomic classifications 
# first, replace the separators in the second column with tabs. then, parse the 






$ sed -E $'s/;[[:space:]]/\t/g' 11_search_results_taxonomy.txt | awk -F '\t' '{print $3}' | sort | uniq -
c | sort -nr > 12_kingdom_distribution_of_search_results+counts.txt 
 
Determination of phylogenetic distribution 
Went through this file and manually assigned the kingdoms into the one of the





for each of the four groups, I summed the counts of their constituent 
kindgoms. Lastly, I summed the counts of each kingdom to ensure that all 
85656 unique search results were accounted for.  
 









# add percent symbols to labels  
slicelabels <‐ paste(slicelabels,"%",sep="") # add % to labels  













BLASTp of C. reinhardtii Proteome against the Combined Search Results 
Setup of AWS Instance 
Launched a new AWS EC2 instance (r3.2xlarge) from the AWS marketplace 
webpage. ncbi-blast-2.6.0+ software came pre-installed on the instance. 
 
Created and downloaded a unique keypair.pem.txt file to grant remote 
access to the instance. 
 
Connect to AWS Instance 
# granted permissions to keypair.pem.txt 
mattbreuer$ chmod 400 keypair.pem.txt 
 
# connected to aws instance using a secure shell 
mattbreuer$ ssh -i keypair.pem.txt ubuntu@54.193.124.117 
 
Perform BLASTp in AWS instance, using the C. reinhardtii proteome as the queries, 
and the unique search results as the subjects 
# in new terminal window, uploaded the unique search results to the aws instance in 
fasta format  
 
mattbreuer$ scp -i keypair.pem.txt ~/Volumes/Transcend/Thesis/bioinformatics_files/2-blast/ 
1_searchresults_apop_necro_pcd_fasta_no_dups.faa ubuntu@54.193.124.117: 
 
# uploaded the C. reinhardtii proteome to the aws instance 
mattbreuer$ scp -i keypair.pem.txt ~/Volumes/Transcend/Thesis/bioinformatics_files/2-blast/ 
1_Creinhardtii_v5.5.proteome.fa ubuntu@54.193.124.117: 
 
# in the first terminal window, confirmed that the files had been uploaded to the aws 
instance 
ubuntu$ ls –l 
 
# created a blastable database from the unique search results 
ubuntu$ makeblastdb -in 1_searchresults_apop_necro_pcd_fasta_no_dups.faa -dbtype 'prot' -out 
2_db_searchresults_apop_necro_pcd 
 
# performed blastp on aws instance 
ubuntu$ blastp -query 1_Creinhardtii_v5.5.proteome.fa -db 
2_searchresults_apop_necro_pcd_accessions_no_dups_blastdb -evalue 1 -max_target_seqs 500 
-outfmt 11 -out 3_blastp_crproteome_against_searchresults.asn 
 
Download and reformat BLAST results 
# converted the blast results to tabular format 
ubuntu$ blast_formatter -archive 3_blastp_crproteome_against_searchresults.asn -outfmt "7 





# downloaded the blast databases to my computer 
mattbreuer$ scp -i keypair.pem.txt ubuntu@54.193.124.117:/ 
2_searchresults_apop_necro_pcd_accessions_no_dups_blastdb.phr . 
 
mattbreuer$ scp -i keypair.pem.txt ubuntu@54.193.124.117:/ 
2_searchresults_apop_necro_pcd_accessions_no_dups_blastdb.psq . 
 
mattbreuer$ scp -i keypair.pem.txt ubuntu@54.193.124.117:/ 
2_searchresults_apop_necro_pcd_accessions_no_dups_blastdb.pin . 
 
# downloaded the blast results to my computer 
mattbreuer$ scp -i keypair.pem.txt ubuntu@54.193.124.117:/ 
3_blastp_crproteome_against_searchresults.asn . 
mattbreuer$ scp -i keypair.pem.txt ubuntu@54.193.124.117:/ 
4_blastp_crproteome_against_searchresults.txt . 
 
# remove all lines containing hash marks in the file containing the tabular format of the 
blast results 
mattbreuer$ sed '/#/d' 4_blastp_crproteome_against_searchresults.txt 
 
Filter BLAST results 
# create a new file of filtered blast results, keeping only the lines in which the percent 
identity is greater than or equal to 25 and the bitscore is greater than or equal to 100 
mattbreuer$ awk '($2 >= 100 ) && ($5 >= 25)' 4_blastp_crproteome_against_searchresults.txt > 
5_blastp_crproteome_against_searchresults_filtered.txt 
 
Count the number of results in the filtered BLAST results 




mattbreuer$ awk '($5 >= 30) && (39.94 >= $5) { ++count } END{ print count }' 
/Volumes/Transcend/Thesis/bioinformatics_files/2-
blasts/5_blastp_crproteome_against_searchresults_filtered.txt  



























Plot the distribution of percent identities between C. reinhardtii and the subject 
sequences 





























Retrieve the C. reinhardtii proteins which aligned strongly with a protein from the 
search results 
# from the list of filtered results, parse the query identifiers, remove the duplicate entries, then 





mattbreuer$ awk -v col=1 '{print $col}' 5_blastp_crproteome_against_searchresults_filtered.txt | 















Analysis of CrPPPs with BLAST2GO 
 
Setup of AWS instance 
#uploaded the query sequences to the previously-launched aws instance  
mattbreuer$ scp -i keypair.pem.txt /Volumes/Transcend/Thesis/bioinformatics_files/2- 
blasts/7_blastp_crproteome_against_searchresults_filtered_query_f astas_no_dups.fa :  
 
# connected to the aws instance  
mattbreuer$ ssh -i keypair.pem.txt ubuntu@54.193.124.117  
 
# confirmed that the file had been uploaded to the aws instance  
ubuntu@ip-172-31-6-69:~$ ls  
 
Performed BLASTp of potential C. reinhardtii PCD proteins against the RefSeq protein 
database 
# performed blastp in the aws instance  
blastp -query 7_blastp_crproteome_against_searchresults_filtered_query_fastas_ no_dups.fa -db 
refseq_protein -max_target_seqs 1000 -evalue 0.1 - num_threads 8 -outfmt 5 -out 
8_blastp_potential_creinhardtii_pcd_proteins_against_refseq_prote in.xml  
 
 
Formatted the BLAST2GO output  
# Used BLAST2GO to assign Gene Ontology terms to the potential C. reinhardtii PCD 
proteins 
 
# parse columns 1 and 2 from the dataset. for lines (c. reinhardtii proteins) containing 
multiple go terms, replace the seperators of the go terms with a newline character and 
a tab character. this places the additional go terms onto a new line and moves them 
into the second column. for all empty cells in column one, replace with the value in the 
cell directly above. 
  
awk -F'\t' '{ OFS="\t"; print $1 "\t" $2 }' 2_b2g_results_seqid+goid+goname.txt | sed -E 
$'s/;[[:space:]]/\ \t/g' | awk -F\\t -v COL=1 ' BEGIN{OFS="\t";} 
$COL=="" {$COL = saved} {saved = $COL; print} 
' > 3_b2g_seq_ids+go_ids.txt  
 
#parse columns 1 and 3 from the dataset. for lines containing multiple go terms, 
replace the separators of the go terms with a newline character and a tab character. 
this places the additional go terms onto their own new line and moves them into the 
second column. for all empty cells in column one, replace with the value in the cell 
directly above  
awk -F'\t' '{ OFS="\t"; print $1 "\t" $3 }' 2_b2g_results_seqid+goid+goname.txt | sed -E 
$'s/;[[:space:]]/\ \t/g' | awk -F\\t -v COL=1 ' BEGIN{OFS="\t";} 
$COL=="" {$COL = saved}  
{saved = $COL; print} 
' > 3_b2g_seq_ids+go_names.txt  
 




paste 3_b2g_seq_ids+go_ids.txt 3_seq_ids+go_names.txt | awk -F\t 'BEGIN{OFS="\t";} {print 
$1,$2,$4}' > 4_seq_ids+go_ids+go_names.txt  
 
 
Analyzed the BLAST2GO data 
# counted the total number of biological processes, cellular components, and molecular 
functions that were assigned to the c. reinhardtii blast results by blast2go  
$grep -c 'P:' 4_b2g_seq_ids+go_ids+go_names.txt $grep -c 'C:' 
4_b2g_seq_ids+go_ids+go_names.txt $grep -c 'F:' 4_b2g_seq_ids+go_ids+go_names.txt  
 
# counted the number of occurrences of each go id/name pair which was assigned to 
the c. reinhardtii blast dataset. then, removed the "f:", "c:", and "p:" from the go terms to 
make them prettier when graphed  
awk -F\t 'BEGIN{OFS="\t";} {print $2,$3}' 4_b2g_seq_ids+go_ids+go_names.txt | grep 'C:' | 
sort | uniq -c | sort -nr | sed -E $"s/^ +//" | sed -e "s/ /$(printf '\t')/" | sed -e 's/[[:alpha:]]://g' > 
5_b2g_cellular_component_counts.txt 
awk -F\t 'BEGIN{OFS="\t";} {print $2,$3}' 4_b2g_seq_ids+go_ids+go_names.txt | grep 'F:' | 
sort | uniq -c | sort -nr | sed -E $"s/^ +//" | sed -e "s/ /$(printf '\t')/" | sed -e 's/[[:alpha:]]://g' > 
5_b2g_molecular_function_counts.txt 
awk -F\t 'BEGIN{OFS="\t";} {print $2,$3}' 4_b2g_seq_ids+go_ids+go_names.txt | grep 'P:' | 
sort | uniq -c | sort -nr | sed -E $"s/^ +//" | sed -e "s/ /$(printf '\t')/" | sed -e 's/[[:alpha:]]://g' > 
5_b2g_biological_process_counts.txt  
 
# counted the number of unique go terms assigned for biological processes, cellular 
components, and molecular functions 
wc -l 5_b2g_biological_process_counts.txt 
 
wc -l 5_b2g_cellular_component_counts.txt  
 
wc -l 5_b2g_molecular_function_counts.txt  
 
# took the count files and opened them in excel. retained the first 15 lines. then added up the 





Created bar graphs in RStudio to represent the BLAST2GO results  
#horizontal bar graph to depict biological processes assigned by blast2go  
















#shift the parameters of the graph so that it will fit onto the output page  
par(mar=c(3, 13, 1, 0),mgp=c(2,0.5,0))  
 














#horizontal bar graph to depict cellular components assigned by blast2go  
 













#shift the parameters of the graph so that it will fit onto the output page  
par(mar=c(3, 12, 1, 1),mgp=c(2,0.5,0))  
 






#take the stock color palette "Spectral" and turn it into a ramped palette. 
This is so that I can use it on datasets containing more than 11 data points 











#add labels for bar heights  
text(x=frequencies,y=barpos,labels=frequencies,cex=0.8,pos=4)  
 
#horizontal bar graph to depict molecular functions assigned by blast2go  
 













#shift the parameters of the graph so that it will fit onto the output page  
par(mar=c(3, 12, 1, 1),mgp=c(2,0.5,0))  
 



























Image Processing for Determination of the Percentage of Fluorescent Cells 
ImageJ macro used to subtract all of the “hot pixels” present in the fluorescent images 
waitForUser("Select the directories in the following order:\n\n1. Input 
directory\n\n2. Output Directory\n\n3. Directory to move images already 
analyzed")  
 
dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 





















File.rename(dir1 + list[i], dir3 + list[i]) 
 
}  
ImageJ macro used to crop the brightfield and fluorescent images of the 
hemacytometer  
waitForUser("Select the directories in the following order:\n\n1. Brightfield 
Directory\n\n2. Fluorescence Directory \n\n3. Brightfield Output 





dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 
dir4 = getDirectory("Choose a Directory") 
 




i++) { showProgress(i+1, list1.length) 
open(dir1+list1[i]) 
 
pc_orig_filename = File.name; 










open(dir2 + shortened_name + "_fl_clean.tif_no_bg.tif") 
fl_orig_filename = File.nameWithoutExtension 
 
run("Images to Stack", "name=Stack title=[] use"); 
run("Scale to Fit"); 
 




run("Stack to Images") 
 
saveAs("tiff", dir4 + fl_orig_filename+"_cropped") 
close(); 
 





ImageJ macro used to automatically score the number of cells in the cropped 
brightfield image of the hemacytometer grid  
waitForUser("Select the directories in the following order:\n\n1.Input 
directory\n\n2. Output Directory\n\n3. Directory to move images already 
analyzed")  
 
dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 






i++) { showProgress(i+1, list.length) 
open(dir1+list[i]) 
 
run("Scale to Fit") 
 
run("Bandpass Filter...", "filter_large=40 filter_small=3 suppress=None 
























open(dir1 + list[i]); 
name = File.nameWithoutExtension 
 
roiManager("Measure"); 
saveAs("Measurements", dir2 + "measurements_" + name + ".csv") 
 
roiManager("Show All without labels") 
roiManager("Set Color", "red") 
roiManager("Set Line Width", 0) 
run("Flatten") 
 











saveAs("Text", dir2+"Cell Counts ") 
ImageJ macro used to manually verify the counts produced from the automated 
counts of the cropped brightfield image. Note that you must select the “multi-point” 
tool from the ImageJ bar for this to work. 
waitForUser("Select the directories in the following order:\n\n1.Input 
directory\n\n2. Output Directory\n\n3. Directory to move images already 
analyzed")  
 
dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 
 
















run("Properties... ", "show") 
setBatchMode(true) 
 
selectWindow("Counts_" + list[i]); 




saveAs("Tiff", dir2 + "Manual Counts - " + list[i]) 
run("Close") 
 
File.rename(dir1 + list[i], dir3 + list[i]) 
 
ImageJ macro used to automatically score the number of cells in the cropped 
fluorescent image of the hemacytometer grid. 
waitForUser("Select the directories in the following order:\n\n1.Input 
directory\n\n2. Output Directory\n\n3. Directory to move analyzed images")  
 
dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 
















run("Analyze Particles...", "size=5-Infinity add summarize") 





open(dir1 + list[i]); 
name = File.nameWithoutExtension; 
File.rename(dir1 + list[i], dir3 + list[i]) 
roiManager("Measure"); 
saveAs("Measurements", dir2 + "measurements_" + name + ".csv") 
 
roiManager("Show All without labels") 
run("Flatten"); 







saveAs("Text", dir2+"Fluorescent Cell Counts") 
 
run("Close") 
ImageJ macro used to manually verify the counts produced from the automated 
counts of the cropped fluorescent image. Note that the “multi-point” tool from the 
ImageJ bar must be selected for this to work.  
waitForUser("Select the directories in the following order:\n\n1. Input 
fluorescence directory\n\n2. Location of Brightfield Images to Overlay \n\n3. 
Output Directory\n\n4. Location to move analyzed images")  
 
dir1 = getDirectory("Choose a Directory") 
dir2 = getDirectory("Choose a Directory") 
dir3 = getDirectory("Choose a Directory") 
dir4 = getDirectory("Choose a Directory") 
 












name = File.name 
 













open(dir2 + shortened_name + "_pc.tif_cropped.tif") 
bf_image = File.nameWithoutExtension 
 
























selectWindow("Counts_" + bf_image + "-1.tif") 
saveAs("Text", dir3 + "Manual Counts - " + list1[i]) 
run("Close") 
 
selectWindow(bf_image + "-1.tif"); 
saveAs("Tiff", dir3 + "Manual Counts - " + list1[i]) 
run("Close") 
 







Analysis and Visualization of Image Data 







raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 





raw_data <- mutate(raw_data, strain = relevel(strain, ref = "wt")) 
 




summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_density = mean(density), 
            stderror_density = sd(density)/sqrt(n())) 
 
#make the plot first 
plot <- ggplot(summ_data, aes(x=time,y=mean_density,colour=strain)) 
 
#make the plot theme 
complete_plot <- plot + theme(panel.border = element_rect(colour = "black", 
fill = NA), 
                              panel.background = element_rect(fill = "white", colour = 
"grey"), 




                              panel.grid.major.y = element_line(colour = "grey", 
linetype = "solid", size=0.1), 
                              axis.text = element_text(size=9), 
                              axis.title = element_text(size=12), 
                              axis.line.x = element_line(colour = "black", linetype = 
"solid"), 
                              axis.line.y = element_line(colour = "black", linetype = 
"solid"), 
                              axis.ticks.x = element_line(size = 0.5), 
                              axis.ticks.y = element_blank(), 
                              legend.box.background = element_rect(), 
                              legend.key = element_rect(fill = "white", colour = "white"), 
                              legend.text = element_text(face="italic")) +  
   
  #then change the axes values and labels 
  scale_x_continuous(breaks = c(1,2,3,4,5,6), expand = c(0,0.1)) + 
  scale_y_continuous(limits = c(0, 12000000), breaks = 
c(0,1000000,2000000,3000000,4000000,5000000,6000000,7000000,80000
00,9000000,10000000,11000000,12000000), expand = c(0,0)) + 
  labs(x="Time (Days)", y = "Cell Density (cells/mL") + 
   
  #then customize how the plots will look. error bars laid down first, then the 
line,  
  #then the black outline for each dot, then the colored dots on top of 
everything.  
  geom_errorbar(aes(ymin=mean_density - stderror_density, 
                    ymax=mean_density + stderror_density), 
                width=0.1) + 
  geom_line() + 
  geom_point(colour = "black", size=1.5) + 
  geom_point(size = 1.2) + 
  ggsave("/Users/mattbreuer/Desktop/scatterplot.tiff", width = 8, height = 6, 








stats_df <- raw_data[,c(1,2,3,5)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 
#turn the time points into factors, since I used numerical values 
stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 













               c("strain.timewt.1 - strain.timeire1.1 = 0", 
                 "strain.timewt.1 - strain.timepig3.1 = 0", 
                 "strain.timewt.1 - strain.timebi1.1 = 0", 
                 "strain.timewt.2 - strain.timeire1.2 = 0", 
                 "strain.timewt.2 - strain.timepig3.2 = 0", 
                 "strain.timewt.2 - strain.timebi1.2 = 0", 
                 "strain.timewt.3 - strain.timeire1.3 = 0", 
                 "strain.timewt.3 - strain.timepig3.3 = 0", 
                 "strain.timewt.3 - strain.timebi1.3 = 0", 
                 "strain.timewt.4 - strain.timeire1.4 = 0", 
                 "strain.timewt.4 - strain.timepig3.4 = 0", 
                 "strain.timewt.4 - strain.timebi1.4 = 0", 
                 "strain.timewt.5 - strain.timeire1.5 = 0", 




                 "strain.timewt.5 - strain.timebi1.5 = 0")),  
        test = adjusted(type = "holm")) 
 







raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 








(raw_data$auto_counted_cells_total + raw_data$uncounted_total_cells - 
raw_data$miscounted_total_cells)*100)) 
 




summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_fluorescence = mean(percent_fluorescence), 
            stderror_fluorescence = sd(percent_fluorescence)/sqrt(n())) 
 
#make the plot first 
plot <- ggplot(summ_data, aes(x=time,y=mean_fluorescence,colour=strain)) 
 
#make the plot theme 
complete_plot <- plot + theme(panel.border = element_rect(colour = "black", 




                              panel.background = element_rect(fill = "white", colour = 
"grey"), 
                              panel.grid.major.x = element_blank(),  
                              panel.grid.major.y = element_line(colour = "grey", 
linetype = "solid", size=0.1), 
                              axis.text = element_text(size=9), 
                              axis.title = element_text(size=12), 
                              axis.line.x = element_line(colour = "black", linetype = 
"solid"), 
                              axis.line.y = element_line(colour = "black", linetype = 
"solid"), 
                              axis.ticks.x = element_line(size = 0.5), 
                              axis.ticks.y = element_blank(), 
                              legend.key = element_rect(fill = "white", colour = "white"), 
                              legend.box.margin = margin(t = 2, r = 2, b = 2, l = 2, unit 
= "pt"), 
                              legend.box.background = element_rect(colour = "black"), 
                              legend.text = element_text(face="italic", size =10)) +  
   
  #then change the axes values and labels 
  scale_x_continuous(breaks = c(0,30,60,90,120,150,180,210,240), expand 
= c(0,3)) + 
  scale_y_continuous(limits = c(0, 105), breaks = 
c(0,10,20,30,40,50,60,70,80,90,100,110), expand = c(0,0)) + 
  labs(x="Time (minutes)", y = "Percentage of Fluorescent Cells") + 
   
  #then customize how the plots will look. error bars layed down first, then 
the line,  
  #then the black outline for each dot, then the colored dots on top of 
everything.  
  geom_vline(xintercept=120, linetype=3) + 
  geom_label(aes(x=150, label="Removal from \nHeat Stress", y=95), 
colour="black", angle=0, size=3.5) + 
  geom_segment(aes(x = 135, y = 95, xend = 120, yend =95, colour = 
"black"), 
               arrow = arrow(length = unit(0.2, "cm")),colour = "black") + 
  geom_errorbar(aes(ymin=mean_fluorescence - stderror_fluorescence, 




                width=2) + 
  geom_line() + 
  geom_point(colour = "black", size=1.5) + 
  geom_point(size = 1.2) + 
  ggsave("~/Desktop/sytox_scatterplot.tiff", width = 8, height = 6, dpi = 1500) 
 
###statistical analysis 
#first use the raw_data dataframe to create a new dataframe to use for stats 
stats_df <- raw_data[,c(1,2,3,10)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 
#turn the time points into factors, since I used numerical values 
stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 
model <- aov(percent_fluorescence ~ (strain*time) + 












               c("strain.timewt.30 - strain.timeire1.30 = 0", 
                 "strain.timewt.30 - strain.timepig3.30 = 0", 
                 "strain.timewt.30 - strain.timebi1.30 = 0", 
                 "strain.timewt.60 - strain.timeire1.60 = 0", 
                 "strain.timewt.60 - strain.timepig3.60 = 0", 




                 "strain.timewt.90 - strain.timeire1.90 = 0", 
                 "strain.timewt.90 - strain.timepig3.90 = 0", 
                 "strain.timewt.90 - strain.timebi1.90 = 0", 
                 "strain.timewt.120 - strain.timeire1.120 = 0", 
                 "strain.timewt.120 - strain.timepig3.120 = 0", 
                 "strain.timewt.120 - strain.timebi1.120 = 0", 
                 "strain.timewt.150 - strain.timeire1.150 = 0", 
                 "strain.timewt.150 - strain.timepig3.150 = 0", 
                 "strain.timewt.150 - strain.timebi1.150 = 0", 
                 "strain.timewt.180 - strain.timeire1.180 = 0", 
                 "strain.timewt.180 - strain.timepig3.180 = 0", 
                 "strain.timewt.180 - strain.timebi1.180 = 0")),  
        test = adjusted(type = "holm")) 
 







raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 









(raw_data$auto_counted_cells_total + raw_data$uncounted_total_cells - 
raw_data$miscounted_total_cells)*100)) 
 







summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_fluorescence = mean(percent_fluorescence), 
            stderror_fluorescence = sd(percent_fluorescence)/sqrt(n())) 
 
#make the plot first 
plot <- ggplot(summ_data, aes(x=time,y=mean_fluorescence,colour=strain)) 
 
#make the plot theme 
complete_plot <- plot + theme(panel.border = element_rect(colour = "black", 
fill = NA), 
                              panel.background = element_rect(fill = "white", colour = 
"grey"), 
                              panel.grid.major.x = element_blank(),  
                              panel.grid.major.y = element_line(colour = "grey", 
linetype = "solid", size=0.1), 
                              axis.text = element_text(size=9), 
                              axis.title = element_text(size=12), 
                              axis.line.x = element_line(colour = "black", linetype = 
"solid"), 
                              axis.line.y = element_line(colour = "black", linetype = 
"solid"), 
                              axis.ticks.x = element_line(size = 0.5), 
                              axis.ticks.y = element_blank(), 
                              legend.key = element_rect(fill = "white", colour = "white"), 
                              legend.box.margin = margin(t = 2, r = 2, b = 2, l = 2, unit 
= "pt"), 
                              legend.box.background = element_rect(colour = "black"), 
                              legend.text = element_text(face="italic", size =10)) +  
   
  #then change the axes values and labels 
  scale_x_continuous(breaks = c(0,60,120,180,240), expand = c(0,3)) + 
  scale_y_continuous(limits = c(0, 105), breaks = 
c(0,10,20,30,40,50,60,70,80,90,100,110), expand = c(0,0)) + 
  labs(x="Time (minutes)", y = "Percentage of Fluorescent Cells") + 




  #then customize how the plots will look. error bars layed down first, then 
the line,  
  #then the black outline for each dot, then the colored dots on top of 
everything.  
  geom_vline(xintercept=120, linetype=3) + 
  geom_label(aes(x=156, label="Removal from \nHeat Stress", y=95), 
colour="black", angle=0, size=3.5) + 
  geom_segment(aes(x = 135, y = 95, xend = 120, yend =95, colour = 
"black"), 
               arrow = arrow(length = unit(0.2, "cm")),colour = "black") + 
  geom_errorbar(aes(ymin=mean_fluorescence - stderror_fluorescence, 
                    ymax=mean_fluorescence + stderror_fluorescence), 
                width=2) + 
  geom_line() + 
  geom_point(colour = "black", size=1.5) + 
  geom_point(size = 1.2) + 
  ggsave("~/Desktop/fda_scatterplot.tiff", width = 8, height = 6, dpi = 1500) 
 
###statistical analysis 
#first use the raw_data dataframe to create a new dataframe to use for stats 
stats_df <- raw_data[,c(1,2,3,10)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 
#turn the time points into factors, since I used numerical values 
stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 
model <- aov(percent_fluorescence ~ (strain*time) + 















               c("strain.timewt.30 - strain.timeire1.30 = 0", 
                 "strain.timewt.30 - strain.timepig3.30 = 0", 
                 "strain.timewt.30 - strain.timebi1.30 = 0", 
                 "strain.timewt.60 - strain.timeire1.60 = 0", 
                 "strain.timewt.60 - strain.timepig3.60 = 0", 
                 "strain.timewt.60 - strain.timebi1.60 = 0", 
                 "strain.timewt.90 - strain.timeire1.90 = 0", 
                 "strain.timewt.90 - strain.timepig3.90 = 0", 
                 "strain.timewt.90 - strain.timebi1.90 = 0", 
                 "strain.timewt.120 - strain.timeire1.120 = 0", 
                 "strain.timewt.120 - strain.timepig3.120 = 0", 
                 "strain.timewt.120 - strain.timebi1.120 = 0", 
                 "strain.timewt.150 - strain.timeire1.150 = 0", 
                 "strain.timewt.150 - strain.timepig3.150 = 0", 
                 "strain.timewt.150 - strain.timebi1.150 = 0", 
                 "strain.timewt.180 - strain.timeire1.180 = 0", 
                 "strain.timewt.180 - strain.timepig3.180 = 0", 
                 "strain.timewt.180 - strain.timebi1.180 = 0")),  
        test = adjusted(type = "holm")) 
 







raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 












(raw_data$auto_counted_cells_total + raw_data$uncounted_total_cells - 
raw_data$miscounted_total_cells)*100)) 
 




summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_fluorescence = mean(percent_fluorescence), 
            stderror_fluorescence = sd(percent_fluorescence)/sqrt(n())) 
 
#make the plot first 
plot <- ggplot(summ_data, aes(x=time,y=mean_fluorescence,colour=strain)) 
 
#make the plot theme 
complete_plot <- plot + theme(panel.border = element_rect(colour = "black", 
fill = NA), 
                              panel.background = element_rect(fill = "white", colour = 
"grey"), 
                              panel.grid.major.x = element_blank(),  
                              panel.grid.major.y = element_line(colour = "grey", 
linetype = "solid", size=0.1), 
                              axis.text = element_text(size=9), 
                              axis.title = element_text(size=12), 
                              axis.line.x = element_line(colour = "black", linetype = 
"solid"), 
                              axis.line.y = element_line(colour = "black", linetype = 
"solid"), 
                              axis.ticks.x = element_line(size = 0.5), 
                              axis.ticks.y = element_blank(), 




                              legend.box.margin = margin(t = 2, r = 2, b = 2, l = 2, unit 
= "pt"), 
                              legend.box.background = element_rect(colour = "black"), 
                              legend.text = element_text(face="italic", size =10)) +  
   
  #then change the axes values and labels 
  scale_x_continuous(breaks = c(0,30,60,90,120), expand = c(0,3)) + 
  scale_y_continuous(limits = c(0, 105), breaks = 
c(0,10,20,30,40,50,60,70,80,90,100,110), expand = c(0,0)) + 
  labs(x="Time (minutes)", y = "Percentage of Fluorescent Cells") + 
   
  #then customize how the plots will look. error bars layed down first, then 
the line,  
  #then the black outline for each dot, then the colored dots on top of 
everything.  
  geom_vline(xintercept=120, linetype=3) + 
  geom_label(aes(x=95, label="Removal from \nHeat Stress", y=95), 
colour="black", angle=0, size=3.5) + 
  geom_segment(aes(x = 105, y = 95, xend = 120, yend = 95, colour = 
"black"), 
               arrow = arrow(length = unit(0.2, "cm")),colour = "black") + 
  geom_errorbar(aes(ymin=mean_fluorescence - stderror_fluorescence, 
                    ymax=mean_fluorescence + stderror_fluorescence), 
                width=2) + 
  geom_line() + 
  geom_point(colour = "black", size=1.5) + 
  geom_point(size = 1.2) + 
  ggsave("~/Desktop/ros_scatterplot.tiff", width = 8, height = 6, dpi = 1500) 
 
###statistical analysis 
#first use the raw_data dataframe to create a new dataframe to use for stats 
stats_df <- raw_data[,c(1,2,3,10)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 




stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 
model <- aov(percent_fluorescence ~ (strain*time) + 












               c("strain.timewt.30 - strain.timeire1.30 = 0", 
                 "strain.timewt.30 - strain.timepig3.30 = 0", 
                 "strain.timewt.30 - strain.timebi1.30 = 0", 
                 "strain.timewt.60 - strain.timeire1.60 = 0", 
                 "strain.timewt.60 - strain.timepig3.60 = 0", 
                 "strain.timewt.60 - strain.timebi1.60 = 0", 
                 "strain.timewt.90 - strain.timeire1.90 = 0", 
                 "strain.timewt.90 - strain.timepig3.90 = 0", 
                 "strain.timewt.90 - strain.timebi1.90 = 0", 
                 "strain.timewt.120 - strain.timeire1.120 = 0", 
                 "strain.timewt.120 - strain.timepig3.120 = 0", 
                 "strain.timewt.120 - strain.timebi1.120 = 0")),  
        test = adjusted(type = "holm")) 
 










raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 








(raw_data$auto_counted_cells_total + raw_data$uncounted_total_cells - 
raw_data$miscounted_total_cells)*100)) 
 




summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_fluorescence = mean(percent_fluorescence), 
            stderror_fluorescence = sd(percent_fluorescence)/sqrt(n())) 
 
#make the plot first 
plot <- ggplot(summ_data, aes(x=time,y=mean_fluorescence,colour=strain)) 
 
#make the plot theme 
complete_plot <- plot + theme(panel.border = element_rect(colour = "black", 
fill = NA), 
                              panel.background = element_rect(fill = "white", colour = 
"grey"), 
                              panel.grid.major.x = element_blank(),  
                              panel.grid.major.y = element_line(colour = "grey", 
linetype = "solid", size=0.1), 
                              axis.text = element_text(size=9), 
                              axis.title = element_text(size=12), 





                              axis.line.y = element_line(colour = "black", linetype = 
"solid"), 
                              axis.ticks.x = element_line(size = 0.5), 
                              axis.ticks.y = element_blank(), 
                              legend.key = element_rect(fill = "white", colour = "white"), 
                              legend.box.margin = margin(t = 2, r = 2, b = 2, l = 2, unit 
= "pt"), 
                              legend.box.background = element_rect(colour = "black"), 
                              legend.text = element_text(face="italic", size =10)) +  
   
  #then change the axes values and labels 
  scale_x_continuous(breaks = c(0,60,120,180,240), expand = c(0,3)) + 
  scale_y_continuous(limits = c(0, 105), breaks = 
c(0,10,20,30,40,50,60,70,80,90,100,110), expand = c(0,0)) + 
  labs(x="Time (minutes)", y = "Percentage of Fluorescent Cells") + 
   
  #then customize how the plots will look. error bars layed down first, then 
the line,  
  #then the black outline for each dot, then the colored dots on top of 
everything.  
  geom_vline(xintercept=120, linetype=3) + 
  geom_label(aes(x=155, label="Removal from \nHeat Stress", y=95), 
colour="black", angle=0, size=3.5) + 
  geom_segment(aes(x = 135, y = 95, xend = 120, yend =95, colour = 
"black"), 
               arrow = arrow(length = unit(0.2, "cm")),colour = "black") + 
  geom_errorbar(aes(ymin=mean_fluorescence - stderror_fluorescence, 
                    ymax=mean_fluorescence + stderror_fluorescence), 
                width=2) + 
  geom_line() + 
  geom_point(colour = "black", size=1.5) + 
  geom_point(size = 1.2) + 








stats_df <- raw_data[,c(1,2,3,10)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 
#turn the time points into factors, since I used numerical values 
stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 
model <- aov(percent_fluorescence ~ (strain*time) + 












               c("strain.timewt.60 - strain.timeire1.60 = 0", 
                 "strain.timewt.60 - strain.timepig3.60 = 0", 
                 "strain.timewt.60 - strain.timebi1.60 = 0",       
                 "strain.timewt.120 - strain.timeire1.120 = 0", 
                 "strain.timewt.120 - strain.timepig3.120 = 0", 
                 "strain.timewt.120 - strain.timebi1.120 = 0", 
                 "strain.timewt.180 - strain.timeire1.180 = 0", 
                 "strain.timewt.180 - strain.timepig3.180 = 0", 
                 "strain.timewt.180 - strain.timebi1.180 = 0", 
                 "strain.timewt.240 - strain.timeire1.240 = 0", 
                 "strain.timewt.240 - strain.timepig3.240 = 0", 
                 "strain.timewt.240 - strain.timebi1.240 = 0")),  












raw_data <- read.csv(file="/Users/mattbreuer/Dropbox/Thesis/II - Mutant 








summ_data <- raw_data %>% 
  group_by(time,strain) %>% 
  summarise(mean_area = mean(total_area), 
            stderror_total_area = sd(total_area)/sqrt(n())) 
 
#first use the raw_data dataframe to create the dataframe to use for boxplot 
boxplot_df <- raw_data[,c(1,2,3,5)] 
 
#then add a column to the boxplot dataframe, specifying the combination of 
the independent variables (strain and time) for each row 
boxplot_df$strain.time <- interaction(boxplot_df$strain, boxplot_df$time) 
 
#then create and save the boxplot 
box_plot <- ggplot(boxplot_df, aes(x = strain.time, y = total_area, fill = 
strain)) + 
  geom_boxplot() + 
  theme(panel.border = element_rect(colour = "black", fill = NA), 
        panel.background = element_rect(fill = "white", colour = "grey"), 
        panel.grid.major.x = element_blank(),  





        axis.text = element_text(size=10), 
        axis.text.x = element_text(face="italic"), 
        axis.title = element_text(size=13), 
        axis.line.x = element_line(colour = "black", linetype = "solid"), 
        axis.line.y = element_line(colour = "black", linetype = "solid"), 
        axis.ticks.x = element_line(size = 0.5), 
        axis.ticks.y = element_blank(), 
        legend.box.background = element_rect(), 
        legend.key = element_rect(fill = "white", colour = "white"), 
        legend.text = element_text(face="italic", size = 10)) + 
  coord_cartesian(xlim = NULL, ylim = c(0, 6.5)) + 
  scale_y_continuous(breaks = c(0,1,2,3,4,5,6,7), expand = c(0,0)) + 
  scale_x_discrete(labels = c("wt.0" = "wt", 
                              "bi1.0" = "bi1", 
                              "ire1.0" = "ire1", 
                              "pig3.0" = "pig3", 
                              "wt.30" = "wt", 
                              "bi1.30" = "bi1", 
                              "ire1.30" = "ire1", 
                              "pig3.30" = "pig3", 
                              "wt.60" = "wt", 
                              "bi1.60" = "bi1", 
                              "ire1.60" = "ire1", 
                              "pig3.60" = "pig3", 
                              "wt.90" = "wt", 
                              "bi1.90" = "bi1", 
                              "ire1.90" = "ire1", 
                              "pig3.90" = "pig3", 
                              "wt.120" = "wt", 
                              "bi1.120" = "bi1", 
                              "ire1.120" = "ire1", 
                              "pig3.120" = "pig3", 
                              "wt.150" = "wt", 
                              "bi1.150" = "bi1", 
                              "ire1.150" = "ire1", 




                              "wt.180" = "wt", 
                              "bi1.180" = "bi1", 
                              "ire1.180" = "ire1", 
                              "pig3.180" = "pig3"),  
                   expand = c(0.025,0)) + 
  labs(x="Strain", y = "Area (Relative)") + 
  facet_grid(. ~ time, labeller = label_both, scales = "free") + 
  theme(strip.text.x = element_text(size = 11, colour = "black", angle = 0)) + 
  geom_label(aes(label="Removal from \nHeat Stress", y=6), colour="black", 
angle=0, size=3.5) + 
  ggsave("~/Desktop/boxplot_test.tiff", width = 12, height = 6, dpi = 1500) 
 
###statistical analysis 
#first use the raw_data dataframe to create a new dataframe to use for stats 
stats_df <- raw_data[,c(1,2,3,5)] 
 
#relevel the dataframe to use the wt strain as the reference 
stats_df <- mutate(stats_df, strain = relevel(strain, ref = "wt")) 
 
#turn the time points into factors, since I used numerical values 
stats_df$time <- factor(stats_df$time) 
 
#carry out the anova 









m <- lmer(total_area ~ strain.time + (1 | replicate:strain) + (1 | replicate:time), 
stats_df) 
summary(glht(m, linfct= 




                 "strain.timewt.30 - strain.timepig3.30 = 0", 
                 "strain.timewt.30 - strain.timebi1.30 = 0", 
                 "strain.timewt.60 - strain.timeire1.60 = 0", 
                 "strain.timewt.60 - strain.timepig3.60 = 0", 
                 "strain.timewt.60 - strain.timebi1.60 = 0",       
                 "strain.timewt.90 - strain.timeire1.90 = 0", 
                 "strain.timewt.90 - strain.timepig3.90 = 0", 
                 "strain.timewt.90 - strain.timebi1.90 = 0",   
                 "strain.timewt.120 - strain.timeire1.120 = 0", 
                 "strain.timewt.120 - strain.timepig3.120 = 0", 
                 "strain.timewt.120 - strain.timebi1.120 = 0", 
                 "strain.timewt.180 - strain.timeire1.180 = 0", 
                 "strain.timewt.180 - strain.timepig3.180 = 0", 
                 "strain.timewt.180 - strain.timebi1.180 = 0")),  
































Results of Statistical Analysis 
 
Annexin V 
Results of ANOVA 
Error: replicate      
 Df Sum_Sq Mean_Sq F_Value Pr(>F)  
Residuals 1 136 136    
 
      
Error: replicate:strain      
 Df Sum_Sq Mean_Sq    
strain 3 6812 2270    
 
      
Error: replicate:time      
 Df Sum_Sq Mean_Sq    
time 4 49544 12386    
 
      
Error: replicate:strain:time     
 Df Sum_Sq Mean_Sq    
strain:time 12 5264 438.7 
 
Error: Within      
 Df Sum_Sq Mean_Sq F-value  Pr(>F) Significance 
strain 3 1287 428.9 10.93 0.000183 *** 
time 4 9435 2358.7 60.08 7.33E-11 *** 
strain:time 12 1630 135.8 3.46 0.006976 ** 
Residuals 20 785 39.3    
---       
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 






Results of Post-Hoc Contrasts 
Simultaneous Tests for General Linear Hypotheses 
 
Linear Hypotheses:     
 Estimate Std_Error z-value Pr(>|z|) Significance 
strain.timewt.60 - 
strain.timeire1.60 == 0 -0.367 5.21E+00 -7.00E-02 1 
 
strain.timewt.60 - 
strain.timepig3.60 == 0 -1.119 5.209 -0.215 1 
 
strain.timewt.60 - 
strain.timebi1.60 == 0 2.909 5.209 0.558 1 
 
strain.timewt.120 - 
strain.timeire1.120 == 0 -4.236 5.209 -0.813 1 
 
strain.timewt.120 - 
strain.timepig3.120 == 0 8.095 5.21E+00 1.55E+00 0.601 
 
strain.timewt.120 - 
strain.timebi1.120 == 0 41.188 5.209 7.908 2.40E-14 *** 
strain.timewt.180 - 
strain.timeire1.180 == 0 26.017 5.209 4.995 3.53E-06 *** 
strain.timewt.180 - 
strain.timepig3.180 == 0 43.087 5.209 8.272 2.22E-15 *** 
strain.timewt.180 - 
strain.timebi1.180 == 0 55.24 5.21E+00 1.06E+01 < 2e-16 *** 
strain.timewt.240 - 
strain.timeire1.240 == 0 30.381 5.209 5.833 3.81E-08 *** 
strain.timewt.240 - 
strain.timepig3.240 == 0 34.038 5.209 6.535 5.09E-10 *** 
strain.timewt.240 - 
strain.timebi1.240 == 0 59.365 5.209 11.397 < 2e-16 *** 
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  






Results of ANOVA 
Error: replicate      
 Df Sum_Sq Mean_Sq F-Value Pr(>F)  
Residuals 1 34 34    
 
      
Error: replicate:strain      
 Df Sum_Sq Mean_Sq    
strain 3 63.03 21.01    
 
      
Error: replicate:time      
 Df Sum_Sq Mean_Sq    
time 6 106454 17742    
 
      
Error: replicate:strain:time     
 Df Sum_Sq Mean_Sq    
strain:time 18 1241 68.94    
 
      
Error: Within      
 Df Sum_Sq Mean_Sq F-Value Pr(>F) Significance 
strain 3 24 8 1.128 0.3546 
time 6 19445 3241 453.736 <2e-16 *** 
strain:time 18 249 14 1.94 5.61E-02 . 
Residuals 28 200 7    
---       






Results of Post-Hoc Contrasts 
 Simultaneous Tests for General Linear Hypotheses 
 
Linear Hypotheses:     
 Estimate Std_Error z-value Pr(>|z|) Significance 
strain.timewt.30 - 
strain.timeire1.30 == 0 -3.45347 2.01904 -1.71 1 
 
strain.timewt.30 - 
strain.timepig3.30 == 0 -4.28793 2.02E+00 -2.12E+00 0.505 
 
strain.timewt.30 - 
strain.timebi1.30 == 0 12.42874 2.01904 6.156 1.27E-08 *** 
strain.timewt.60 - 
strain.timeire1.60 == 0 10.88579 2.01904 5.392 1.12E-06 *** 
strain.timewt.60 - 
strain.timepig3.60 == 0 -3.37246 2.01904 -1.67 1 
 
strain.timewt.60 - 
strain.timebi1.60 == 0 0.87 2.02E+00 4.31E-01 1 
 
strain.timewt.90 - 
strain.timeire1.90 == 0 1.96083 2.02E+00 9.71E-01 1 
 
strain.timewt.90 - 
strain.timepig3.90 == 0 -3.79664 2.02E+00 -1.88E+00 0.841 
 
strain.timewt.90 - 
strain.timebi1.90 == 0 -14.80224 2.02E+00 -7.33E+00 4.10E-12 *** 
strain.timewt.120 - 
strain.timeire1.120 == 0 0.02267 2.01904 0.011 1 
 
strain.timewt.120 - 
strain.timepig3.120 == 0 -0.73855 2.01904 -0.366 1 
 
strain.timewt.120 - 
strain.timebi1.120 == 0 -2.93006 2.01904 -1.451 1 
 
strain.timewt.150 - 
strain.timeire1.150 == 0 -0.36866 2.01904 -0.183 1 
 
strain.timewt.150 - 
strain.timepig3.150 == 0 
-0.12112 
2.01904 -0.06 1 
 
strain.timewt.150 - 
strain.timebi1.150 == 0 -0.8987 2.01904 -0.445 1 
 
strain.timewt.180 - 
strain.timeire1.180 == 0 -0.11958 2.01904 -0.059 1 
 
strain.timewt.180 - 






strain.timebi1.180 == 0 -0.29238 2.01904 -0.145 1  
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  






Results of ANOVA 
Error: replicate      
 Df Sum_Sq Mean_Sq F-Value Pr(>F)  
Residuals 1 2.58E+13 2.58E+13    
 
      
Error: replicate:strain      
 Df Sum_Sq Mean_Sq    
strain 3 3.51E+12 1.17E+12    
 
      
Error: replicate:time      
 Df Sum_Sq Mean_Sq    
time 6 1.13E+15 1.88E+14    
 
      
Error: replicate:strain:time     
 Df Sum_Sq Mean_Sq    
strain:time 18 7.51E+12 4.17E+11    
 
      
Error: Within      
 Df Sum_Sq Mean_Sq F-Value Pr(>F) Significance 
strain 3 1.44E+11 4.81E+10 0.078 0.971 
time 6 2.34E+14 3.89E+13 62.95 5.84E-15 *** 
strain:time 18 5.81E+12 3.23E+11 0.523 9.23E-01 
 
Residuals 28 1.73E+13 6.18E+11 
   
---       






Results of Post-Hoc Contrasts 
 Simultaneous Tests for General Linear Hypotheses 
 
Linear Hypotheses:     
 Estimate Std_Error z-value Pr(>|z|) Significance 
strain.timewt.1 - 
strain.timeire1.1 == 0 120000 617626 0.194 1 
 
strain.timewt.1 - 
strain.timepig3.1 == 0 -33333 617626 -0.054 1 
 
strain.timewt.1 - 
strain.timebi1.1 == 0 146667 617626 0.237 1 
 
strain.timewt.2 - 
strain.timeire1.2 == 0 -1246667 617626 -2.018 0.61 
 
strain.timewt.2 - 
strain.timepig3.2 == 0 -566667 617626 -0.917 1 
 
strain.timewt.2 - 
strain.timebi1.2 == 0 -1080000 617626 -1.749 1 
 
strain.timewt.3 - 
strain.timeire1.3 == 0 -800000 617626 -1.295 1 
 
strain.timewt.3 - 
strain.timepig3.3 == 0 -826667 617626 -1.338 1 
 
strain.timewt.3 - 
strain.timebi1.3 == 0 -1446667 617626 -2.342 0.287 
 
strain.timewt.4 - 
strain.timeire1.4 == 0 -240000 617626 -0.389 1 
 
strain.timewt.4 - 
strain.timepig3.4 == 0 -413333 617626 -0.669 1 
 
strain.timewt.4 - 
strain.timebi1.4 == 0 -640000 617626 -1.036 1 
 
strain.timewt.5 - 
strain.timeire1.5 == 0 66667 617626 0.108 1 
 
strain.timewt.5 - 
strain.timepig3.5 == 0 -360000 617626 -0.583 1 
 
strain.timewt.5 - 
strain.timebi1.5 == 0 -320000 617626 -0.518 1 
 
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  






Results of ANOVA 
Error: replicate      
 Df Sum_Sq Mean_Sq    
strain 1 3.71E-02 3.71E-02    
 
      
Error: 
replicate:strain      
 Df Sum_Sq Mean_Sq    
strain 3 2.15E+00 7.17E-01    
 
      
Error: replicate:time      




1    
time 5 222.19 44.44    
 
      
Error: replicate:strain:time     
 Df Sum_Sq Mean_Sq    
strain 1 0.407 0.4074    
strain:time 17 10.485 0.6168 
 
Error: Within      
 Df Sum_Sq Mean_Sq F-Value Pr(>F) Significance 





0 135.935 <2e-16 *** 
strain:time 18 5.51 0.306 4.727 0.000129 *** 
Residuals 28 1.81 0.065 
   
---       
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 






Results of Post-Hoc Contrasts 
 Simultaneous Tests for General Linear Hypotheses 
 
Linear Hypotheses:     
 Estimate Std_Error z-value Pr(>|z|) Significance 
strain.timewt.30 - 
strain.timeire1.30 == 0 -0.60833 0.27979 -2.174 0.386 
 
strain.timewt.30 - 
strain.timepig3.30 == 0 -2.56867 0.27979 -9.181 < 2e-16 *** 
strain.timewt.30 - 
strain.timebi1.30 == 0 -1.52033 0.27979 -5.434 7.72E-07 *** 
strain.timewt.60 - 
strain.timeire1.60 == 0 0.19967 0.27979 0.714 1 
 
strain.timewt.60 - 
strain.timepig3.60 == 0 -0.404 0.27979 -1.444 1 
 
strain.timewt.60 - 
strain.timebi1.60 == 0 -0.126 0.27979 -0.45 1 
 
strain.timewt.90 - 
strain.timeire1.90 == 0 -0.23933 0.27979 -0.855 1 
 
strain.timewt.90 - 
strain.timepig3.90 == 0 -0.18867 0.27979 -0.674 1 
 
strain.timewt.90 - 
strain.timebi1.90 == 0 -0.18667 0.27979 -0.667 1 
 
strain.timewt.120 - 
strain.timeire1.120 == 0 -0.07633 0.27979 -0.273 1 
 
strain.timewt.120 - 
strain.timepig3.120 == 0 -0.29133 0.27979 -1.041 1 
 
strain.timewt.120 - 
strain.timebi1.120 == 0 0.01367 0.27979 0.049 1 
 
strain.timewt.180 - 
strain.timeire1.180 == 0 -0.137 0.27979 -0.49 1 
 
strain.timewt.180 - 
strain.timepig3.180 == 0 -0.15967 0.27979 -0.571 1 
 
strain.timewt.180 - 
strain.timebi1.180 == 0 -0.08067 0.27979 -0.288 1 
 
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1  






Results of ANOVA 
Error: replicate      
 Df Sum_Sq Mean_Sq F-Value Pr(>F)  
Residuals 1 5.75E+01 5.75E+01    
 
      
Error: replicate:strain      
 Df Sum_Sq Mean_Sq    
strain 3 2.24E+02 7.47E+01    
 
      
Error: replicate:time      
 Df Sum_Sq Mean_Sq    
time 4 2.78E+04 6.94E+03    
 
      
Error: replicate:strain:time     
 Df Sum_Sq Mean_Sq    
strain:time 12 1.35E+04 1.13E+03    
 
      
Error: Within      
 Df Sum_Sq Mean_Sq F-Value Pr(>F) Significance 
strain 3 4.60E+01 1.53E+01 0.384 0.7657 
time 4 5.75E+03 1.44E+03 36.041 7.05E-09 *** 
strain:time 12 2.24E+03 1.87E+02 4.686 1.20E-03 ** 
Residuals 20 7.98E+02 3.99E+01 
   
---       






Results of Post-Hoc Contrasts 
 Simultaneous Tests for General Linear Hypotheses 
Linear Hypotheses:      
 Estimate Std_Error z-value Pr(>|z|) Significance 
strain.timewt.30 - 
strain.timeire1.30 == 0 63.643 3.985 15.97 <2e-16 *** 
strain.timewt.30 - 
strain.timepig3.30 == 0 63.942 3.985 16.045 <2e-16 *** 
strain.timewt.30 - 
strain.timebi1.30 == 0 37.396 3.985 9.384 <2e-16 *** 
strain.timewt.60 - 
strain.timeire1.60 == 0 -5.891 3.985 -1.478 0.4181 
 
strain.timewt.60 - 
strain.timepig3.60 == 0 -7.257 3.985 -1.821 0.3431 
 
strain.timewt.60 - 
strain.timebi1.60 == 0 -4.755 3.985 -1.193 0.4656 
 
strain.timewt.90 - 
strain.timeire1.90 == 0 -64.299 3.985 -16.134 <2e-16 *** 
strain.timewt.90 - 
strain.timepig3.90 == 0 -51.06 3.985 -12.812 <2e-16 *** 
strain.timewt.90 - 
strain.timebi1.90 == 0 -53.849 3.985 -13.512 <2e-16 *** 
strain.timewt.120 - 
strain.timeire1.120 == 0 -3.588 3.985 -0.9 0.4656 
 
strain.timewt.120 - 
strain.timepig3.120 == 0 -10.308 3.985 -2.586 0.0582 . 
strain.timewt.120 - 
strain.timebi1.120 == 0 -6.897 3.985 -1.731 0.3431 
 
---      
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1   






Results of ANOVA 
 Df  Sum_Sq  Mean_Sq  F‐value  Pr(>F)  Significance 
Residuals  1  4.701  4.701      
       
       
 Df  Sum_Sq  Mean_Sq      
strain  3  7288  2429      
       
       
 Df  Sum_Sq  Mean_Sq      
time  6  34661  5777      
       
       
 Df  Sum_Sq  Mean_Sq      
strain:time  18  8953  497.4      
       
       
 Df  Sum_Sq  Mean_Sq  F‐value  Pr(>F)   
strain  3  1593  530.8  93.54  1.06E‐14  *** 
time  6  5787  964.6  169.97  <2.0E‐16  *** 
strain:time  18  2547  141.5  24.94  1.18E‐12  *** 
Residuals  28  159  5.7      
‐‐‐         






Results of Post-Hoc Contrasts  
 Simultaneous Tests for General Linear Hypotheses 
Linear Hypotheses:       
 Estimate  Std. Error  z value  Pr(>|z|)  Significance 
strain.timewt.30 ‐ 
strain.timeire1.30 == 0  0.7359  2.5368  0.29  1   
strain.timewt.30 ‐ 
strain.timepig3.30 == 0  3.5045  2.5368  1.381  0.66855   
strain.timewt.30 ‐ 
strain.timebi1.30 == 0  0.5101  2.5368  0.201  1   
strain.timewt.60 ‐ 
strain.timeire1.60 == 0  4.1492  2.5368  1.636  0.5096   
strain.timewt.60 ‐ 
strain.timepig3.60 == 0  11.9458  2.5368  4.709  2.24E‐05  *** 
strain.timewt.60 ‐ 
strain.timebi1.60 == 0  6.4741  2.5368  2.552  0.07496  . 
strain.timewt.90 ‐ 
strain.timeire1.90 == 0  ‐2.8254  2.5368  ‐1.114  0.79611   
strain.timewt.90 ‐ 
strain.timepig3.90 == 0  15.52  2.5368  6.118  9.48E‐09  *** 
strain.timewt.90 ‐ 
strain.timebi1.90 == 0  4.9373  2.5368  1.946  0.30973 
strain.timewt.120 ‐ 
strain.timeire1.120 == 0  9.8931  2.5368  3.9  0.00077  *** 
strain.timewt.120 ‐ 
strain.timepig3.120 == 0  17.4135  2.5368  6.864  7.34E‐11  *** 
strain.timewt.120 ‐ 
strain.timebi1.120 == 0  44.8609  2.5368  17.684  < 2e‐16  *** 
strain.timewt.150 ‐ 
strain.timeire1.150 == 0  18.9602  2.5368  7.474  1.01E‐12  *** 
strain.timewt.150 ‐ 
strain.timepig3.150 == 0  17.6055  2.5368  6.94  4.70E‐11  *** 
strain.timewt.150 ‐ 
strain.timebi1.150 == 0  63.8686  2.5368  25.177  < 2e‐16  *** 
strain.timewt.180 ‐ 
strain.timeire1.180 == 0  25.5299  2.5368  10.064  < 2e‐16  *** 
strain.timewt.180 ‐ 
strain.timepig3.180 == 0  28.7827  2.5368  11.346  < 2e‐16  *** 
strain.timewt.180 ‐ 
strain.timebi1.180 == 0  76.627  2.5368  30.206  < 2e‐16  *** 
‐‐‐        
Signif. codes:  0 ‘***’ 0.001 ‘**’ 0.01 ‘*’ 0.05 ‘.’ 0.1 ‘ ’ 1   
(Adjusted p values reported ‐‐ holm method)     
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